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Summary
The insulin sensitive hexose transport system of the isolated 
rat adipocyte has been studied. 3-0-methyl-D-glucose, D-allose and 
D-xylose are all transported by the hexose transport system.
By studying the inhibition of D-allose transport by a range of 
hexose analogues the hydrogen bonding and spatial requirements of the 
transporter have been investigated. The transporter accepts the hexose 
molecule in a pyranose ring form. The results indicate that the important 
hydrogen bonding positions are the ring oxygen, C-1 and C-3. There may be 
a weaker hydrogen bond to C-6. Sugar hydroxyls in non-glucose configurations 
may sterically hinder transport. The inhibition by alkyl substituted 
hexoses indicates that the hexose transporter requires a specific orient­
ation of the hexose molecule as it approaches the external binding site.
C-1 faces the transporter whilst C-4 faces the external solution. When 
the hexose molecule is bound to the hexose transporter there is little 
space around C-1 and C-2. There is more space around C-3, C-4 and C-6 
with the possibility of a hydrophobic region adjacent to 6-6.
4,6-0-ethylidene-D-glucose and alkyl-g-D-glucosides enter the 
adipocyte independently of the hexose transport system. The results 
indicate that 4,6-0-ethylidene-D-glucose is a good side specific analogue 
with a high affinity for the external site. In contrast alkyl-g-D-gluco-
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sides are good side specific inhibitors^of the hexose transport system.
Both 4,6-0-ethylidene-D-glucose and n'-propyl-&-D-glucoside are competitive 
inhibitors of the hexose transport system.
Treatment of basal adipocytes with lOnM insulin can lead to a 
50-fold stimulation of hexose transport. The hydrogen bonding and spatial 
requirements of the hexose transporter are unchanged by insulin.
D-glucose and 2-deoxy-D-glucose showed reduced inhibition of 
D-allose transport when the intracellular ATP levels were depleted by 
cyanide poisoning. There was no effect of cyanide on the inhibition of 
transport by 3-0-methyl-D-glucose. This result suggests a possible effect 
of hexose metabolites on the hexose transporter.
A range of purine and pyrimidine nucleosides, nucleotides and 
cyclic nucleotides were tested for possible effects on hexose transport 
when added exogenously to adipocyte suspensions. Adenosine (lOpM) and 
inosine (O.lmM) were found to give small stimulations of hexose transport 
in basal adipocytes. Xanthine stimulated hexose transport in basal adi- 
pocytes and inhibited transport in tnsuU,\ cells. Exogenous ATP inhibited 
hexose transport in insulin-stimulated cells. Cyclic nucleotides did not 
affect the rate of hexose transport in adipocytes.
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The membrane surrounding a cell provides a barrier separating 
the cell contents from the external environment allowing the cell to 
maintain a constant internal environment. This barrier cannot be 
totally impermeable and arrangements must be made to allow for the 
controlled passage of substrates and waste products.through the 
membrane.
The structure of biological membranes
The study of the composition of biological membranes from a 
wide variety of sources show membranes to contain approximately 40% 
of their dry weight as lipid and 60% as protein. There is also a 
small percentage of carbohydrate present. In addition, native membranes 
contain approximately 20% of their total weight as water which is 
tightly bound and essential for the maintenance of membrane structure.
Phospholipids isolated from biological membranes are polar 
lipids with a hydrophobic tail group and a hydrophilic head group.
Most models for membrane structure incorporate a lipid bilayer arrange­
ment where the aliphatic chains are sequestered within the interior 
of the membrane and the hydrophilic heads face the aqueous solution.
This structure is maintained by entropie factors rather than specific 
hydrophobic interactions.
In addition to glycerol based phospholipids, sphingamine 
derivatives and sterol derivatives are also present. The properties 
of the membrane, for example the fluidity of the hydrophobic core, 
are determined by the ratio of these components in the membrane.
2.
Current views on the structure of biological membranes are 
based on the fluid mosaic model of Singer & Nicolson (1972). In this 
model globular proteins are embedded in a lipid bilayer. Some of 
these proteins are able to span the membrane and are accessible at 
both faces. In this model the hydrophilic portions of both lipids 
and proteins are in contact with the aqueous surroundings whilst the 
non polar portions are sequestered in the interior of the membrane 
away from water. A schematic representation of the fluid mosaic model 
is shown in Fig. 1.
In addition to the closely associated intrinsic protein 
molecules, which are embedded in the membrane and interact with hydro- 
phobic regions, other protein molecules are believed to be; associated 
with the polar head groups of the lipid bilayer. It is believed that 
these extrinsic proteins are attached to the membrane by electrostatic 
interactions. Thus some membrane proteins can be removed by increases 
in ionic strength or enzymic removal of polar head groups, but a large 
proportion of the membrane proteins are intimately associated with the 
membrane and can only be removed by complete disruption of the membrane 
by detergents.
At physiological temperatures the hydrocarbon chains of the
lipids are mobile within the bilayer, whereas at lower temperatures the
hydrocarbon chains form semi crystalline regions which give the membrane
gel-like properties. Thus,at physiological temperatures,intrinsic
proteins are free to move in the plane of the membrane. The lateral
diffusion coefficient of intrinsic membrane proteins has been estimated 
-10 2 -1as 2 X 10 cm sec which is slower than that of phospholipids 
-8 2 - 1(2 X 10 cm sec ) (Harrison & Lunt, 1975). There is, however, considerable
3.
Fig. 1. The Singer Nicolson fluid mosaic model for the structure 
of biological membranes
O O QQ
A schematic representation of a section through a biological 
membrane to illustrate the main features
(1) Phospholipid molecules forming bilayer
(2) Intrinsic membrane proteins spanning bilayer
(3) Intrinsic protein molecule which is accessible from one face only.
(4) Extrinsic membrane proteins associated with both phospholipids and
intrinsic proteins.
(5) Carbohydrate residues on an intrinsic membrane protein. These 
residues are usually found on the outer face of the membrane.
4.
variation in the rate of lateral diffusion of different proteins within 
a membrane, an important factor being association with other proteins 
in the membrane. There is, for example, evidence that the intrinsic 
band III glycoprotein of the erythrocyte membrane is associated with 
the extrinsic protein spectrin. In some cell types it is important 
that the lateral diffusion of protein molecules is controlled; 
intestinal cells, for example, segregate two different hexose transport 
activities at opposite ends of the cell.
Facilitated diffusion 
The passage of a solute through the cell membrane requires it 
to enter the hydrophobic lipid region of the membrane and pass through 
it in order to enter the solution on the opposite side. Observations 
of biological transport processes indicate that specific substrates 
are transported in a manner markedly different from simple diffusion 
through the lipid bilayer. Danielli (1954) named this process for the 
energy independent transport of selected compounds ’facilitated 
diffusion’.
Facilitated diffusion systems for the transport of a range of 
substrates are present in most mammalian cell types. All facilitated 
diffusion systems utilise an existing electrochemical gradient bringing 
about transfer of solute from regions of high concentration to low. 
Facilitated diffusion systems, including the adipocyte and erythrocyte 
hexose transport systems, show the following features
(1) The penetration rate of specific substrates into cells
containing a facilitated diffusion system is considerably faster 
than the rate calculated on the basis of the number of hydrogen 
bonding groups present on the substrate molecule. For example.
5.
D-glucose penetrates human and rabbit erythrocytes considerably 
faster than would be expected for penetration by simple diffusion 
(Laris, 1958). This rate is also faster than that calculated for 
diffusion through non specific aqueous channels in the membrane 
(Sha'afi et al ., 1971).
(2) Facilitated diffusion systems are stereospecific for their sub­
strates. For example L-glucose penetrates the erythrocyte mem­
brane very slowly when compared to D-glucose. Simple diffusion 
systems would be expected to be unable to distinguish between 
stereoisomers, giving similar rates for both isomers.
(3) The rate of penetration of a substrate through a facilitated 
diffusion system is not directly proportional to the concentration 
as predicted by Ficks law of diffusion (Fick, 1855). Instead the 
rate reaches a limiting rate as the substrate concentration is 
raised (Le Fevre, 1954, and Widdas, 1954). This observation 
suggests that the substrate interacts with a limited number of 
membrane sites responsible for transport. Simple kinetic analysis 
of the erythrocyte hexose transport system and other facilitated 
diffusion systems show the flux (u) to be given by an equation of 
the form:
u = S . Vmax (1)
Km + S
Where S is the substrate concentration, Vmax and Km are constants 
unique to any transporter/substrate combination, Vmax is the 
maximal velocity of transfer and Km the substrate concentration 
at which half maximal velocity is achieved. Both Km and Vmax 
are analagous to the Michaelis Menten constants for an enzymic 
reaction.
6.
(A) The rate of facilitated diffusion is competitively inhibited by
molecules which possess a similar structure to the substrate.
Competitive inhibition of hexose transport in the erythrocyte 
was first established by Le Fevre & Davies (1951) .
(5) Non-competitive inhibition of penetration has also been observed 
with molecules which interact irreversibly with the membrane. 
Mercuric chloride irreversibly inhibits hexose transport in 
erythrocytes under conditions where no gross morphological 
change in the membrane is caused (Van Steveninck et al., 1965).
(6) Under certain circumstances it is possible to link the movement
of one substrate down its electrochemical gradient with the move­
ment of a structurally similar molecule which is driven up its 
electrochemical gradient. This process of counterflow was first 
described by Rosenberg & Wilbrandt (1957) for the uphill transport 
of D-glucose in the presence of a gradient of D-mannose or un­
labelled D-glucose across the erythrocyte membrane. This experiment 
indicates the presence of sugar binding sites at both surfaces of 
the transport system; either one facing inward with the other 
facing outward, or a single site which is alternately available
at the inner and outer surfaces.
7.
Kinetic measurements of facilitated diffusion
A number of different experimental protocols are available 
to study the kinetics of facilitated diffusion. Eilam & Stein (1973) 
described a nomenclature for such protocols. The transport of a 
substrate from one face of the membrane (cis) to the opposite face of 
the membrane (trans) is followed. The most commonly used method of 
measuring transport rates is to follow the flux of a radiolabelled 
substrate into (entry) or out of the cell (exit). In order to measure 
unidirectional flux it is necessary to measure initial rates of trans­
port. The initial rate of transport can be determined either by the 
use of very short uptake periods or by the use of integrated rate 
equations which compensate for the backflux that occurs with longer 
uptakes.
Zero trans experiments. In these experiments the initial rate of flux 
of substrate is measured when there is no substrate at the opposite 
face of the membrane. These experiments give the Km and Vmax for influx 
and efflux.
Equilibrium exchange. In these experiments the initial rates of uni­
directional flux of substrate are measured when the substrate concentration is 
same on both sides of the membrane. Under these conditions there is no 
net transfer of substrate and the rates of entry and exit are therefore 
equal for a non-accumulating system. These experiments give the Km and 
Vmax for equilibrium exchange.
Infinite cis experiments. In these experiments the net flux is measured 
when the substrate concentration on the cis face of the membrane (outside 
for infinite cis entry, inside for infinite cis exit) is at a saturating 
concentration, which is at least 10 times the zero trans Km. Infinite cis
8.
experiments measure the Km for the trans site. Sen & Widdas (1960a) 
described a method for performing infinite cis exit experiments in 
erythrocytes using an osmotic swelling method. Cells were loaded with 
a high concentration of sugar and the rate of efflux into solutions 
containing low concentrations of sugar was followed. With this method 
the substrate concentration which gives half maximal inhibition of 
efflux is equivalent to the Km for backflux using the external site.
Infinite trans experiments. In these experiments the substrate con­
centration at the trans face of the membrane (inside for infinite trans 
entry, outside for infinite trans exit) is at a saturating concentration, 
The rate of net flux from the cis face is then measured. This protocol 
is equivalent to counterflow experiments and measures the Km at the cis 
face of the membrane.
Hexose transport 
A facilitated diffusion system for the transport of hexoses is 
present in the plasma membrane of most mammalian cell types. In addition 
to facilitated diffusion processes the intestine and kidney also show 
the phenomenon of active transport. In these tissues D-glucose is 
transported against its concentration gradient.
The measurement of hexose transport is complicated by the 
difficulty of preparing isolated homogeneous cell populations and by 
the rapid metabolism of D-glucose when it enters the cell. These 
technical difficulties have been overcome in some tissues by the 
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Hexose transport in the rat adipocyte
The technical difficulties associated with the study of 
hexose transport in the rat adipocyte have only recently been overcome. 
Many of the earlier characterisations of hexose transport in adipose 
tissue have relied on indirect measurements of sugar uptake such as the 
rate of glucose oxidation. Crofford & Renold (1965) first reported the 
presence of a facilitated diffusion system in whole adipose tissue.
Rodbell (1961) has described a method for the preparation of
isolated adipocytes, in which the collagen network surrounding the cells 
was broken down by the action of a bacterial collagenase preparation. 
This method releases viable cells which respond to hormonal stimulation 
in a similar manner to intact tissue (Gliemann, 1967). The adipocyte 
contains a large lipid droplet within the cell which gives adipocytes 
a low density compared to other cell types. . This difference in den­
sities allows adipocytes to be prepared as a homogeneous population free 
from contamination by other cell types.
Since D-glucose entering the adipocyte is rapidly metabolised
it is impossible to directly study the transport of D-glucose. Since
the transport of D-glucose is rate limiting for metabolism when the 
external D-glucose concentration is below l-2iriM (Gliemann, 1968) 
transport can be followed by indirect methods such as the rate of 
D-glucose oxidation. The movement of molecules through the membrane 
transport system can be studied independently of metabolism by the use 
of D-glucose analogues which are transported but not metabolised.
The D-glucose epimer,D-allose,has been shown by Loten et al. 
(1976) to be transported by adipocytes but not metabolised. The trans­
port of D-allose is much slower than D-glucose due to the high Km of 
D-allose (> 150mM). Loten et al. showed D-allose transport to be com-
11.
petitively inhibited by D-glucose and also demonstrated counterflow 
in the presence of a D-glucose gradient. They also showed that the 
rate of D-allose transport was increased in the presence of insulin.
Foley et al. (1978) studied the transport of L-arabinose in 
the adipocyte. L-arabinose is a D-galactose analogue lacking the C-5 
hydroxymethyl group and is therefore non-metabolised. Their results 
showed that L-arabinose was transported by the hexose transport system 
and,like D-allose, L-arabinose is transported slowly due to its high Km 
(> 50mM). Foley et al. also showed L-arabinose transport to be insulin 
sensitive and competitively inhibited by D-glucose.
C-3 hydroxyméthylation of D-glucose to give 3-0-methyl-D-glucose 
does not affect the transport of the molecule by the hexose transport 
system but does prevent phosphorylation by hexokinase. When whole cells 
are incubated with 3-0-methyl-D-glucose there is little or no conversion 
to other compounds (Csaky & Wilson, 1956). Olefsky (1978) has shown that 
at equilibrium 3-0-methyl-D-glucose is in free solution within the cell 
water and in equilibrium with the suspending buffer. The high ratio of 
surface area to cytoplasmic volume in adipocytes relative to other 
cell types (Angel & Farkas, 1970) leads to a rapid equilibration of 
3-0-methyl-D-glucose between the suspending medium and cytoplasm. This 
leads to very rapid rates of uptake which have hindered study of transport. 
Recently Whitesell & Gliemann (1979) developed a new procedure for 
measuring the uptake of 3-0-methyl-D-glucose. They used the hexose 
transport inhibitor phloretin to block transport after short time inter­
vals, followed by separation of the cells from the bulk medium by rapid 
centrifugation through light oil (Gliemann et al., 1972). The results 
of Whitesell & Gliemann were similar to those of Taylor & Holman (1981)
12.
shown in Table 1. From this kinetic analysis it can be seen that the 
transport of 3-0-methyl-D-glucose is symmetrical with equal kinetic 
parameters for all the experimental protocols used. The rate of 
3-0-methyl-D-glucose transport is markedly increased in the presence of 
insulin and a number of investigators have reported that this change is 
due to an increase in the Vmax rather than a change in the Km (Czech 
(1976a); Olefsky (L978);Whitesell & Gliemann (1979); Siegel & Olefsky 
(1980) and Taylor & Holman (1981)).
The transported D-glucose analogue 2-deoxy-D-glucose is a 
substrate for hexokinase (Olefsky, 1978) and on entering the cell is 
rapidly phosphorylated to form 2-deoxy-D-glucose-6-phosphate. The 
phosphorylated sugar is not further metabolised and, since it cannot pass 
through the membrane is trapped within the cell. Thus 2-deoxy-D-glucose 
has been widely used as a means of measuring net uptake. Caution must 
however be used when interpreting the effects of these experiments as 
long incubations lead to depletion of the intracellular ATP with the 
result that the transport rate exceeds the rate of phosphorylation.
This allows backflux of 2-deoxy-D-glucose to occur. Foley et al. (1980b) 
have shown that the phosphorylation of 2-deoxy-D-glucose may become 
the rate limiting step for uptake under some circumstances. Thus the 
total uptake of 2-deoxy-D-glucose may not give a true indication of the 
transport rate.
A detailed study of the specificity of the adipocyte hexose 
transport system has not been previously performed. One of the aims of 
the study presented in this thesis is to examine the specificity of the 
adipocyte hexose transporter and to relate the results of this study to 
the hydrogen bonding and spatial requirements for binding to the hexose 
transport system. Also presented in this thesis is a study of the
13.
spatial requirements for the binding of hexoses to the hexose trans­
porter of the adipocyte.
Hexose transport in the adipocyte is markedly stimulated by 
insulin and a number of other compounds. The proposed mechanisms for 
the regulation of hexose transport in the adipocyte will be discussed 
later (see p. 55).
Hexose transport in erythrocytes
The fetalf- erythrocytes of many mammals possess a facilitated 
diffusion system for monosaccharides but in many species this activity 
declines rapidly after birth (Widdas, 1955, 1980; Aubby and Widdas, 
1980). In primates, however, the transport activity of erythrocytes 
is not lost after birth. Human erythrocytes are easily prepared in 
large quantities, and since the rate of D-glucose metabolism is low 
these cells provide an ideal system for the study of transport.
Kinetic studies of hexose transport in human erythrocytes 
have been carried out over many years using a full range of experimental 
methods. A summary of the results of kinetic analysis of D-glucose 
transport in erythrocytes is presented in Table 1. A similar pattern 
of kinetic parameters is shown with other transported hexoses, for 
example D-galactose (Ginsberg & Stein, 1975). The important features 
of kinetic analysis of human erythrocyte hexose transport are that 
zero trans experiments show asymmetric rates of transport. Thus zero- 
trans entry has a low Km and low Vmax whilst zero trans exit has a 
high Km and Vmax. The rate of equilibrium exchange is rapid with a 
high Km and Vmax. In contrast the infinite trans and infinite cis 
experiments both show symmetrical low Km values for both sides of the 
membrane.
14.
The temperature dependence of sugar transport in human 
erythrocytes was studied by Sen & Widdas (1960b and 1962a) and by 
Lacko et al. (1972). These results show the interaction of hexoses with 
the transporter to have a high activation energy atypical of free 
solution diffusion (Lieb & Stein, 1972). This is consistent with the 
formation of several hydrogen bonds between the sugar and the trans­
porter. Zala et al. (1974) measured the enthalpy of the specific inter­
action of D-glucose with the erythrocyte membrane and concluded that 
interactions other than D-glucose binding were involved. From their 
results Zala et al. inferred that a conformational change in the membrane 
occurred during hexose binding. Lacko et al. (1972) also showed that the 
change in activation energy for equilibrium exchange and infinite trans 
experiments was approximately half that for net entry. The temperature 
coefficient for net exit (Sen & Widdas 1962a)was much less than that 
for net influx (Lacko et al. 1972).and these differences indicate that 
exchange is a different process from net flux. As the temperature is 
lowered the asymmetry of hexose transport in the human erythrocyte 
increases.
Additional evidence for exchange being a different process comes 
from the observation of changes in the pH dependence of transport.
Bloch (1974) showed that the pH dependence of net flux differs from that 
for infinite trans flux. Le Fevre (1963) showed that there is no rapid 
exchange of low affinity sugars such as D-ribose or L-sorbose and, this 
suggests that high affinity sugars induce changes within the membrane 
which are not induced by low affinity sugars.
15.
The substrate specificity of the human erythrocyte hexose transport system 
Le Fevre & Marshall (1958) first studied the substrate 
specificity of the hexose transport system of the human erythrocyte.
Their results showed that the transport system accepted hexoses in the
4 . 1ring conformation. Hexoses in the .Ĉ  conformation had greatly
reduced affinity for the transport system and Le Fevre & Marshall
4
reported decreasing affinity as the relative stability of the 
conformation was reduced.
The hydrogen bonding requirements for the interaction of 
D-glucose with the human erythrocyte hexose transporter were investi­
gated by Kahlenberg & Dolansky (1972) who studied the inhibition of 
D-glucose uptake by D-glucose analogues. Kahlenberg & Dolansky also 
studied the inhibition of D-glucose binding to erythrocyte membranes 
by D-glucose analogues. In a similar study Barnett et al. (1973a) 
measured the inhibition constants of D-glucose analogues by the 
inhibition of L-sorbose entry into human erythrocytes. Both groups pro­
posed that hydrogen bonds were directed towards the hydroxyls at C-1 and 
C-3. Barnett et al. observed that fluorine substituted hexoses showed a 
higher affinity than the corresponding deoxy sugars and proposed that 
since the fluorine accepted a hydrogen bond in a similar way to the 
oxygen of the hydroxyl, hydrogen bonds were directed towards the oxygen 
of the hydroxyl. Kahlenberg & Dolansky also proposed that hydrogen 
bonds were directed towards the ring oxygen and the C-4 hydroxyl. The 
results of Barnett et al. indicated that the hydrogen bond to the C-4 
hydroxyl could also interact with the C-6 hydroxyl. Overall these 
results show that when D-glucose interacts with the hexose transport 
system of the human erythrocyte, hydrogen bonds are at some stage during 
transport directed towards the ring oxygen C-1, C-3, C-4 and C-6.but
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that none of these hydrogen bonds is essential for transport.
Lacko & Burger (1962) studied the interaction of disaccharides with 
the human erythrocyte hexose transport system. They observed that 
non-reducing disaccharides did not inhibit the transport of hexoses.
In contrast the reducing disaccharides maltose and cellobiose 
inhibited hexose transport but were not transported into the cell.
Lacko & Burger also reported that methyl glucoside did not inhibit
hexose transport and concluded that the interaction of hexoses with
the transport system occurred via the reducing residue of the disaccharide.
Baker & Widdas (1973a) reported that the glucose analogue
4,6-0-ethylidene D-glucose was an inhibitor of the erythrocyte hexose 
transport system. The rate of 4,6-0-ethylidene-D-glucose entry was much 
slower than would have been expected from its inhibition constant and 
their results suggested that 4,6-0-ethylidene-D-glucose entered the cell 
by a non-mediated route. Baker & Widdas (1973b) found that 4;6-0-ethylidene- 
Drglucose was much less effective as an inhibitor inside the cell than it 
was outside. Thus purified 4-,6-0-ethylidene-D-glucose has an asymmetry 
of affinities as high as 60-fold (Baker et al., 1978). 4,6-0-ethylidene-
D-glucose is also an asymmetric inhibitor of hexose transport in the 
erythrocytes of fetal and new born guinea pigs (Aubby & Widdas, 1980).
Barnett et al. (1973b, 1975) showed that alkyl derivatives of 
D-glucose also entered the cell by a non-mediated route. 6-0-alkyl 
derivatives were found to be inhibitors at the outside of the cell 
whereas n'-propyl-g-D-glucoside was a more effective inhibitor inside the 
cell than outside. From their results Barnett et al. (1973b, 1975) 
proposed that a glucose molecule approaching from the outside was 
bound to the active site of the transporter by the C-1 end of the 
molecule. The transporter was then proposed to undergo a conformational
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change and the glucose molecule is transferred to the inner site with 
C-1 facing the internal solution (see Fig. 2).
Evidence for two spatially different sites is consistent with 
the data of Kahlenberg & Dolansky (1972) who showed that methyl gluco- 
sides inhibited glucose binding to erythrocyte membrane fragments, 
although these compounds did not inhibit glucose transport in whole cells. 
Kahlenberg & Dolansky also showed phenyl-g-D-glucoside to be a non­
competitive inhibitor of D-glucose uptake, an observation consistent 
with the ability of C-1 modified hexoses to bind to the inside site.
In contrast to these results Novak & Le Fevre (1974) reported 
that hexoses with alkyl substitutions at both ends of the molecule were 
inhibitors of hexose transport. On the basis of the results of 
Barnett et al. (1973b, 1975) these compounds would not be expected to 
bind to either site. Baker et al. (1978) reported that 1,2-isopropylidene- 
D-glucose was an asymmetric inhibitor of hexose transport in the 
erythrocyte with a higher affinity for the outside site (Ki 59mM) 
compared to the inside site (Ki 74mM). It has also been suggested 
(Widdas, 1980) that methyl^2-3-di-0-methyl-a-D-glucopyranoside may also 
have a higher affinity for the external site.
In addition to glucose analogues,a number of structurally 
unrelated compounds also show asymmetric competitive inhibition of glucose 
transport. The fungal metabolite cytochalasin B was shown to be a good 
inhibitor of glucose transport in the erythrocyte by Taverna & Langdon 
(1973) and Bloch (1973). Jung & Rampai (1975, 1977) reported that 
cytochalasin B was a competitive inhibitor of D-glucose exchange. When 
the inhibition by cytochalasin B of infinite cis exit (Sen & Widdas 
experiment) was studied (Taverna & Langdon, 1973; Bloch, 1973 and 
Basketter & Widdas, 1977, 1978) the results showed no increase in the
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From Barnett et al. (1975)
I
6-0-propyl-D-glucose (R = C^H^; R = H) can bind to the
transport system in conformation A, but is not transported for steric
»
reasons. Similarly, propyl-B-D-glucoside (R = H; R = C^H^) can bind to 
conformation B but cannot be transported. D-glucose can bind to both 
conformations and as the transport site changes from conformation A to 
conformation B is effectively transported from outside tc inside. Only 
some of the probable hydrogen bonds are shown.
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infinite cis Km. These results were interpreted by Basketter &
Widdas (1977) as cytochalasin B binding to the internal site only, 
Basketter & Widdas (1978) also studied the inhibitor phloretin and con­
cluded that phloretin could react with both inner and outer sugar 
binding sites.
Studies with the irreversible inhibitor l~fluoro-2-4-dinitro- 
benzene (FDNB) by Bowyer & Widdas (1958) revealed that inhibition of 
exit developed more rapidly than inhibition of entry. Further studies 
by Barnett et al. (1975) revealed that non-transported inhibitors modi­
fied at C-4 and C-6 protected against FDNB inactivation whereas those 
modified at C-1 enhanced FDNB inactivation of the transport system.
From this information Barnett et al. proposed that FDNB reacted with the 
inward facing form of the transporter.
The transport of hexoses in the hepatocyte
Hexoses have been shown to be taken up rapidly by the perfused 
liver (Williams et al. 1968). The uptake is stereospecific with D-glucose 
being transported more rapidly than L-glucose. The uptake of D-glucose 
was inhibited by phloretin.
The use of an isolated hepatocyte preparation (Baur & Heldt, 
1977) has allowed kinetic studies of hexose transport to be performed 
without major assumptions. The isolated hepatocyte preparation is not 
an homogeneous cell preparation but contains several different types of 
cell. Baur & Heldt (1977) showed that hexoses were transported into the 
cell at a rate exceeding that of metabolic conversion. The rate of 
hexose transport was shown to decrease in the order D-glucose ^  
3-0-methyl-D-glucose > D-galactose > 2-deoxy-D-glucose > D-fructose >> 
L-glucose. In the presence of metabolic inhibitors,transport of
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D-glucose continued until equilibrium was reached,and this result 
suggested that there was no active accumulation of hexoses. Hexose 
transport in the hepatocyte was shown to be sodium independent but was 
inhibited by cytochalasin B, phloretin and phloridzin.
Craik & Elliot (1979) studied the kinetics of 3-0-methyl-D- 
glucose transport in hepatocytes and showed that 3-0-methyl-D-glucose 
is transported symmetrically (see Table 1). D-fructose and D-galactose 
are also transported symmetrically ( Craik & Elliot, 1980) but are 
transported more slowly due to their higher Km value. 3-0-methyl-D- 
glucose is a competitive inhibitor of D-fructose and D-galactose transport 
indicating that all these sugars are transported by the same transport 
system (Craik & Elliot, 1980).
A variety of hormones have been shown to exert effects on 
hepatic metabolism. Short term changes in glucose production or con­
sumption can usually be correlated with changes in the rate of glycogen 
degradation or synthesis (Hems & Whitton, 1980). Baur & Heldt (1977) 
found no effect of insulin on glucose transport in isolated hepatocytes.
In the intact perfused liver Mondon et al. (1975) reported a small 
reduction in D-glucose output in the presence of insulin. This result.; 
appears to be due to changes in glycogen metabolism rather than direct 
effects on the hexose transport system.
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Hexose transport in the thymocyte
The thymus is a primary lymphoid organ which supports 
extensive division of stem cells which go on to form T-lymphocytes. 
Thymocyte populations can be prepared from the thymus of rats by 
gentle mechanical disruption (Whitesell et al., 1977). The population 
of cells produced consists of active cells which equilibrate 3-0-methyl- 
D-glucose rapidly (minute range) and quiescent cells which equilibrate 
3-0-methyl-D-glucose slowly (hours).
Whitesell et al. (1977) studied the kinetics of 3-0-methÿl- 
D-glucose transport in active rat thymocytes and showed that the rate 
of equilibrium exchange was faster than that of zero trans entry. The 
presence of 3-0-methyl-D-glucose on the trans face of the membrane 
(inside the cell) lead to an acceleration of the rate of unidirectional 
influx. The results of Whitesell et al's experiments are presented in 
Table 1.
Whitesell & Regen (1978) studied hexose transport in quiescent 
rat thymocytes and showed the zero trans entry Km to be approximately 
25mM and the Vmax to be 0.14pMol/min/ml packed cells. As with active 
cells quiescent thymocytes showed trans stimulation of the transport 
rate and also showed accelerated exchange.
Transport in quiescent thymocytes can be stimulated by the 
addition of a number of compounds such as the calcium ionophore, tetra­
caine, phenazine methosulphate and arsenate. The stimulation of transport 
is rapid and does not require protein synthesis (Reves, 1977) 
indicating that the quiescent cell has a full complement of transport 
systems. In the thymocyte a stimulation of transport occurs with 
changes in both the Km and Vmax for transport (Whitesell & Regen, 1978).
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Hexose transport in muscle 
The hexose transport system of muscle has been shown to have 
many of the features of a facilitated diffusion process. Norman et al.
(1959) Narahara et al. (1960) and Chaudry & Gould (1969) showed satur­
ation kinetics in skeletal muscle. Morgan & Neely (1972) showed the 
system to be stereospecific and also Morgan et al. (1964) demonstrated 
counterflow. One of the major difficulties in studying muscle preparations 
is the preparation of a sample sufficiently thin to allow rapid 
equilibration of oxygen and substrates between the sample of muscle and 
the incubation medium. Due to these difficulties detailed kinetic 
analysis of the transport system has not been performed.
There is no; detailed specificity data available for the 
muscle hexose transport system. D-galactose (Fis her & Lindsay, 1956), 
D-arabinose, L-arabinose, L-xylose (Carlin & Hechter, 1961), D-xylose 
(Kipnis & Cori, 1957), D-fructose (Nakada, 1956) and D-glucosamine 
(Nakada et al., 1955) have all been shown to be transported into muscle 
by an insulin sensitive route. Since D-glucose is rapidly metabolised 
by muscle preparations the glucose analogues 3-0-methyl-D-glucose and
2-deoxy-D-glucose have also been used (Morgan et al., 1964 and Narahara 
and Ozand, 1963).
The muscle hexose transport system is regulated by a number of 
hormones and physiological states. Kohn & Clausen (1971) showed that 
insulin rapidly stimulates hexose transport in muscle. Ruderman et al. 
(1971) reported up to 15-fold increases in the rate of hexose transport 
in muscle with insulin. They also showed that this effect was not 
coupled to phosphorylation of D-glucose inside the cell. Under basal 
conditions the concentration of free D-glucose in the cytoplasm is close 
to zero (Chaudry & Gould, 1969) indicating that the transport of D-
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glucose is the rate limiting step in its metabolism.
Stimulation of the hexose transport system in muscle is also 
brought about by contractile activity (Kohn & Clausen, 1971) though the 
effect is somewhat smaller and later in onset than that of insulin.
Kohn & Clausen also reported that anoxia and metabolic poisons 
stimulated the rate of hexose transport.
Hexose transport in the small intestine 
The epithelial cells of the small intestine actively transport 
D-glucose from the gut lumen itito the bloodstream. Thus D-glucose is 
transported against its concentration gradient. D-glucose is first 
transported across the brush border of the epithelial cell by an active 
transport system coupled to the flux of sodium ions down their concen­
tration gradient. The sodium ion gradient is generated by a separate 
sodium potassium ATPase. The glucose molecules accumulated in the
VA
epithelial cell then diffuse out of the cell by a sodium ̂ dependent 
facilitative diffusion system present in the basal lateral membrane.
The sodium dependent and sodium independent hexose transport systems 
are located at different ends of the cell and can be separated by sub- 
cellular fractionation of epithelial cells (Murer et al., 1974).
Active hexose transport in the small intestine
Murer & Kinne (1976) studied the transport of D-glucose by 
brush border vesicles isolated from rat small intestinal epithelium.
The transport of D-glucose was increased two-fold when sodium ions 
were added under non-gradient conditions compared to a similar concen­
tration of potassium ions. In the presence of a sodium isothiocyanate
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gradient the rate of D-glucose transport was increased four-fold and 
there was a transient accumulation of D-glucose within the vesicles. 
There is also a transsient accumulation of sodium in the vesicles 
when glucose transport occurs. When a non-penetrating anion such as 
sulphate was used the rate of glucose transport was considerably 
reduced. These results are interpreted as electrogenic coupling of the 
flux of D-glucose to the flux of sodium ions. The rate of transport is 
then dependent on both the magnitude of the sodium ion gradient and the 
membrane potential.
A study of the specificity of active transport in the hamster 
intestine was performed by Wilson & Crane (1958) and Wilson & Landau
(1960). The results of these experiments (reviewed by Crane 1960) 
indicated that a pyranose ring structure with a gluco configuration 
hydroxyl at C-2 was required for active transport. Crane (1960) also 
suggested that hexoses in the conformation had a higher affinity
for the transport system.
Barnett et al. (1968, 1969, 1970) also studied the active 
transport of hfxoses in the hamster small intestine. Their results 
confirmed those of Crane et al. and in addition they proposed hydrogen 
bonds to the C-1, C-3, C-4 and C-6 hydroxyls. Barnett et al. also 
reported that 5-thio-D-glucose had a high affinity for the transporter, 
and from this observation they concluded that there is no hydrogen 
bond to the ring oxygen. None of the hydrogen bonds to C-1, C-3, C-4 
or C-6 were essential, since analogues in which these hydroxyls were 
epimerised or removed were still transported,but with reduced affinity. 
Barnett et al. also studied the transport of halo-substituted sugars. 
Both chloro and fluoro sugars were transported well,and from this 
observation Barnett et al. proposed that hydrogen bonds were directed
25.
towards the oxygen of the hydroxyl at C-1, C-3, C-4 and C-6. Chloro 
or fluOro substitution at C-2 however prevented sodium dependent 
transport,and Barnett et al. proposed that a covalent bond was ■ 
formed between the transporter and the C-2 hydroxyl.
The sodium dependent hexose transport system also transports 
methyl-a-D-glucoside whereas sugars alkylated at C-3 are poorly trans­
ported. Muflih & Widdas (1976) showed that 4,6-0-ethylidene-D-glucose 
was an inhibitor of sodium dependent hexose transport in the rat intestine.
Sodium independent hexose transport in the small intestine
Bihler & Cybulsky (1973) studied the sodium independent hexose 
transport system by perfusing the gut lumen with a solution of mercuric 
chloride before preparing isolated cells. This allowed the study of 
transport in the uninhibited basal lateral membranes. These results 
together with those of Kimmich & Randles (1975, 1976.) showed that sodium 
independent transport Ojf 2-deoxy-D-glucose and 3-0-methyl-D-glucose 
occurred via a facilitative diffusion system. The Km for sodium 
independent D-glucose transport in purified basal lateral membrane 
vesicles was estimated to be 44mM (Wright et al., 1980). The sodium 
independent hexose transport system is more sensitive to inhibition 
by phloretin than phloridzin.
Wright et al. (1980) studied the substrate specificity of the 
sodium independent hexose transport system in purified basal lateral 
membranes. They measured the inhibition of D-glucose transport by 
D-glucose analogues and concluded that there is no requirement for an equatoria 
hydroxyl except at C-1. Their results showed no requirement for a 
gluco-configuration C-2 hydroxyl, since D-mannose and 2-deoxy-D-glucose 
both inhibited D-glucose transport. A study of the spatial requirements
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for binding by Wright et al., showed that the sodium independent 
system is unable to transport methyl-a-D-glucoside unlike the sodium 
dependent system which transports this analogue. N-acetyl-glucosamine 
shows a low affinity for the sodium independent transporter indicating 
the possibility of steric hindrance at C-2. Wright et al. show no 
evidence for steric hindrance at C-3 and C-4 but 6-0-methylation leads 
to a reduction in affinity. Wright et al. concluded that the sodium 
independent hexose transport system of the basal lateral membrane is 
similar in its substrate specificity to the hexose transport system of 
the human erythrocyte reported by Barnett et al. (1973a).
Regulation of intestinal transport
Studies on the regulation of active transport of D-glucose in 
the small intestine are difficult to interpret due to possible changes in 
intestinal function or metabolism (Crane 1960). Some of the changes 
observed are due to effects on fast growing tissue, with an individual 
cell having a useful life span of two or three days. Thus for example j
the reduction in glucose uptake observed on long term starvation may be 
related to a loss of cells from the intestine. Crane (1960) observed 
no effects on hexose transport when insulin was added to intestinal 
preparations in vitro.
Hexose-transport in the kidney 
Investigations on renal sugar transport have indicated that the 
proximal tubule i-s the main site of sugar reabsorbtion (Walker et al., 
1941). Studies by Silverman (1976) and Knight et al. (1977) indicate 
that several sugar transport pathways with overlapping specificities 
may be present along the nephron. Kleinzeller et al. (1980) have suggested
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that only one of these systems is responsible for the active transport 
of D-glucose and D-galactose.
The epithelial cells of the proximal tubule actively transport 
sugars from the interstitial fluid into the cell and then transfer the 
sugar back into the bloodstream. The mechanism of action of these 
cells is very similar to that of the epithelial cells of the small 
intestine (see p.23 ). As with intestinal cells the active transport 
of sugars through the brush border is coupled to the flux of sodium 
ions down their concentration gradient (Crane, 1962). Transport of 
hexoses across the basal lateral membranes into the bloodstream is by 
sodium independent facilitated diffusion, Kinne et al. (1975) described 
the separation of the two activities by means of subcellular fraction­
ation procedures which yield purified brush border and basal lateral . 
membranes.
Sodium dependent sugar transport in the kidney
Kinne et al. (1975) observed a similar sodium dependent 
accumulation of D-glucose in brush border vesicles isolated from the rat 
kidney to that observed in brush border vesicles from the intestine.
Silverman et al. (1970) and Silverman (1974) studied renal 
hexose transport in the whole dog kidney using a multiple indicator 
dilution technique. In this method material is injected into a tubule 
and the rate of removal is measured. Their results showed the following 
sugars to be reabsorbed in order of decreasing affinity. D-glucose > 
methyl-a-D-glucoside = methyl-g-D-glucoside > D-galactose > 2-deoxy-D- 
glucose > D-fructose > myoinositol. The affinity of 2-deoxy-D-glucose is 
low and was estimated to be 2-3 ordersof magnitude less than that of D- 
glucose. Whilst the methyl a and 3 D-glucosides were absorbed from the
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tubule, reabsorbtion into the blood was negligible.
Since the methyl a and 3 D-glucopyranoses are only trans­
ported by the sodium dependent hexose transport system of the brush 
border Kleinzeller et al. (1980) studied the inhibition of methyl-3- 
D-galactoside uptake into rabbit renal cortex using a range of sugar 
analogues. Their results showed a closed ring structure to be 
required for sugar transport since 1-deoxy-D-glucose and 1-deoxy- 
fluoro-D-glucose, which are in a fused ring form are inhibitors of 
transport. This study also suggested fhgt hydrogen bonds were directed 
towards C-1, C-2 and C-4 oxygens. There is also a hydrogen bond 
directed towards the ring oxygen, since 5-thio D-glucose is a poor 
inhibitor (Whistler & Lake, 1972, Kleinzeller et al., 1980, and 
Silverman, 1980). The requirement for a C-6 hydroxyl does not seem to 
be as important as those at other ring positions for binding to the 
transporter since 6-deoxy-D-glucose inhibited methyl-a-D-glucoside trans­
port. The C-6 hydroxyl is however required for transport as 6-deoxy- 
D-glucose is not transported. 6-deoxy-6-fluoro-D-glucose did not 
inhibit methyl-a-D-glucoside transport indicating that this analogue 
does not interact with the transporter. 2-deoxy-2-fluro-D-glucose is a 
poor inhibitor of methyl-a-D-glucoside transport in the kidney (as 
opposed to showing no inhibition in the intestine (Barnett et al. 1970) 
which suggests hydrogen bonding rather than the formation of a covalent 
bond to the C-2 hydroxyl. 4,6-0-ethylidene-D-glucose was also shown to 
interact with the transporter but was not actively transported.
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Sodium independent hexose transport in the kidney
The studies of Kinne et al. (1975) showed a stereospecific 
D-glucose transport system in the basal lateral membranes of rat kidney. 
This transport was not dependent on the presence of sodium ions and 
was relatively insensitive to inhibition by phloridzin but strongly in­
hibited by phloretin. The substrate specificity of this system in the 
dog kidney has been studied by Silverman et al. (1970) and Silverman 
(1974, 1980) by studying the removal of material injected via the 
renal On the basis of their results Silverman et al. proposed
that the hydroxyls at C-1 and C-2 and the ring oxygen were important 
for the binding of D-glucose to the transporter,and they proposed that 
hydrogen bonds were directed towards these positions.
Hexose transport in the brain 
The mammalian brain depends under normal conditions almost 
exclusively on glucose as its source of energy, and it accounts for about 
25% of the total body glucose consumption (Bachelard & Mcllwain, 1969). 
The existence of a selective permeability barrier between blood and 
brain is well established,and it has been proposed that the capillary 
endothelial cells limit the movement of solutes into the brain. Glucose 
transport into the brain through this barrier exhibits the character­
istics of a facilitated diffusion system. Buschiazzo et al. (1970) 
studied 3-0-methyl-D-glucose transport into the whole brain. The trans­
port of 3-0-methyl-D-gluoose exhibits saturation kinetics with a Km of 
approximately 7mM. Buschiazzo et al. also demonstrated counterflow of
3-0-methyl-D-glucose and D-glucose in the whole brain. Glucose trans­
port in the brain is inhibited by phloretin and phloridzin (Betz et al., 
1975) and cytochalasin B (Drewes et al., 1977).
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Betz et al. (1975 and 1976) have studied the substrate 
specificity of the D-glucose transporter in whole dog brain by the 
inhibition of D-glucose uptake by glucose analogues. Their results 
show competition between the analogues,suggesting the presence of a 
single hexose transport system. Their results showed that a pyranose 
ring is required for binding to the transporter. There is no absolute 
requirement for any specific hydroxyl, since épimérisation or removal of 
a given hydroxyl did not prevent the glucose analogue from binding.
The hydroxyl at C-2 is not required since 2-deoxy-D-glucose was trans­
ported at a similar rate to D-glucose, yet D-mannose, the C-2 epimer of 
D-glucose, was a poor inhibitor compared to 2-deoxy-D-glucose,.and 
Betz et al. proposed Steric hindrance by a manno configuration hydroxyl. 
5-thio-D-glucose, 1-deoxy-D-glucose, i-inositol, D-galactose, D-xylose and 
L-glucose were all poor inhibitors of glucose uptake by the brain.
Betz et al. proposed hydrogen bonds to the ring oxygen C-1, C-3, C-4 
and C-6. From these results it was suggested (Betz et al., 1976) that 
the blood brain barrier hexose transport system has a similar substrate 
specificity to that of the human erythrocyte (Le Fevre & Marshall, 1958, 
Barnett et al., 1973a and Kahlenberg & Dolansky, 1972).
Hexose transport has also been studied in isolated brain 
capillaries (Betz et al., 1979) and synaptosomal preparations (Heaton & 
Bachelard, 1973). Clucose transport in these fractions is inhibited by 
Cytochalasin B, phloretin and phloridzin. Phloretin is a more potent 
inhibitor than phloridzin. There is no effect of ouabain, 2,4,dinitro- 
phenol,or insulin on hexose transport, and hexose transport in these 
fractions is sodium independent.
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Hexose transport in cultured cells
Cultured animal cells have provided a convenient model system 
for the study of facilitated diffusion. These cells are easily prepared 
in suspension culture as a homogeneous preparation of isolated cells. 
Graff et al. (1978) reported that 3-0-methyl-D-glucose was rapidly 
transported by Novikoff hepatoma cells with a t^ of between 15 and 40 
seconds depending on the substrate concentration. This rapid transport 
rate requires the use of rapid sampling techniques in order to make 
accurate determinations of the transport rate (Wohlheuter et al., 1978).
Plagemann et al. (1981) studied the kinetics of 3-0-methyl-D-
glucose transport in a range of cultured cell lines. They reported that
human HeLa cells, mouse L cells, P388 leukaemia cells, Chinese hamster
ovary cells and Novikoff hepatoma cells (Graff et al., 1978) all showed
directional symmetry, with the rates of zero trans entry and exit being
equal. The rate of equilibrium exchange in these cell lines is however
greater than that for zero trans experiments. The human HeLa cell shows
= 36mM and = 87.6mM min  ̂ compared to the zero trans experiment
where = 20mM and = 33.6mM min ̂ . There were no2-1 1-2 2-1
significant changes in the kinetics of 3-0-methyl-D-glucose transport 
in these cell lines when the intracellular ATP levels were depleted by 
cyanide poisoning and there was no evidence for the active transport of 
hexoses.
A detailed study of the substrate specificity of these cultured 
cell lines has not been performed. The study of Plagemann et al. showed 
that the for D-glucose analogues was in the order 2-deoxy-D-glucose
< 3-0-methyl-D-glucose = D-glucose < D-galactose << D-glucosamine. All 
these sugars are capable of causing trans stimulation of 3-0-methyl-D- 
glucose and 2-deoxy-D-glucose entry. 2-deoxy-D-glucose and 3-0-methyl-D-
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glucose inhibited the transport of each other in a simple competitive -, 
manner,and the apparent Ki values were similar to the transport Km 
values.
Another cultured cell line of great interest is the murine 
3T3-pre adipocyte line (Green & Kehinde, 1974). These cells, upon 
achieving a growth inhibited state, can be transformed into cells 
possessing many of the biochemical and morphological attributes of adi­
pocytes. The transformation may be brought about by insulin, isobutyl 
methyl xanthine and dexamethasone (Rosen et al., 1978). After trans­
formation the hexose transport system of these cells is stimulated by 
the addition of insulin. Rosen et al. (1978) suggested that the stim­
ulation of hexose transport was due to an increase in the Vmax with no 
effect on the Km which was approximately 2mM for the uptake of 2-deoxy- 
D-glucose in the presence and absence of insulin.
Other cultured cell lines such as the Novikoff hepatoma cell 
line can be transformed by stimuli such as mitogens or DNA and RNA 
tumour viruses so that normal density dependent growth inhibition does 
not occur. These transformed cells show an increased rate of 2-deoxy- 
D-glucose uptake (Plagemann & Richey, 1974) . Chick embryo fibroblasts 
have been shown to have an increased hexose transport activity after 
hexose starvation (Martineau et al ., 1972). These effects appear to be 
independent of phosphorylation and represent increases in the Vmax of 
the transport system. With the exception of transformed 3T3-pre adi­
pocytes, hormone responses have not been reported in cultured cells.
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Hexose transport in the lens of the eye 
The lens of the eye offers a convenient tissue in which to 
study hexose transport. The lens has no vascular system and is 
dependent on substrate available from the surrounding humours.
Lou & Kinoshita (1967) showed that glycolysis is the principal route 
for metabolism in the lens.
Elbrink & Bihler (1972a) studied the kinetics of 3-0-methyl-D- 
glucose transport in the lens and showed that 3-0-methyl-D-glucose was 
transported by a facilitated diffusion process. The Km for 3-0-methyl-D- 
glucose transport was approximately 90raM. Transport of 3-0-methyl-D- 
glucose was inhibited by phloretin and phloridzin, with phloretin being 
the more effective inhibitor. Elbrink & Bihler (1972b) also showed that 
D-xylose and L-arabinose were transported into the lens but at a lower 
rate than 3-0-methyl-D-gluccse. L-glucose and methyl-a-D-glucoside 
were not transported. From their results Elbrink & Bihler proposed 
that the hexose transport system of the lens was similar to that of the 
erythrocyte.
Free glucose is found in the lens (Lou & Kinoshita, 1967) and 
transport does not appear to be the rate limiting step in hexose meta­
bolism. Elbrink & Bihler (1972a) found no evidence for hormonal 
regulation of hexose transport in the eye.
Hexose transport in the placenta 
The placenta is primarily an organ for the interchange of material 
between the fetal and maternal bloodstream without actual mixing of the 
two bloodstreams. Widdas (1952) proposed that hexoses cross the placental 
membranes by a facilitated diffusion process. There is no evidence for 
active transport of hexoses by the placenta since the maternal blood
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glucose level is usually equal to or higher than that of the fetal 
bloodstream. Thus hexoses pass into the fetal circulation by simple 
diffusion down their concentration gradient. D-fructose was observed 
to be transported from the maternal to the fetal bloodstream at a much 
slower rate than D-glucose (Widdas, 1952).
Models for the facilitated diffusion of hexoses 
A number of models have been proposed in order to account for 
the properties of facilitated diffusion systems. Since the hexose trans­
port system of the human erythrocyte is one of the most intensively 
studied facilitated diffusion systems, the majority of models for sodium 
independent hexose transport have been developed to account for the 
asymmetric transport parameters observed in the human erythrocyte.
The carrier hypothesis 
The lipid soluble carrier model for membrane transport pro­
cesses was first proposed by Le Fevre (1948) who suggested that the 
transported molecule could form a complex with a lipid soluble component 
of the membrane which was able to cross the membrane. This model was 
further developed by Widdas (1952) who went on to propose that the 
carrier could return across the membrane in order to ferry another
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substrate molecule across. Thus the basic carrier hypothesis calls for 
a lipid soluble carrier with a specific substrate binding site for the 
transported substrate. At the cis face of the membrane the substrate 
binds to the carrier to form a complex which diffuses across the lipid 
interior of the membrane. At the trans face the complex breaks down 
to release the substrate into the trans solution. The carrier is then 
free to return to the cis face of the membrane.
Physical and chemical studies have suggested that this 
mechanism is unlikely. Singer & Nicolson (1972) suggested that the 
rate of diffusive or rotational movement of membrane proteins across 
the membrane is slow compared to the rate which would be required for 
a facilitated diffusion system. Also, studies on other transport systems 
have suggested that the movement of a protein molecule within the bi­
layer is unnecessary for translocation to occur. Kyte (1974, 1975) 
reported that the protein forming the sodium potassium ATPase is exposed 
on both faces of the membrane simultaneously and that there is no 
reorientation of the molecule during transport. Similar observations 
have been made on the sarcoplasmic calcium magnesium ATPase (Martonosi 
& Fortier, 1974 and Dutton et al., 1976).
Vidaver (1966) suggested that the mobile component of the 
carrier system may be as small as the movement of one or two hydrogen 
bonds. Thus a conformational change in a trans membrane protein would 
lead to the conversion of an outward facing site to an inward facing 
site bringing about the transfer of substrate across the membrane.
Such a system would be consistent with the studies of Barnett et al. 
(1973b, 1975) who showed different spatial requirements for the inside 
and outside sites. A scheme for this carrier model can be drawn as
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The kinetic predictions of this model will be identical to those of 
the lipid soluble carrier and will be discussed later. Thus the 
different rates of diffusion for loaded and unloaded lipid soluble 
carrier can be interpreted as different rates of conformational 
change for the loaded and unloaded forms of the transmembrane protein.
Pore models
The simplest of all models for facilitated diffusion is the 
simple pore model. In this iQodel a water filled pore spans the membrane 
allowing a continuous passage for solute through the membrane (Danielli, 
1954). The presence of a limited number of pores will give rise to 
saturation kinetics (Stein & Danielli, 1954, and Zierler, 1961). In 
order that transport through pores is stereospecific at least one 
recognition site ; is required, with binding to this site being required 
before translocation can occur (Adair, 1956). Some form of restriction 
in the pore is also required in order to prevent molecules smaller than 
the substrate passing freely through the membrane.
Physical studies are consistent with the model of a water 
filled route through the membrane. Naftalin & Holman (1977) showed 
sugar dependent increases in the water content of human erythrocyte 
membranes. This increase was prevented by the addition of mercuric 
chloride which inhibits transport activity. Bowman & Levitt (1977)
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have studied the glucose dependent permeability of a series of 4 to 6
carbon polyols in erythrocyte membranes. Their results indicate that
polyol permeability is inversely proportional to molecular size and
they suggest that this may be related to the ability of these compounds
to enter a pore. The volume of a typical membrane protein spanning the
5 ° 3membrane has been estimated at at least 2.5 x 10 A (Holman, 1980)
which gives a space within the molecule capable of allowing two sugar
2 ° 3molecules (of 1.25 x 10 A each) to pass one another.
Kinetic predictions of models
Carrier models
The kinetics of carrier mediated transfer have been developed 
by a number of authors (Widdas 1952, Regen & Morgan, 1964, and Stein &  
Lieb, 1972). A reaction scheme can be drawn for carrier models in which 
a single substrate molecule (S) combines with the carrier (E). The 





Using Steady state kinetics these two reaction schemes are 
indistinguishable (Lieb & Stein, 1972). Pre-steady state kinetic 
analysis is required to identify different forms of the carrier substrate 
complex. Lieb & Stein (1972, 1974a) have derived a steady state equation
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for the unidirectional flux of substrate through this model.
U. =  ^12 ^1 ^1 ^2__________________________ (2)
12 "'21 ■ "'21 "'12 "1 ' "'12 "'21 "2 ' "'l 2̂
The unidirectional flux equation for flux in the reverse 
direction (U2^^) is given by reversing the subscripts in equation (2).
The parameters for this equation are defined in Table 2 and describe 
the movement of the different forms of the carrier across the membrane 
in different directions when loaded with substrate or unloaded. Terms 
in R are sums of specific resistances for the movement of the carrier 
in its different forms. Thus R^^ is the sum of the specific resistance 
of loaded carrier moving in the direction 1 to 2 and the specific 
resistance of the unloaded carrier returning in the direction 2 to 1.
Ree is the sum of the specific resistance of loaded carrier moving in 
the direction 1 to 2 and the loaded carrier moving in the direction 2 to 
1. Roo is similarly the sum of resistances to movement of the unloaded 
carrier in both directions. K is the operative affinity of the system 
for substrate when the system is unperturbed by the presence of substrate
For a symmetrical carrier the sites on faces 1 and 2 have equal 
affinities for substrate i.e. f^ = f^ and b^ = b^. Regen & Morgan (1964) 
showed that unequal rates of movement of loaded and unloaded carrier 
within the membrane would lead to asymmetry. Thus for the erythrocyte 
Ree < Roo. Lieb & Stein (1972) showed that this assumption predicts that 
the Km for the infinite cis experiment should be greater than or equal 
to one half of the Km for equilibrium exchange. This observation pro­
vides an important rejection criterion for this model.
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Table 2. Steady state solutions for the one and two complex forms 
of the simple carrier
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K21 k2
ki k^ l>2 + 82
From the law of micro­
scopic reversibility ’’1 '"1 ^2 ” ‘’2 ’"2 Si *’2 "̂2 ' ®2 *̂ i
then R + Ree 00 R i 2 + %21
also K^2 “ K21
Where n is the total number of carriers per unit membrane.
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Geek (1971) proposed an asymmetric carrier model with unequal 
half saturation constants on either side of the membrane. The uni­
directional flux through this model is also given by equation 2. Since 
a facilitated diffusion system must achieve equilibrium with no 
accumulation on one side of the membrane, the Haldane relationships for 
net entry and exit must be the same i.e.
Vi Vo
Ki Ko
where i and o refer to the inside and outside respectively. Thus the
presence of asymmetric affinities implies there must also be asymmetric
Vmax values.
The values of the basic carrier parameters can be determined 
experimentally since equation 2 reduces to a Michaelis Menten form for 
all the experimental protocols described earlier (Lieb & Stein, 1972).
The Km and Vmax values given by different experimental protocols are 
related to the different parameters, and these relationships are given 
in Table 3. To test the asymmetric carrier model the values for the 
model parameters are estimated using the complete range of protocols.
If the asymmetric carrier model holds the values for the different para­
meters should be identical regardless of the; protocol used to estimate 
them.
Regen & Tarpley (1974) proposed an asymmetric carrier model 
with the additional assumption of unstirred layer effects. This model 
assumes a relatively thick unstirred layer effect at the inner membrane 
surface and accounts for most of the observed operational transport para­
meters in the erythrocyte. It cannot, however, account for the low Km 
for infinite cis entry of D-glucose in the erythrocyte since the affinity
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Table 3. The evaluation of the kinetic parameters of the carrier model
procedure Vmax Km
Zt 1 Zt
Zero trans *12 = *̂ 12 *12
^ _1__ „Zt = foo
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of the inside site must be low in all circumstances.
Pore models
The simplest of pore models is that of a narrow pore which can 
allow a single substrate molecule to pass through the membrane. Substrate 
(S) and pore (E) combine to form a complex whilst the substrate crosses 
the membrane from side 1 to side 2. A kinetic scheme for this transfer 
can be drawn.
ES
S1 ^2 ^2 or ES 1 ES.
g.
Lieb & Stein (1974b) have derived a unidirectional flux equation for this 
model. As with the carrier model steady state analysis cannot reveal 
different forms of the complex and therefore the same equation holds for 
both schemes.
U ^21 ^1l->2
^12 ^21 ^21 ^12 1̂ ^12 ^21 2̂
(3)
These parameters are defined in Table 4. As with the carrier model the 
unidirectional flux in the reverse direction is given by reversing the 
subscripts. The values for the pore parameters can be determined 
experimentally since equation 3 reduces to a Michaelis Menten form for 
zero trans and equilibrium exchange experiments (Table 5).
The major prediction of this model is that trans inhibition of 
uridirectional flux will occur (Hodgkin & Keynes, 1956) so that as 
approaches infinite concentration will approach zero.
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where n is the total number of pores per unit membrane.
From the law of microscopic reversibility b^ f^ = b^ f^ and 
hi ^2 ^2 = ^2 ^1 H' Hence = ^21.
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Table 5. Experimental determination of parameters for simple pore
procedure Vmax Km
Zt , „Zt ^12zero trans V,  ̂ K
121-2 R—  1-2 1l2
.ee ..ee .,ee 1 Kf®= *̂ 12
equilibrium V = = « + R „  1 1 “ T  R
exchange 12 21 12 21
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Bypass pore models
More complex pore models have also been proposed in which 
the pore can be occupied by several substrate molecules at one time.
In these models substrate molecules can pass one another within the 
pore*and therefore trans inhibition does not occur.
The polar creep model
Bowyer & Widdas (1956) proposed a model in which hexose 
molecules pass down a series of hexose binding sites in the pore. As 
considered previously, steady state analysis cannot differentiate 
between the different intermediates; however, for this type of model 
the half saturation constants for each face of the membrane can be 
determined (Widdas, 1980). The half saturation constants for the two 
faces are given by 0 and a0 respectively where a is the asymmetry of 
affinities, thus for a symmetric model a = 1. For net transfer from 
side 1 to side 2 to occur the substrate concentration at side 2 must be 
less than that at side 1. Thus the probability of net transfer from side 
1 to side 2 is given by a rate constant (V^) multiplied by the probability 
of saturation of side 1 times the probability that the site on side 2 is 
emp ty.
Transfer V., ^1
1-̂ 2 =  ̂ ^c^ + 0 C2 + a0
where c^ and c^ are the substrate concentrations at sides 1 and 2
respectively. A similar equation holds for transfer in the reverse
direction except that the rate constant will be .
Transfer V
2-̂ 1 " ^
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bn
Cg  + a 0  + 0
In order that this model can achieve true equilibrium and does 
not lead to accumulation of substrate on one side of the membrane 
* aV^. When both sites are saturated an exchange of substrate 
molecules occurs between the two sites. The rate constant for this 
exchange is Vex and, the unidirectional flux will be given by
V^ c^ . a0 + Vex c^ c^
(c^ + 0) (c^ + a0)
When a = 1 this model predicts symmetrical transport parameters. Also 
the Vmax for exchange may be greater than the zero trans Vmax. When 
a # 1 the Km and Vmax for zero trans experiments will be asymmetric.
The infinite cis experiment Km’s will also be asymmetric for this model. 
Thus the model gives similar predictions to the asymmetric carrier.
Lattice pores
The lattice pore model of Naftalin (1970) is similar to the 
polar creep model, in that hexose molecules pass through the membrane 
by one dimensional diffusion between binding sites. This model was 
initially developed to account for the heteroexchange results of 
Miller (1968) who observed that the exit of glucose was accelerated 
more by galactose or mannose than by glucose in the trans solution.
Thus Naftalin proposed that the exchange of two different substrates 
between adjacent binding sites has a higher probability of occurring 
than simple migration of a single substrate molecule to an adjacent 
site. Similarly the exchange of two different substrates between a 
surface binding site and the bulk solution is more likely than * 
dissociation of the substrate from the pore. Computer simulations of
47.
this model (Naftalin,1970) predict accelerated heteroexchange and 
uphill counterflow. In order to fully simulate Miller's (1968) 
results an unstirred layer effect was proposed by Naftalin. This 
model is however symmetrical with respect to the rates of zero trans 
entry and exit.
Le Fevre's introverting hemiport model
Le Fevre (1973) proposed a model in which microcarriers in 
the membrane acted as gates to an intramembrane pool. These micro­
carriers were proposed to be able to face either inwards towards the 
intramembrane pool, or outwards to contact the solution. Le Fevre 
proposed that the probability of the microcarriers facing inward or 
outward was altered by the binding of substrate. Computer simulations 
based on a change in the probability of the site facing inward of 0.3 
for unloaded to 0.99 when loaded were performed by Le Fevre (1973).
These computer simulations predicted a high Km for zero trans exit and 
a low Km for both infinite cis entry and exit. The Km and Vmax for 
equilibrium exchange were both high. The model is however symmetrical 
with respect to the zero trans K m ’s.
The tetramer model
Lieb & Stein (1970, 1971) proposed the tetramer model in which 
two pairs of subunits at each face of the membrane act as microcarriers 
to a pore. The two pairs of subunits have different affinities for the 
substrate; one pair has low affinity (L site) whilst the other pair has 




At low substrate concentrations the substrate molecule being 
transported remains preferentially bound to the high affinity site.
The interconversinn of subunits from an outside to an inside facing 
form is substrate induced. The model predicts the presence of two 
operational affinities on each face of the membrane. The zero trans 
Km is determined primarily by the low affinity site (the L site) whereas 
the infinite cis Km is determined by the high affinity site. This model 
is symmetrical with the rates of net entry and exit being equal.
The pore of Foley et al.
Foley et al. (1980a)proposed a model where a water filled pore 
spans the membrane. The pore is gated at each end by a microcarrier.
The kinetics of this model are complex with 11 different parameters 
describing the flux of substrate through the pore. A full kinetic 
analysis of this model has not been carried out though the model 
predicts that the Vmax for net flux through the pore will be governed 
by the rate limiting microcarrier (Holman et al., 1981). Such a model 
may therefore show similar kinetics to the model of Regen & Tarpley 
(1974) of an asymmetric carrier with an unstirred layer.
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The aTlosteric pore
Holman (1980) described a model for hexose transport with a 
protein lined pore composed of three subunits. The points of contact 
between these subunits form the gates to the pore. Substrate molecules 
are able to bind to each subunit. The subunits are proposed to be 
capable of adopting three conformations; conformation A being un­
occupied, donformation B is adopted when a substrate molecule is bound 
from the outside and conformation C is adopted when substrate is 
bound from the inside. The pore can be occupied by a maximum of three 
substrate molecules at any given time and all the possible subunit 
conformations are shown in Fig. 3.
Monovalent occupancy of the allosteric pore by a substrate 
molecule leads to low Km and Vmax transport parameters since monovalent 
occupancy does not lead to destabilisation of the gate trans to the 
occupied subunit. Monovalent occupancy also leads to the exposure of 
a high Km site (negative cooperativity) on a neighbouring subunit. If 
the substrate concentration is sufficiently high, then binding to this 
site leads to the destabilisation of the trans gate leading to a high 
Vmax for transport. Thus monovalently occupied pores (A2B and A2C 
forms) show low Km low Vmax parameters for transport whilst divalently 
occupied pores (AB2 and ABC forms) show high Km high Vmax transport 
parameters. Equilibrium exchange occurs in a similar manner with low 
Km and Vmax exchange in the ABC configuration and high Km and Vmax 
exchange occurring in B2C and C2B forms of the pore.
The unidirectional flux equation for zero trans entry through 
the allosteric pore was derived by Holman et al. (1981) and is:
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A schematic representation of the allosteric pore showing all 
the proposed occupancy states. (0) A subunits, (□) B subunits,
(A) C subunits. A linear arangement of subunits is assumed.








in the allosteric pore.
a) In the absence of substrate the interfaces of the subunits are
stable and the pore is closed.
b) The ABC form of the pore where the pore is occupied from the
outside and inside by substrate.
c) When the pore is doubly occupied from the outside the subunit inter­
faces (pore gates).are greatly destabilised and negative cooperativity 
results. The right panel of this scheme shows cross sections through 
the pore. The dotted line indicates that two subunits with separate 
domains at inner and outer surfaces would be equivalent to a linear 
arrangement of three subunits since both arrangements have inner and 
outer subunit interfaces.
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L %s Sp + Vy %S (6)Tôt (V, S_ + V„ K
1 + Kg So + >'s'
where Tot is the total concentration of all forms of the transporter,
S" is the outside substrate concentration, K_ is the subunit association o b
constant, is the subunit interface stability constant for a BB inters
face and V and V are the Vmax values for the singly and doubly occupied 
forms of the pore. The flux equation for zero trans exit is similar 
except that the subunit interface stability constant is If the
subunit interface stability constants are unequal then the allosteric 
pore will show asymmetric rates of zero trans entry and exit.
Holman et al. (1981) also derived a unidirectional flux equation for 
equilibrium exchange.
where Kg
''’SîE “ ĤE *̂S '̂Sb * *̂CĈ
■Sffi = (>Sb + %cc) Ki)L
Kgc» Kgg and are subunit interface stability constants for 
BC, BB and. CC interfaces. V ^  is the high Vmax for exchange in the 
triply occupied allosteric pore.
Due to the complex kinetics of this model detailed predictions 
of the model depend upon the choice of values for the seven independent 
parameters. Holman (1980) estimated these parameters for the erythrocyte
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hexose transporter using computer simulations. The model shows 
slight evidence for nonlinearity of reciprocal plots under some 
conditions (due to the negative cooperativity). For the estimated 
values for the parameters for human erythrocyte hexose transport^the
combinations of low K and low and high K high V transport parameters^
for the transport of a single substrate reduced the nonlinearity to
barely detectable levels. If then the model shows asymmetric
rates for zero trans experiments with a higher Km and Vmax for efflux 
than for influx. The model also shows accelerated exchange and low 
symmetrical Km’s for infinite cis and infinite trans experiments.
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The regulation of carbohydrate metabolism
Circulating blood glucose is derived from two major sources; 
dietary carbohydrates and the process of gluconeogenesis. An intricate 
control system is responsible for the maintenance of blood glucose 
levels at between 60-110mg/100ml of blood in normal men. Blood glucose 
is the major energy source for the central nervous system, red blood 
cells, the adrenal medulla and bone marrow. Undoubtedly, the fine
control of glucose levels has evolved to serve these functions.
Most ingested carbohydrate is converted to glucose and the 
resulting post absorbtive raised blood glucose level stimulates the 
release of insulin from the 3 islets of the pancreas. This process is 
mediated by mechanisms involving glucose, glucagon, and vagus impulses. 
In conditions of lowered blood glucose following starvation, blood 
glucose levels are replenished by glycogenolysis (via catecholamines 
and glucagon), gluconeogenesis (via cortisol), lipolysis (via growth 
hormone), decreased glucose utilisation, and increased fatty acid 
oxidation.
The major target tissues for hormones involved in glucose 
homeostasis are muscle, adipose tissue and the liver. The liver is 
mainly concerned with glucose homeostasis through the formation of 
glycogen or the formation of carbohydrates from non carbohydrate 
sources. As discussed previously (p. 20 ) there is no evidence that 
hepatic glucose metabolism is regulated by changes in hexose transport 
across the hepatocyte membrane. In contrast hexose metabolism in both 
muscle (see p. 22) and adipose tissue (see p. 10) is rate limited by 
the transport of hexoses in these tissues. In both muscle and adipose 
tissue the hexose transport system is subject to hormonal regulation.
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The regulation of hexose transport
The regulation of hexose transport offers a convenient site for 
the regulation of hexose metabolism. Due to the technical difficulties 
of studying hexose transport in muscle the isolated adipocyte has 
provided a convenient model system in which to study the regulation 
of hexose transport. A large number of compounds of both physiological 
and ncn-physiological relevance have been shown to alter the rate of 
sugar transport. Unfortunately the lack of a relationship between the 
effects of these compounds has reduced their usefulness in providing 
an insight into the mechanism of the regulation of transport.
Hormonal regulation of hexose transport
Insulin
Insulin is a polypeptide hormone of approximately 6500 daltons 
molecular weight. The major effect of insulin on its target tissues is 
to stimulate the uptake of sugars, amino acids, fatty acids, ions, and 
nucleic acid precursors (Pilkis & Park 1974). To date however it has 
not been possible to ascribe all of insulin's effects on target tissues 
to changes in membrane transport.
The initial step in the action of insulin is now recognised 
as binding to receptors in the plasma membrane (Czech 1977). It has 
also been demonstrated that insulin is able to enter the cell and bind 
to receptor sites within the cell (Goldfine 1977). The interaction of 
insulin with its plasma membrane receptors shows reversible non-covalent 
binding with negative cooperativity (Kahn 1975). Insulin receptors are 
also present in a number of non-target tissues and the binding of insulin 
has been described in many tissues,including adipocytes, muscle, liver,' 
lymphocytes, erythrocytes, placenta and fibroblasts. (for recent review 
see Goldfine 1981). In addition to the plasma membrane,insulin binding
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sites have been described in nuclei (and nuclear membranes), smooth 
and rough endoplasmic reticulum and golgi apparatus (Goldfine 1981).
Cuatrecasas (1969) first coupled insulin to sepharose beads and 
reported that this conjugate showed full biological activity. Since 
the sepharose bead was much larger than the: cell it was suggested that 
insulin did not need to enter the cell. Garwin & Gelehrter (1974) 
showed that free insulin was able to leak out of such conjugates and, 
the free insulin had biological activity. Insulin has since been 
coupled to agarose via biotin avidin reactions (May et al ., 1978). This 
derivative has reduced biological activity although even these complexes 
may still be able to release sufficient free insulin to cause biological 
activity.
Goldfine et al. (1978) studied the fate of radioactive insulin 
in mouse fibroblasts following its binding to cell surface receptors.
In a similar study Schlessinger et al. (1978) used an insulin molecule 
which was covalently linked to a fluorescent dye to study the distribution 
of insulin in cultured %M9 lymphocytes. The results of both experiments 
showed insulin to bind diffusely over the whole cell surface and then, 
within a few minutes, the hormone receptor complexes aggregated into 
patches on the cell surface. These patches were then endocytosed to a 
location on the rough and smooth endoplasmic reticulum. The incubation 
of cells with insulin leads to a time and dose dependent decrease in the 
number of cell surface insulin receptors (Neville & Chang, 1978) with 
such effects being observed within 10 minutes (Goldfine, 1981).
The multiple effects of insulin on target cells can be 
separated into three classes:-
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Rapid (occurring in seconds) - these are principally effects on the plasma 
membrane and constitute a change in the rate of transport and a change 
in the membrane potential.
Intermediate (occurring in minutes) - these effects occur at a number of 
sites within the cell. Cytosolic, mitochondrial and endoplasmic 
reticulum enzymes are activated,and there is increased protein synthesis 
at the ribosomal level. There is also an inhibition of protein 
degradation in lysosomes.
Delayed (occurring in hours) - these are principally effects at the 
nucleus on the modulation of DNA and RNA synthesis.
In view of these multiple effects of insulin on target cells 
it is possible that the actions of insulin could be mediated-by binding 
to both surface and intracellular binding sites.
The insulin receptor
Detailed studies on the insulin receptor from a number of tissues 
indicate that it is an intrinsic membrane glycoprotein of apparent molecular 
weight 350,000 daltons (Czech et al., .1981). Electrophoretic studies 
by Massague et al. (1980) indicate that it is composed of two types of 
subunit, a and 3 of apparent molecular weights, 125-130,000 daltons and 
90,000 daltons respectively. In the plasma membrane the receptor exists 
in a3 and (03)2 complexes with the subunits linked by disulphide bonds 
(Massague & Czech, 1980). The a3 complex is able to bind insulin, though 
the subunits do not appear to become physically dissociated when the 
disulphide bridges linking them are reduced. The subunit composition 
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In order to elicit a maximal biological response from the target cell 
insulin needs to bind to between 2 and 5% of the total receptors present 
(Kono & Barham, 1971) . Within 30 to 90 seconds of this binding a large 
increase in the rate of 3-0-methyl-D-glucose transport is observed 
(Kono et al ., 1976, and Barring et al., 1978). Kinetic analysis of the 
parameters for 3-0-methyl-D-glucose transport in basal and insulin stim­
ulated cells (Whitesell & Gliemann, 1979, Czech, 1976a, Vinten, 1978, 
Vinten et al., 1976, and Taylor & Holman, 1981) have shown that the 
increased rate is due to an increase in the Vmax for transport with no 
apparent change in the Km. The values of the kinetic constants measured 
by the different investigators showed some variation; this appears to be
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due to different times being used for the measurement of initial rates. 
Too long a time point has been shown by Taylor & Holman (1981) to lead 
mainly to an underestimate of Vmax. Czech (1980) has also proposed that 
the variation may be due to different collagenase preparations being 
used by different authors.
The activation of hexose transport by insulin was shown to 
require ATP by Gliemann et al., 1975 and Kono et al.,(1976) who showed 
that the addition of uncouplers of oxidative phosphorylation (which 
reduce cellular ATP) prevented the stimulation of adipocytes by insulin. 
A similar energy requirement is also shown for the inactivation of 
hexose transport following the removal of insulin (Vega et al, 1980, 
Laursen et al., 1981). Kono et al . (1977) also showed in a similar 
study that insulin was not internalised in the presence of metabolic 
uncouplers. However no effect of ATP depletion was observed on the 
binding of insulin to the membrane of isolated fat cells (Kono et al., 
1977). The use of protein synthesis inhibitors such as cyclohexamide 
(Fain, 1964) have shown that the activation of hexose transport by 
insulin does not require de novo synthesis of protein.
Studies on the transport of D-glucose in plasma membranes iso­
lated from rat adipocytes (Martin & Carter (1970); Carter et al. (1972); 
Chandramouli et al. (1977) and Ludvigsen & Jarett (1979, 1980)) have 
shown that plasma membranes isolated from basal adipocytes did not 
show an increase in the rate of D-glucose transport on the addition of 
insulin, even in the presence of ATP. Plasma membranes which were iso­
lated from cells which had been stimulated with insulin exhibited an 
increased rate of D-glucose transport (Carter &  Martin, 1970). This 
fossil effect of insulin is remarkably stable and persists even after
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the extraction of extrinsic membrane proteins (Pillion et a l , 1978).
These studies showed that in addition to ATP an intact cell structure 
is also required for insulin to stimulate hexose transport.
Catecholamines
Catecholamines (adrenaline and noradrenaline) are known to 
reverse the effects of insulin on lipogenesis and also bring about break­
down of glycogen. Adrenaline stimulation of isolated adipocytes has 
been shown to increase the rate of glucose oxidation (Cahill et al.,
1960, and Luzio et al., 1974). Ludvigsen et al. (1980) studied the uptake 
of 3-0-methyl-D-glucose by isolated adipocytes and showed a two-fold 
increase in the rate of glucose transport when 0.25yM adrenaline was 
present. Ludvigsen et al. also showed a fossil effect of adrenaline in 
plasma membranes similar to that of insulin. Kinetic analysis of this 
effect revealed that the increased rate of transport was due to an 
increase in the Vmax for transport rather than a change in the Km.
The regulation of glycogen metabolism by adrenaline has been 
shown to involve increase in the intracellular concentration of its 
second messenger cyclic AMP (Robinson et al., 1971). A number of com­
pounds which mimic adrenaline's action through binding to surface 
adrenergic receptors have been described. The use of these compounds 
has revealed two classes of adrenaline receptors in the plasma membrane. 
These receptors have been designated as a and 3 adrenergic receptors 
(Stein & Hales, 1972). It is generally regarded that the activation of 
lipolysis and the activation of adenyl cyclase are mediated via 3 
receptors, which are part of the adenyl cyclase complex in the plasma 
membrane. Luzio et al. (1974) showed that the adrenaline stimulation 
of glucose oxidation could continue in the presence of propranalol
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(a 3 adrenergic blocker) at concentrations which prevented increases in 
the intracellular levels.of cyclic AMP and the stimulation of lipolysis. 
Conversely the a adrenergic blocking agent phenoxybenzamine prevented 
the stimulation of glucose oxidation by adrenaline at concentrations 
which did not inhibit lipolysis and cyclic AMP formation. The presence 
of phenoxybenzamine had no effect on the stimulation of glucose oxidation 
by insulin. Luzio et al. concluded that a substantial portion of the 
adrenaline stimulation of glucose oxidation in rat adipocytes is not 
mediated by cyclic AMP.
In contrast the results of Ludvigsen et al. (1980) indicated 
that a large part of adrenaline’s action on hexose transport may be 
mediated by 3 adrenergic receptors, as in their experiments the 
stimulation of glucose transport was blocked by propranalol.
Phenylephrine ^n a directed adrenaline analogue produced only slight 
stimulation of hexose transport.
Thus the mechanism of adrenaline stimulation of hexose transport 
is unclear and the role of cyclic AMP cannot be eliminated.
Glucagon
This polypeptide hormone (molecular weight 3485 daltons) is
produced g.n the a islet cells of the pancreas and counteracts the actions
of insulin. Its principle site of action is believed to be the liver 
where glycogen is hydrolysed to yield glucose which is released into 
the bloodstream (Hemms & Whitton, 1980). Glucagon has no effect on 
glycogen breakdown in muscle whereas adrenaline causes breakdown of 
glycogen in both muscle and liver. Like adrenaline, glucagon is
believed to act through the cyclic AMP protein kinase system. Increased
62.
cyclic AMP levels lead to an increase in the activity of phosphorylase a 
in the liver through phosphorylation of the enzyme (Exton et al., 1971)
Glucocorticoids
Cortisol is the major glucocorticoid found in man. It is a 
sterol derivative produced in the adrenal cortex. The principal effect 
of cortisol is on the process of gluconeogenesis, increasing the rate 
of synthesis of enzymes responsible for gluconeogenesis. Yorke (1967) 
reported that the corticosteroid analogue dexamethasone decreased the 
rate of glucose utilisation in adipose tissue. These results suggested 
that the maximal rate of uptake was reduced with no change in the con­
centration of glucose, which gave half maximal uptake of D-glucose. 
Similar results were observed in rat thymocytes by Junker (1981) who 
showed that the Vmax for 3.0-methyl-D-glucose transport was reduced in 
the presence of dexamethasone. The effect of dexamethasone is slow in 
onset and reaches a maximum only after a two hour preincubation.
Makman et al. (1971) reported that the cortisol effect on 2-deoxy- 
D-glucose uptake in thymocytes was prevented by inhibitors of protein 
synthesis,and they concluded that protein synthesis was involved in the 
action of glucocorticoids.
Growth hormone
Growth hormone is a single chain polypeptide hormone of molec­
ular weight 21,500 daltons which is produced by cells in the anterior 
pituitary. Growth hormone is believed to antagonise the effects of 
insulin thus decreasing the conversion of glucose to fat in adipose 
tissue (Bacchus, 1976). Growth hormone has been shown to accelerate 
the entry of L-arabinose into heart muscle after a 15 minute pre­
incubation (Henderson et al., 1961). This affect was prevented by the
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addition of inhibitors of protein synthesis.
In addition to these hormones a number of other compounds 
have been implicated in the regulation of hexose transport.
Prostaglandins
Fain (1968) demonstrated that prostaglandin El increased 
glucose oxidation and conversion into fatty acids in adipose tissue and 
isolated adipocytes. The maximal stimulation was about 10% of that 
produced by insulin. The general finding is that prostaglandins are 
more potent as anti-lipolytic agents than they are as stimulators of 
glucose transport.
Prostaglandin E2 has been shown to enhance the effect of 
insulin on glucose transport in adipocytes but has no effect when added 
on its own (Clef sky 1977). Clefsky has proposed that prostaglandin E2 
is a second messenger for insulin action.
Adenosine
Adenosine has been reported to have insulin-like actions on 
adipose tissue. Dole (1962) reported that adenosine brought about an 
increase in the rate of glucose utilisation and oxidation in whole adi­
pose tissue. Adenosine has also been reported to reduce hormone stimu­
lated adenylcyclase activity, intracellular cyclic AMP concentrations 
and rates of lipolysis (Raben & Matsuzaki, 1966, Fain et al., 1972 and 
Schwabe et al (1973). Further studies by Taylor & Halperin (1976) 
suggested that adenosine could also increase the rate of hexose trans­
port. When insulin and adenosine were added together a potentiation of 
the effect of insulin was observed. Raben & Matsuzaki (1966) suggested
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that the effects of adenosine may be due to increased hydrogen peroxide 
formation due to the oxidation of purine bases by xanthine oxidase.
May & De Haen (1979) have also proposed that hydrogen peroxide can 
stimulate hexose transport in adipocytes, and reported increased 
catalase activity in insulin treated cells. Therefore direct inter­
pretation of the effects of purine bases upon sugar transport are 
further confused by possible effects of metabolites.
Malbon et al. (1978) have reported that adenosine and adenosine 
analogues bind reversibly to two classes of receptors on the adipocyte 
plasma membrane. These binding sites are not related to adenosine 
deaminase or the adenosine transport system and may therefore represent 
specific adenosine receptors analagous to the insulin receptor. Similar 
purinergic receptors have been reported in smooth muscle by Burnstock 
(1976) and adenosine and its nucleotides have been proposed to act as 
neurotransmitters in the sympathetic nervous system.
Adenosine 5' phosphates
Adenosine 5' monophosphate (AMP) and adenosine 5' diphosphate 
(ADP) were also shown by Dole (1962) to have similar effects to those of 
adenosine in reducing lipolysis and stimulating glucose oxidation.
However higher concentrations of AMP and ADP were required to have a 
similar effect to adenosine.
Adenosine 5 ’ triphosphate (ATP) has been shown to inhibit 
insulin stimulated glucose oxidation (Chang et al., 1974). ATP was also 
effective in reducing the effect of other known activators of hexose 
transport such as lectins, sulphydryl reagents and spermidine.
Exogenous ATP has also been reported to restore insulin responsiveness to
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ATP depleted muscles (Yu & Gould, 1978). ATP was found to phosphorylate 
two low molecular weight plasma membrane polypeptides (Chang et al., 1974), 
and this phosphorylation was substantially inhibited by the glucose trans­
port inhibitor phloretin. The protein kinase responsible for this phos­
phorylation was found by Chang et al. to be subject to regulation by 
cyclic AMP.
Hon-physiological modifiers of hexose transport
In addition to these physiological compounds a number of non- 
physiological compounds and conditions have also been found to cause 
stimulation of glucose oxidation and transport in isolated adipocytes.
Table 6 summarises the major classes of compounds and their effects.
The action of insulin 
Possible second messengers in insulin action
The events leading to the activation of hexose transport 
following the binding of insulin to its cell surface receptor are still 
unclear. Many intracellular enzymes have been linked to the regulatory 
influence of cyclic AMP and a number of studies have been directed 
towards identifying possible second messengers for the action of insulin.
Cyclic AMP
It has been proposed that several of the insulin responsive 
intracellular enzyme systems such as glycogen synthetase,glycogen phos- 
phorylase (Miller et al., 1975a,b), and the hormone sensitive lipase 
(Corbin et al., 1970), are regulated by cyclic AMP and the cyclic AMP 
dependent protein kinase system (Robinson et al., 1972). Insulin has been 










glucose uptake in brown and 
white fat cells
No change in 3-0-methyl-D- 
glucose transport in un­
stimulated adipocytes. 
Sulphydryl blockade prevents 
the action of insulin
Spermine and spermidine 
stimulate conversion of 
glucose to COg in isolated 
adipocytes. The effect 
is similar to that of 
insulin.
Reference
Czech et al. (1974a) 
Mukherjee & Lynn 1977 
May & de Haen 1979
Czech et al.(1974b) 
Czech (1976b)
Lockwood et al. (1971) 






Concanavalin A and wheat germ Czech et al., 1974a 
aglutinin activate glucose Czech & Lynn, 1973 
transport. These lectins Cuatrecasas, 1973 
have also been shown to inter- Katzen & Soderman, 1975 
act with carbohydrate groups 
on the insulin receptor.
These antibodies cause Cuatrecasas & Tell (1973)
insulin-like stimulation of Pillion & Czech (1978) 
glucose transport rates. Fab Pillion et al. (1979) 
fractions are inactive, anti- Jacobs et al. (1978) 
bodies must be multivalent.
Purified antibody prepar­
ations indicate that both 
anti-insulin receptor anti­
bodies and non-specific 
anti-membrane antibodies 
lead to increased hexose 
transport rates.
Gentle trypsin digestion 
causes marked stimulation 
of glucose transport. 
After 15-20 min. cells 
return to normal trans­
port rates. All other 











Marked increase in glucose 
metabolism and a loss of 
insulin sensitivity.
Stimulates glucose oxi­
dation and prevents the 
action of insulin. Neur­
aminidase has a similar 
effect to trypsin but is 
effective at a much lower 
concentration.
Stimulates the rate of 
glucose conversion to 
CO2 and the rate of 3-0- 
methyl D-glucose exit in 
isolated adipocytes and 
soleus muscle. Effect 
very similar to that of 
insulin.
Stirring or centrifugation 
cause increases in the 
rate of transport. Cells 
recover after stimulation 
and return to basal rates.
Reference
Rodbell 1967 
Rosenthal & Fain (1971)
Rosenthal & Fain 1971 
Cuatrecasas & Illiano
(1971)
Clausen et al. (1970)
Vqga & Kono (1979)
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Renner, 1972). This appears to be due to the inhibition of adenyl 
cyclase (Hepp & Renner, 1972) and the activation of cyclic nucleotide 
phosphodiesterase activity by insulin (House et al., 1972, and Loten & 
Sneyd, 1970).
The role of cyclic AMP in the regulation of hexose transport 
is not clear. There are varying reports on the effects of cyclic AMP 
when it is added externally to cell suspensions. The general lack of 
effect of cyclic AMP has been assumed to be due to the inability of 
such a charged compound to penetrate the plasma membranes of whole cells. 
Cyclic AMP has however been shown to be present in the bathing medium of 
whole tissue experiments, and in the perfusates from perfusion experi­
ments (Davoren & Sutherland, 1963; Doore et al., 1975; King & Mayer,
1974 and Nickols & Brooker, 1978). Under some conditions the amount of 
cyclic AMP released appears to reflect the tissue level (Broadus et al., 
1970, Exton et al., 1971).
Studies on the uptake and metabolism of exogenous cyclic AMP 
in cultured hepatoma cells by Granner et al. (1975) have indicated that 
the adenosine moiety can enter cells. These experiments do not however 
rule out extracellular hydrolysis of cyclic AMP to release free adenosine,
which is rapidly transported into cells.
Holman (1978; 1979) demonstrated the existence of a facilitated 
diffusion system for cyclic AMP in the human erythrocyte membrane.
Plagemann & Erbe (1977) described the release of a 7-deazapurine analogue 
of AMP from cultured mouse L cells. This system was apparently an active 
transport process which was inhibited by ATP depletion of the cells.
Rindler et al. (1978) also reported efflux of cyclic AMP from a number of
cultured cells. In their experiments Rindler et al. could find no relation­
ship between membrane potential and the rate of cyclic AMP efflux,, and they
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suggested that cyclic AMP efflux shared many of the characteristics of 
the organic anion transport system.
In order to overcome the poor penetration of exogenous cyclic
6 2AMP the lipophillic derivative N -o -dibutyryl cyclic AMP was prepared 
(Henion et al., 1967). This compound was presumed to enter the cell by 
simple diffusion through the plasma membrane and Henion et al., showed 
dibutyryl cyclic AMP to be more effective than cyclic AMP in activating 
lipolysis in fat cells. Corbin & Krebs (1969) showed, however, that 
dibutyryl cyclic AMP did not stimulate the adipocyte protein kinase.
This suggests dibutyryl cyclic AMP must either h Q  metabolised to a 
compcund which can activate protein kinase or it may act via an indirect 
mechanism such as the inhibition of phosphodiesterase activity. Fain 
(1973) has reported that dibutyryl cyclic AMP is a poor inhibitor of 
phosphodiesterase activity in fat cell homogenates. It is difficult to 
detect the metabolism of dibutyryl cyclic AMP in fat cells since high 
concentrations are required to elicit effects. A 1% conversion to 
cyclic AMP would be sufficient to maximally activate lipolysis 
(Belcher, 1971). The. mechanism of dibutyryl cyclic AMP is therefore 
still unclear. Dibutyryl cyclic AMP has been shown to stimulate glucose 
oxidation in intact adipose tissue (Bray, 1967 and Schimmèl & Goodman, 
1971). These results indicated that whilst the effect of dibutyryl cyclic 
AMP is mainly a stimulation of the enzymes involved in glucose oxidation, 
Schimmel & Goodman reported that part of the effect was due to a stimu­
lation of hexose transport.
70.
Cyclic GMP
Illiano et al. (1973) reported that insulin elevates the 
intracellular levels of guanosine 3'5' cyclic monophosphate (cyclic GMP) 
by three to four fold. Agents such as carbamyl choline which also 
elevate cyclic GMP levels in adipocytes do not all affect lipolysis 
(Fain & Butcher, 1976). Furthermore exogenous cyclic GMP or dibutyryl 
cyclic GMP do not mimic insulin action on glycogen synthesis (Pinkett & 
Perlman, 1975). 8-bromo-cyclic GMP has however been reported to stim­
ulate hexose uptake in rat diaphragm (Pinkett & Perlman, 1975) .
One of the aims of the experiments reported in this thesis 
was therefore to examine the effects of nucleosides, nucleotides and 
cyclic nucleotides on the regulation of hexose transport in adipocytes.
Ion fluxes
Insulin has been shown to regulate both anion and cation 
fluxes in intact cells (Clausen & Hansen, 1977). The effect of insulin 
on membrane potential and ion fluxes have been shown to be rapid and 
occur independently of the action of insulin on hexose transport (Czech 
1977). Thus, changes in ion transport may lead to activation of the 
hexose transport system.
Monovalent cations
Since hexose transport in adipocytes is not sodium dependent, 
direct regulation of hexose transport by sodium ions is unlikely. Letarte & 
Renold (1967) reported that when sodium ions were not present in the 
suspending medium the stimulation of glucose oxidation by insulin was 
reduced. Clausen (1970) suggested that this effect may be due to a 
sodium requirement for metabolism rather than transport.
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In contrast the omission of potassium ions from muscle cell 
media (Clausen, 1969) or inhibition of the sodium potassium ATPase of 
isolated fat cells (Bihler, 1968, Bihler & Sawh, 1971a,b) lead to an 
increase in hexose transport activity. High potassium-content buffers 
lead to a reduction in the rate of sugar transport (Bihler & Sawh, 1971 b ) . 
The intracellular level of potassium ions rather than sodium potassium 
ATPase activity appeared to modulate these effects. Insulin however 
leads to opposite effects in the membrane potential with an increased 
potassium ion concentration inside the cell.
Divalent cations
Several of the effects of insulin on whole cells and the effects 
of compounds which mimic insulin action have been shown to require 
calcium ions in the incubation medium (Kissebah et al., 1975). Calcium 
release from isolated fat cells had been shown to increase with insulin 
treatment (Martin et al., 1975). Letarte & Renold (1969) observed no 
effects of high or low calcium concentrations on glucose oxidation by 
adipocytes. Similarly Rihan et al. (1975) observed no effects on glucose 
oxidation in the presence of the calcium chelator EDTA. In contrast, 
Ludvigsen & Jarrett (1980) reported that omission of calcium from the 
incubation buffer before cell disruption significantly lowered (by 24%) 
the fossil insulin stimulation of hexose transport observed in plasma 
membranes. There was no effect on hexose transport in isolated membranes 
when calcium ions were present or absent.
Vanadium ions have been reported to increase the rate of 
transport and oxidation of D-glucose in adipocytes (Dubyak & Kleinzeller 
1980 and Shechter & Karlish, 1980). Dubyak & Kleinzeller reported that 
the effect of vanadate was comparable to that of insulin, though vanadate
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and insulin together produced no additional effect. The effects of 
vanadate on hexose transport were observed before significant inhibition 
of the sodium potassium ATPase occurred. Clausen et al. (1981) also 
reported effects of vanadate on muscle and adipocytes though they report 
effects that are somewhat smaller than those exerted by a supramaximal 
concentration of insulin. Clausen et al. also reported that vanadate 
stimulated calcium washout from the tissues and suggested that the action 
of vanadate is related to inhibition of the calcium sensitive ATPase of 
the endoplasmic reticulum.
Coulston & Dandona (1980) reported that zinc exerts a stim­
ulating action of lipogenèsis in adipocytes.
The Jarett peptide
Jarett & Seals (1979) have reported the;:isolation of a low 
molecular weight polypeptide which is released from isolated adipocyte 
plasma membranes on the addition of insulin. This polypeptide is capable 
of activating the mitochondrial pyruvate dehydrogenase complex. The 
polypeptide is released by insulinomimetic agents other than insulin 
(Seals & Jarett, 1980) suggesting that it is not a product of the insulin 
molecule itself, but rather that it is derived from a plasma membrane 
component. Reports of the action of this material are so far confined 
to its action on intracellular enzymes and it has not been studied for 
effects on the hexose transport system.
Whilst cyclic nucleotides, cellular ion fluxes and other second 
messengers may be involved in insulin action, these do not give an 
indication of the mechanism of insulin activation of the hexose transport 
system.
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Models for the regulation of hexose transport
In target tissues insulin and adrenaline both increase the
Vmax for hexose transport without affecting the Km. A central problem 
in the regulation of hexose transport is thus whether or not the actual
number of transporters in the plasma membrane is changed by hormonal
stimulation. Insulin can either increase the number of functional 
transporters by conversion from an inactive to an active form or through 
recruitment of transporters from another cellular compartment to the 
plasma membrane. Alternatively the Vmax for individual transporters can 
be changed by insulin. Both these hypotheses are consistent with the 
observed enhancement of Vmax with no change in the Km. The hypothesis 
of an increased number of functional transporters suggests that the 
characteristics of the transporters (e.g. temperature dependence, pH 
profile and substrate specificity) would be similar in both basal and 
insulin stimulated cells. The hypothesis of activation of existing trans­
porters by increasing the Vmax suggests that different properties would 
be exhibited by the transport of basal and insulin stimulated cells.
Studies on the properties of the D-glucose transport system 
of both basal and insulin stimulated adipocytes suggest that the pH 
dependence of the transport system is altered by insulin (Whitesell & 
Gliemann, 1979). In contrast the results of Ludvigsen & Jarett (1980) 
suggested that the pH profile of D-glucose transport in isolated plasma 
membranes was similar in plasma membranes from basal and insulin stimu­
lated cells. Whitesell & Gliemann (1979), Amatruda & Finch (1979) and 
Kono et al. (1977) have all reported differences in the temperature 
dependence of hexose transport in basal and insulin stimulated adi­
pocytes, although Vinten (1978) and Olefsky (1978) did not report such 
a difference. Ludvigsen & Jarett (1980) also reported identical temper­
ature dependence for hexose transport in plasma membranes from basal and
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insulin stimulated adipocytes.
Differences in the fluidity of the plasma membrane have been 
proposed as a means of regulating the rate of glucose transport in plasma 
membranes. Pilch et al. (1980) reported an increase in the rate of 
glucose transport in plasma membranes from basal adipocytes when cis 
vaccenic acid or oleic acids were added directly to isolated plasma 
membranes. Similar results were obtained when these unsaturated fatty 
acids were added to liposomes containing reconstituted adipocyte hexose 
transporter proteins. There were no changes observed when these exper­
iments were performed on membranes derived from insulin treated cells.
In contrast when stearate was incorporated into membranes from insulin 
treated cells the transport rate was reduced to basal levels, but there 
was no effect of stearate in membranes from basal cells.
Insulin has been reported to increase fatty acid desaturase 
activity (Prasad & Joshi, 1979) and increase phospholipase activity 
(Bereziat et a l , ,  1978) though no reports of changes in phospholipids 
following insulin stimulation have been published. Czech (1980) has 
proposed that insulin either affects bilayer fluidity in localised mem­
brane regions or increases the partition of the hexose transporter in 
more fluid regions of the plasma membrane.
The observation that multivalent agents such as lectins or 
anti-membrane antibodies mimic the effects of insulin (Czech et al.,
1974a, Cuatrecasas & Tell, 1973) has lead to the suggestion that the 
initial effect of insulin is to cause aggregation of insulin receptors 
on the cell surface. Kahn et al. (1978) have reported that the addition 
of anti-insulin antibodies to adipocytes, submaximally stimulated with 
insulin, leads to an increased stimulation of transport.
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Studies by Jarett & Smith (1977, 1979), using ferritin labelled 
insulin which can be visualised under the electron microscope, showed 
that insulin receptors formed clusters which were disaggregated in the 
presence of cytochalasin B at similar concentrations to that which blocks 
hexose transport activity. Jarett & Smith (1979) proposed that these 
clusters formed hexose transport pores through the plasma membrane, 
cytochalasin B causing inhibition of transport by disaggregating the 
clusters. Carter-Su et al. (1980) have shown that the insulin receptor 
and the hexose transporter behave differently as detergent solubilised 
proteins and that the two activities are distinct polypeptide molecules. 
This does not rule but the possibility that in the membrane hexose 
transport protein(s) are associated with insulin receptors by non- 
covalant means that are disrupted by mild detergents. Thus, aggregation 
of membrane components appears to be involved in the action of insulin; 
however the aggregation of insulin receptors is a preliminary step which 
leads to the activation of the transport system.
The effects of oxidants on whole cells has lead to the 
proposal by Czech (1977) that membrane redox reactions may be involved 
in the action of insulin. Czech proposed that the activation of hexose 
transport involves oxidation of membrane sulphydryl groups to the 
disulphide form. Studies on isolated plasma membranes by Ludvigsen & 
Jarett (1980) showed that sulphydryl reagents inhibit both basal and 
insulin stimulated transport proportionately. Goldstein & Livingston 
(1978) reported that sulphydryl agents such as diamide affect cell 
integrity and lead to non-specific uptake. Their results also showed 
that there was no change in the levels of reduced glutathione in adi­
pocytes when insulin was added. Thus no direct evidence for the thiol 
redox model has yet been presented.
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Wardzala et al. (1978) proposed that the action of insulin 
is to increase the number of functional transport sites within the plasma 
membrane. Their studies suggest that insulin treatment increases the 
number of glucose displaceable cytochalasin B binding sites in the 
plasma membrane. They have proposed that the glucose displaceable 
cytochalasin B binding represents binding to the hexose transporter in 
the adipocyte membrane, and conclude that the action of insulin is to 
increase the number of functional transport sites in the membrane.
In an extension of this study Cushman & Wardzala (1980) showed that 
glucose displaceable cytochalasin B binding was also present on micro­
somal membranes of the adipocyte. Their results showed a reciprocal 
transfer of these cytochalasin B binding sites from the microsomal 
membranes to the plasma membrane on stimulation with insulin. The total 
number of sites per cell remained constant on the addition of insulin but 
the distribution was altered. Karnieli et al. (1981) have further extended 
this study and have shown-the transfer of cytochalasin B binding sites to 
be reversible and the magnitude of the transfer to be dependent on the 
insulin concentration. The time course for the transfer of cytochalasin 
B binding sites is very similar to the time course for insulin acti­
vation of hexose transport, showing a similar lag before the initiation 
of activation. A similar transfer of cytochalasin B binding sites has 
also been shown by Wardzala & Jeanrenaud (1981) in muscle preparations.
Independently, Suzuki & Kono (1980) proposed a similar 
mechanism for the action of insulin. They studied glucose transport in 
liposomes containing extracts of membrane proteins from adipocytes. They 
were able to extract proteins which catalysed stereospecific D-glucose 
transport from both plasma membrane fractions and from a low density 
membrane fraction enriched in UDP-galactose-N-acetyl glucosamine
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galactosyl transferase activity, a marker enzyme for the golgi apparatus. 
When membranes from basal and insulin stimulated cells were compared 
there was an apparent transfer of the glucose transport activity from 
the golgi apparatus to the plasma membrane. Kono et al. (1981) have 
shown that the transfer of transporters was prevented by agents which 
lowered intracellular ATP. They also showed that protein synthesis 
inhibitors did not prevent the transfer of transporters.
Thus, two hypotheses are presented for the action of insulin, 
a direct effect on existing transporters, or the transfer of existing 
transporters from an intracellular site to the plasma membrane. Since 
the supporting evidence for both hypotheses is based on indirect evidence^ 
neither hypothesis can at present be regarded as proven.
MATERIALS AND METHODS
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The preparation of isolated adipocytes 
Rat epididymal adipocytes were prepared by the method of 
Rodbell (1961) as modified by Gliemann (1967) and Foley et al. (1980a)
Materials
Disposable polystryrene sample containers and polypropylene 
centrifuge tubes were from Walter Sarstedt Ltd., Leicester. All other 
vessels were cleaned using Decon-90 and then soaked overnight in 6M 
hydrochloric acid in order to remove detergent residues. After acid 
treatment, vessels were thoroughly washed with hot tap water, distilled 
water and finally, double distilled water. Double distilled water was 
used to prepare all the buffers used.
Hepes buffer
N-2-hydroxyethylpiperazine-N'-2-ethane sulphonic acid (Hepes) 
was from the Sigma Chemical Co. All other chemicals were BDH Analar 









The buffer was prepared as two 10 x concentrated stock solutions, one 
containing Na , K^, Ca^*, and Mg^\ and the other contained Hepes and PO^
.1
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Both these solutions were adjusted to pH 7.6 at 20°C, filtered and 
stored at 4°C until required. Both solutions were replaced fortnightly.
Preparation of bovine serum albumin
Bovine serum albumin (Fraction V) Lot No.A 4503 from the 
Sigma Chemical Co. was used. Before use the albumin was extensively 
dialysed in order to remove any hormones present.
lOOg of bovine serum albumin was dissolved in 500ml double 
distilled water and dialysed for 24 hours against 10 volumes of double 
distilled water at 4°C. The dialysis water was changed at least three 
times in this period. After dialysis the albumin solution was diluted 
to give a 10% w/v solution and the pH adjusted to 7.4 by the addition of lOM 
sodium hydroxide. Jhe solution was sterilised by filtration, first through 
a Whatman 41 paper filter, then a Whatman 42 paper filter and, finally, 
an 0.8p Millipore filter. This albumin solution was separated into 
aliquots and then stored at -20°C until required. The albumin stocks 
were not re-frozen more than once. In order to prepare albumin containing 
buffers an appropriate quantity of this stock was then added in place of 
double distilled water during the preparation of the buffers.
Collagenase
Batches of collagenase from Worthington enzymes, the Sigma 
Chemical Co. and PL Biochemicals were all tested by preparing isolated 
adipocytes. Criteria for cell viability were the magnitude of the 
insulin stimulation of lipogenesis from [u-^^c]D-glucose,and the release 
of lactate dehydrogenase activity. Lot No (4197 CLS 40 B) IIP from 
Worthington enzymes (activity 142 U/mg) gave the largest response to 
insulin and the lowest rate of lactate dehydrogenase release. This batch
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of collagenase was used in all the experiments described.
The preparation of isolated adipocytes
Male Wistar rats weighing between 150-160g, which had been 
maintained on standard laboratory chow and water ad libit um, were 
killed by cervical dislocation and the epididymal fat pads were rapidly 
removed. Typically the pads from two animals were washed in lOmls of 
1% albumin Hepes buffer, then minced with scissors (or in some initial 
experiments minced with a Mcllwain tissue chopper into 0.5mM cubes) and 
transferred to a polystyrene vessel containing 6ml of 3.5% albumin Hepes 
buffer containing 0.5mg/ml collagenase and 0.5mM D-glucose. The tissue 
was then allowed to digest, the contents of the vessel being stirred 
slowly with a teflon coated magnetic stirrer flea. The digestion was 
terminated when no lumps of undigested material remained; this was 
normally after approximately 1 hour. The digest was filtered through a 
nylon mesh (mesh size 250pm) and the adipocytes were allowed to float to 
the surface over a period of 3-5 minutes. The infranatant buffer was 
carefully removed with a siliconised pasteur pipette and the cells were 
gently resuspended in approximately 10ml of Hepes buffer containing 1% 
albumin. This washing procedure was repeated five times, with one change 
of the polystyrene vessel holding the cells. The cells were maintained 
at 37°C throughout the washing procedure. The cell suspension was then 
adjusted to the required packed cell volume using a micro haematocrit 
tube. The tube was centrifuged at 1000% g for 15 seconds and the 
volume of cells and buffer measured.
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The preparation of insulin solutions
Img of recrystallised porcine insulin (Novo) was dissolved 
in 1ml of 0.03mM HCl and this solution was then diluted with 2ml double 
distilled water. 1ml of this stock was then diluted to 50ml with 1% 
bovine serum albumin in Hepes buffer pH 7.4. This stock was stored at 
-20°C until required. Appropriate dilutions of this lyM stock solution 
were then used with cell suspensions.
Submaximal doses of insulin
In order to achieve accurate estimates of the effects of sub- 
maximal doses of insulin, cells were suspended in 3.5% w/v albumin Hepes 
buffer containing 0.05% w/v bacitracin (Sigma Chemical Co. ) as described 
by Whitesell & Cliemann (1979).
The rate of lipogenesis in adipocytes
_ _
The rate of conversion of |_U- C_|-D-glucose to lipids by
isolated adipocytes was estimated in order to assess the hormonal res­
ponsiveness of the adipocyte preparation. The method of Dole & Meinertz
f” 1A “I • •(I960) was used. |_U- C_|-D-glucose was from The Radiochemical Centre,
Amersham. All other chemicals were BDH Analar grade.
50yl of an adipocyte suspension at 40% packed cell volume was 
preincubated for 15 minutes in 500yl of 1% albumin Hepes buffer with or
without the test hormone. lOyl of -D-glucose was then added
together with sufficient unlabelled D-glucose to give a final concentration 
of ImM. The incubation was continued for 15 to 30 minutes. The preparation 
was mixed gently every 5 minutes in order to resuspend the cells. The 
reaction was terminated by the addition of 2.5ml Dole medium (3:2 propan-
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l-ol:n’-heptane) and the mixture was shaken vigorously. 1.5ml of
n ’-heptane was then added and mixed followed by 1ml of distilled water.
The phases were allowed to separate and 0.5ml of the n-heptane phase
was removed. The radioactivity present was determined by liquid scin-
-1
tillation counting using 5ml of toluene-PPO scintillant (5g PPO 1 ).
The estimation of lactate dehydrogenase activity
The release of the cytosolic enzyme lactate dehydrogenase 
provides a means of measuring the rate of cell lysis. Lactate dehydro­
genase activity was estimated by the method described by Bergmeyer &
Bernt (1974). The rate of oxidation of NADH by pyruvate was followed by 
the change in absorbtion at 340nm. NADH (type IV) was from the Sigma 
Chemical Co. All other chemicals were BDH Analar grade.
An adipocyte suspension was incubated in 1% Albumin Hepes buffer 
At different times the cells were allowed to float to the surface and 
samples of the infranatant were taken. In order to estimate the total 
lactate dehydrogenase content^whole tissue or isolated cells were lysed 
in an 0.05% v/v solution of Triton X-100 in distilled water. Samples 
were stored at 4°C before assaying for lactate dehydrogenase.
The assay was carried out at 25°C in a 3ml volume containing 
48mM sodium phosphate buffer pH 7.5, 0.6mM Na pyruvate, and 0.18mM NADH. 
in a silica cuvette. The reaction was started by the addition of 50ij1 
of enzyme suspension and the change in absorbance at 340nm was followed 
by a spectrophotometer.
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The preparation of 3*-5*-cyclic AMP binding protein
3 ’-5’ cyclic AMP binding protein was prepared by the method of 
Toyey et al. (1974) from rabbit skeletal muscle. The entire preparation 
was carried out at 4°C.
350g of rabbit skeletal muscle was cut into small pieces and 
homogenised in 500ml of 4mM EDTA (pH 7.0) for 2 min using a Waring 
Blender. The homogenate was centrifuged at 27,000x g for 30 minutes.
The pellet was discarded and l.OM acetic acid was glowly added to the 
supernatant until the pH was 4.8. The mixture was allowed to stir for 
10 minutes and then centrifuged at 27,000xg.for 30 minutes. The pellet 
was discarded and the supernatant brought to pH 6.5 by the addition of 
l.OM potassium phosphate buffer (pH 7.0). 32.5g/100ml ammonium sulphate
was then added very slowly with continual stirring in order to precip­
itate the crude binding protein, which was collected by centrifugation 
at 27,000X g for 30 minutes. The pellet was dissolved in 6% of the 
volume before precipitation, of 5mM potassium phosphate buffer (pH 7.0) 
containing 2mM EDTA and dialysed overnight against three changes of 5mM 
potassium phosphate buffer containing 2mM EDTA. This yeilded 4.28g of 
crude binding protein.
The binding protein was further purified by ion exchange 
chromatography on DEAE cellulose (DE52-Whatman). The DEAE cellulose 
column (approximately 200ml bed volume) was equilibrated with 5mM 
phosphate buffer (pH 7.0) containing 2mM EDTA. After the sample was 
applied in 5mM phosphate buffer + 2mM EDTA the elution was commenced with 
O.IM phosphate buffer (pH 7.0) and 10ml fractions of the eluate were 
collected. After 30 fractions the elution buffer was changed to 0.3M 
phosphate buffer (pH 7.0) and a further 30 fractions were collected.
The entire procedure was carried out at 4°C.
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The fractions from the column were assayed for cyclic AMP 
binding (as described below) and protein was measured by the solution 
absorbtion at 260 and 280nm. The column elution profile is shown in 
Fig. 4. Fractions 11-19 gave the optimal cyclic AMP binding character­
istics (Tovey et al., 1974) and after being pooled were used for the 
estimation of cyclic AMP. The prepared binding protein was stored as 
aliquots at -20°C. The binding properties were found to be stable for 
at least six months under these conditions.
Cyclic AMP binding assay 
Cyclic AMP was assayed by the binding assay of Tovey et al. 
(1974). Norrit CSX charcoal was from BDH, cyclic 3'5' [8“^h ] Adenosine 
monophosphate (30Ci/mMol) was from the Radiochemical Centre Amersham, 
and Bovine serum albumin and cyclic 3'5' adenosine monophosphate were 
from the Sigma Chemical Co.
The extraction of cyclic AMP from cells
Cyclic AMP was extracted from whole cells in order for the 
assay to be performed. 50yl of a 40% PCV cell suspension was incubated 
in 200yl of 1% albumin-Hepes buffer for the appropriate time, and the 
reaction was terminated by the addition of 200yl of 5mM tris-HCl buffer + 
4mM EDTA (pH 7.4). The samples were immediately placed in a boiling water 
bath for 5 min. The precipitated protein was removed by centrifugation at 
10,000X g for 4 min and the supernatant was removed. The precipitate 
was then resuspended in a further 200yl of distilled water, centrifuged, 
and the supernatants combined. The samples were then lyophylised and 
dissolved in lOOyl of assay buffer. This sample was then assayed for 
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The ion exchange chromatography of crude cyclic AMP binding protein 
on DEAE cellulose. For details see materials and methods.
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The assay of cyclic AMP
The assay was performed in 50mM tris-pCl(pH 7.5) containing 
4mM EDTA. The optimal dilution of the stock binding protein (which 
retained 55% of the added tracer cyclic AMP) was found to be a 1 + 5 
dilution of the stock binding protein with assay buffer. The charcoal 
adsorbent was 520mg of Norit GSX charcoal suspended in 20ml of assay 
buffer containing 2% w/v bovine serum albumin.
Method
The components of the reaction mixture were added in the
following order: 50yl of tritiated cyclic AMP (5yCi of stock isotope in
10ml of assay buffer), 50yl of unlabelled cyclic AMP (standard or
unknown) and lOOyl of binding protein solution. After mixing the tubes
were incubated for 2 hours at 4°C. lOOyl of charcoal suspension was
then added to each tube which was then vortex mixed for 10 seconds. The
tubes were then centrifuged for 1 minute at 10,000x g at 4°C. 200yl of
the supernatant (bound fraction) was removed and the radioactivity
measured by liquid scintillation counting in 2ml.i triton: toluene:PPO
-1scintillant (30:70:5gl ). A blank was determined by measuring the cpm
in 200yl of supernatant from a tube containing 50yl tritiated cyclic 
AMP, 150yl assay buffer and lOOyl of charcoal suspension. This blank 
reading was subtracted from all other results.
The cpm bound in the absence of unlabelled cyclic AMP (i.e. 
the zero dose binding) was designated Co and the cpm bound in the pre­
sence of unlabelled cyclic AMP (calibration standard or unknown) was 
designated Ox. The ratio of Co/Cx was calculated for all the standard 
cyclic AMP samples and a calibration curve was obtained by plotting Co/Cx 
against pMoles standard cyclic AMP. The amount of cyclic AMP in the
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unknowns was then read off this line using the measured Co/Cx values.
Sources of chemicals for regulation study
Adenosine; adenosine deaminase (from calf intestinal mucosa); 5'adenosine
monophosphate; 5 ’adenosine diphosphate; 3'-5* cyclic adenosine mono-
6 2phosphate; 8-bromoadenosine-3,5,-cyclic-monophosphoric acid; N ,0 - 
dibutyryl adenosine-3'5 ’-cyclic-monophosphoric acid; 3 ’,5’cyclic 
guanosine monophosphate; 5' guanosine monophosphate; 8-bromoguanosine-3', 
5 '-cyclic-monophosphoric acid; 8-bromoinosine-3'5 '-cyclic monophosphoric 
acid; inosine; xanthine; hypoxanthine; guanosine, 3 nicotinamide adenine 
dinucleotide; 3 nicotinamide adenine dinucleotide reduced form (NADH); 
and chlorpromazine were all from the Sigma Chemical Co.
[S- 1̂̂ 1-adenosine was from the Radiochemical Centre, Amersham.
2'(3') adenosine monophosphate (mixed isomer); uridine; nicotinamide; and 
4-acetamido-4'-isothiocyano-stilbene-2-2-disulphonic acid (SITS) were 
from BDH Ltd.
5' adenosine triphosphate was from P.L. Biochemicals. 3-amino- 
benzamide was synthesised by Dr. M.R. Purnell.
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Sources of chemicals for the study of the substrate specificity of the 
adipocyte hexose transporter 
1-deoxy-D-glucose; 5-thio-D-glucose; D-galactose; 2-deoxy-D- 
glucose; D-glucosamine; 2-deoxy-D-galactose; N-acetyl-D-glucosamine; 
D-talose; L-arabinose; D-xylose; 6-deoxy-D-glucose; D-fucose and phenyl- 
3-D-glucoside were from the Sigma Chemical Co. 2,3-di-O-methyl-D-glucose; 
6-0-methyl-D-galactose; 4,6-0-ethylidene-D-glucose and methyl-3-D-glucose 
were from Koch Light. D-glucose; methyl-a-D-glucoside, trehalose, and
I
maltose were from BDH Ltd. Cytochalasin B was from Aldrich Chemicals Ltd. 
r 14-,D-Lp- C_|-xylose was from the Radiochemical Centre, Amersham.
r 3 “I . r 14 -i1-deoxy-D-[6- H|-glucose; 4,6-0-ethylidene-D-[U- C^|-glucose; n'-propyl-
3~D-[6-^h |-glucoside; methyT-3-D-[6-^Hj-glucoside, and n'-butyl-3~D- 
r 3 -[_6- Hj-glucoside were all synthesised by Dr. G.D. Holman.
3“fluoro-D-glucose; 3-deoxy-D-glucose; 3-deoxy-3-fluoro-D-glucose; 
3-0-propyl-D-glucose; 6-deoxy-6-fluoro-D-glucose; 6-0-pentyl-D-gglactose; 
6-0-propyl-D-galactose; n ’-propyl-3~D-glucoside and n'-butyl-D-glucoside 
were synthesised by Dr. G.D. Holman.
89.
Transport assays with whole cells
The rate of hexose transport in whole adipocytes was measured
r3by the method of Whitesell & Gliemann (1979). 3-0-[_ H-methyy -D-glucose
rl4 -,and 3 - 0 - C-methylj-D-glucose were synthesised by the method described
later, or purchased from the Radiochemical Centre, Amersham or the New
England Nuclear Corp. Isotopes from all these sources behaved identically.
[p-^H]-D-allose was prepared by Dr. G.D. Holman by the method of Sowa &
Thomas (1966) as described by Rees & Holman (1981). Tritiated isotopes
were regularly purified by preparative paper chromatography (see p. 100).
Phloretin was from K & K Laboratories, unlabelled 3-0-methyl-D-glucose and
D-allose were from the Sigma Chemical Co. and the Silicone fluid was Dow
Corning 100-200cs supplied by Hopkin & Williams. 
rrLC-iV. O -t CL .
Zero trans entry
50pl of an adipocyte suspension, either basal or insulin stimu­
lated at 40% packed cells, was added to 15yl albumin free buffer containing 
radiolabelled sugar + cold sugar (or inhibitor) in a 3.5ml polypropylene 
centrifuge tube. Since the bulk of the volume of an adipocyte is a non- 
aqueous lipid deposit, the cell volume of the adipocytes is not regarded 
as free solution and the starting concentrations were adjusted to take 
account of this. D-allose transport was followed over a period of 1, 2 
and 3 minutes in insulin stimulated cells, and over a 30 minute period 
in basal cells. 3-0-methyl-D-glucose transport was followed over 30,
60 and 90 seconds in basal cells and 1, 2 and 3 seconds in insulin stim­
ulated cells. For rapid uptakes, timing was aided by the use of a metro­
nome set to two beats/second. Transport was terminated by the rapid 
addition of 3ml of 0.33mM phloretin in albumin free Hepes buffer. The 
phloretin stopping solution was prepared by first dissolving the phloretin
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in ethanol (0.2% of final volume), then adding dimethyl sulphoxide
(0.08% final volume) and this mixture was rapidly dispersed in albumin
free Hepes buffer. A layer of silicone oil was then placed on top of
the buffer and the tubes were centrifuged at 2500 x g for 1 minute in a
swing-out centrifuge. After centrifugation the cells were removed from
the top of the oil layer with a pipe cleaner. The radioactivity
associated with the cells was then determined by liquid scintillation
-1counting using 5ml toluene : Triton X-100:ppo scintillant (30:70:5gl ).
Blanks were estimated by adding 1ml of phloretin stopper to the tubes 
before the addition of the cells. Equilibrium volumes were determined 
by allowing the cells to equilibrate with tracer for 30-45 min before 
isolating the cells.
Equilibrium exchange
A similar technique to that described for zero trans entry was 
used except that the cells were preequilibrated with substrate (and 
inhibitor) before assaying transport. An adipocyte suspension at 44% 
packed cells wois preincubated for 30 minutes with unlabelled substrate 
(and inhibitor) so as to give a final cell volume of 40% and the 
desired substrate (and inhibitor) concentration. These concentrations 
were adjusted to allow for the non-aqueous volume of the adipocytes.
For both zero trans entry and equilibrium exchange experiments 
the average rate of uptake was estimated using the integrated rate 
equation.
V _ ,—  — InS I j / ^  (8)
Where S is the substrate concentration, f is the fractional filling and 
t is the time of uptake.
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Average inhibition constants (Ki’s) were derived from the
equation
f ■ ‘ • H -  <’>
Where Vo is the uninhibited rate, V is the inhibited rate and I is the 
inhibitor concentration.
For both zero trans entry and equilibrium exchange the non­
mediated rates were estimated as that transport which was not inhibited 
by 50yM cytochalasin B.
Zero trans exit
Cells were prepared to 44% packed cells and radiolabelled sub­
strate (and inhibitor) were added and allowed to equilibrate for 30-45 
minutes before the assay. The concentrations were corrected to allow for 
the non-aqueous volume of the adipocytes and to bring the adipocyte sus­
pension to 40% packed cells.
The exit rate was measured by adding 50yl of the adipocyte 
suspension to 5ml of albumin free buffer which was magnetically stirred.'
At the appropriate time transport was terminated by the addition of 5ml 
of Hepes buffer containing 0.6mM phloretin. 1ml of silicon oil was 
placed on the surface of the tube, and : the tube was centrifuged at 
2500X g for 1 minute. The cells were removed from the surface of the 
oil using a pipe cleaner and the trapped radioactivity estimated by 
liquid scintillation counting as described for zero trans entry experi­
ments. In order to determine zero time (blank) values the cells were 
first treated with 50yM cytochalasin B and then added to 5ml of albumin 
free Hepes buffer containing 50pM cytochalasin B. 5ml of phloretin 
stopping solution was then added and the samples treated as described
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above. Total exit was determined over a period of 10 minutes. 3-0- 
methyl-D-glucose exit was measured over 2 and 3 seconds in insulin stim­
ulated cells.
Average exit rates for tracer were calculated using an 
integrated rate equation similar to equation 8.
I IIt ‘ ; (10)
where fr is the fraction remaining at time t and Si is the substrate 
concentration at zero time.
Inhibition constants for the inhibition of tracer exit were 
calculated using equation 9. The Km for zero trans exit was calculated 
using equation
Vo _ _ , S corr
V Km
where S corr = S. / 1 - fr1 (11)
Si is the substrate concentration, fr is the fraction remaining, Vo is 
the rate for tracer (a concentration very much less than the Km) and V is 
the rate for substrate concentration Si.
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The preparation of subcellular fractions of adipocytes
Subcellular fractions of adipocytes were prepared by a modi­
fication of the methods of McKeel & Jarett (1970) and Jarett (1974).
Materials
As described for the adipocyte preparation, all vessels used
were extensively washed to remove detergent residues. All buffers used
were prepared with double distilled water. Sucrose-tris-EDTA buffer
contained 0.25M sucrose; lOmM tris-HCl (pH 7.4) and 0.5mM EDTA. After
preparation the buffer was filtered and autoclaved then stored at 4°C
2+until required. In experiments where Mg dependent enzymes were assayed. 
EDTA was replaced by 0.5mM EGTA. All reagents were BDH Analar grade.
Ficoll-400 was obtained from Pharmacia. Before use a 30% 
solution of Ficoll in double distilled water was dialysed overnight 
against 10 volumes of double distilled water, with at least four changes 
of the dialysis medium. After dialysis the Ficoll was lyophylised and 
ground to a fine powder.
Method
Homogenisation of the cells
Isolated adipocytes were prepared as described in the previous 
section. The cells were first preincubated with hormone (if required) for 
15 min then washed with 15ml of sucrose-tris-EDTA buffer at 37°C (con­
taining hormone if required). The cells were then transferred to a
II tt
Potter-Elvejhem homogeniser with a clearance of 0.006 -0.010 .
Typically 4mls of cells at 40% packed cells were homogenised in 25ml of 
sucrose tris EDTA buffer at room temperature by ten strokes of the homo­
geniser turning at 1,600 rpm. The homogenate was transferred to a
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centrifuge tube and the homogeniser washed with a further 25ml of buffer
The homogenate was then centrifuged at 16,000x g for 15 min 
at 4°C. After centrifugation the fat cake was discarded and the super­
natant (SI) removed for preparation of the microsomal fraction. The 
pellet (PI) was resuspended in 50ml sucrose tris EDTA buffer for the 
preparation of the plasma membrane and mitochondrial fractions.
Preparation of the microsomal fraction
The supernatant (SI), after homogenisation, was centrifuged at 
100,000 for 70 minutes at 4°C. The supernatant was carefully removed
with a Pasteur Pipette (due to the loose pellet formed) and the pellet
was resuspended in the required volume to form the microsomal fraction.
Separation of plasma membranes and mitochondria
The resuspended pellet (PI), after homogenisation, was centri­
fuged at 16,000X g for 20 min at 4°C. The supernatant was discarded and 
the pellet resuspended in 2ml of sucrose tris EDTA buffer; this material 
was carefully layered onto 4ml of 6% Ficoll in sucrose tris EDTA buffer 
in a Beckman SW 50.1 centrifuge tube. This size of gradient could 
separate the material from 4ml of 40% packed cells without evidence of 
overloading. The Ficoll gradient was centrifuged at 44,OOOxg for 45 min 
at 4°C. The plasma membrane formed a cloudly layer at the buffer Ficoll 
interface, which could be removed with a pasteur pipette. The mito­
chondria and nuclei formed a pellet (P2) at the bottom of the tube. Mito­
chondria and nuclei were recovered by diluting the pellet with 50ml 
sucrose tris EDTA buffer in order to wash out the Ficoll and collecting 
by centrifugation at 16,000xg for 20 min at 4°C.
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The plasma membrane fraction was diluted with 30ml sucrose 
tris EDTA buffer and centrifuged at 100,000 x g for 70 min. The super­
natant was removed carefully without disturbing the loose pellet, and 
the pellet resuspended in the required volume. This suspension was then 
sonicated for 30 seconds in a 75W ultrasonic water bath. Once prepared 
the plasma membrane fraction could be stored overnight in liquid 
nitrogen, without loss of transport activity.
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Marker enzymes for subcellular fractions 
Protein was estimated using the method of Lowry et al. (1951) 
using bovine serum albumin (Fraction V) as standard.
Succinic dehydrogenase (EC.1.3.99.1)
Succinic dehydrogenase activity was assayed by the method of 
Pennington (1961) .
50yl of material was incubated with 0.8ml of: 0.125% 2-(p- 
iodophenyl)-3-(p-nitrophenyl)-5-phenyl tétrazolium chloride; 30mM sucrose; 
60mM sodium phosphate buffer (pH 7.5) and 50mM sodium succinate at 37°C 
for 15 min. A blank was performed using similar conditions except that 
the sodium succinate was omitted. The reaction was terminated by the 
addition of 1ml of 10% (w/v) trichloroacetic acid in water. 4ml of 
ethyl acetate was added and after the phases had separated the ethyl 
acetate layer was removed and 0.3ml of methanol was added. The optical 
density of the ethyl acetate phase was read at 490nM against an ethyl
acetate blank. The molar extinction coefficient of the formazan produced
3 -1 -1by the reaction is 20.1 x 10 M cm
NADH oxidase (EC 1.6.99.3)
NADH oxidase activity was measured spectrophotometrically by the 
method of Avruch & Wallach (1971). NADH and potassium ferricyanide were 
from the Sigma Chemical Co.
The reaction was carried out in a 1ml silica cuvette containing 
O.OlmM NADH, 4mM tris-HCl(pH 7.4) and 0.22mM potassium ferricyanide. The 
reaction was initiated by the addition of 50yl membrane suspension. The 
reference cuvette contained the same solution but no membrane suspension. 
The reaction was followed by the change in absorbtion at 340nm by a Pye
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Unicam SP-8-lOO-dual beam recording spectrophotometer.
5' nucleotidase (EC 3.1.5.3)
5' nucleotidase was assayed by the radioenzyme assay of 
Avruch & Wallach (1971) as modified by Newby et al. (1975).
Purification of [8-^H|-AMP
[8-^h | adenosine 5 ’ monophosphate (The Radiochemical Centre,
3Amersham) was found to deteriorate on storage. H-AMP was purified by
ion exchange chromatography on Dowex AG-XlOO resin (400-800 mesh, acetate
3form) in a .5 X 0.5cm column. H-AMP was applied as a solution in dis­
tilled water and the column washed thoroughly with 20ml distilled water.
3The H AMP was then eluted with 20ml IM acetic acid, the fractions con­
taining the activity were pooled and lyophylised, then made up to 
ImCi/ml with distilled water.
Assay of 5' nucleotidase activity in whole cells
50yl of an adipocyte suspension at 20% packed cells was
incubated in a lOOyl volume containing: ImM AMP + [8-^I^|AMP; 0.2mg/ml
adenosine; 5mM Mg SO^ and 50mM tris HCl (pH 7.4). The reaction was
allowed to proceed for 10 minutes before being stopped by the addition
of 200yl of 0.15M 2inc sulphate. 200yl of 0.15M barium hydroxide
was then added followed by a further lOOyl of 0.15M zinc sulphate. The
precipitate formed was removed by centrifugation at 10,000 x g for
2 minutes. A 500yl aliquot of the supernatant was removed and the
radioactivity was determined using liquid scintillation counting in 5ml
-1of triton toluene ppo scintillant (30:70:5gl ). Blanks were performed
by adding cells to the incubation immediately before the addition of the
zinc sulphate. Under these conditions the rate of AMP hydrolysis remained
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constant for up to 30 minutes.
Assay of 5* nucleotidase in isolated membrane fractions
50jjl of membrane suspension was added to a 200yl volume con­
taining ImM AMP+ [8-^h |-AMP; 50mM tris-Cl (pH 8.0) and 5mM Mg SO^. The 
reaction was allowed to proceed for 30 minutes before being stopped by 
the addition of 200yl 0.15M zinc sulphate followed by 200yl of Barium 
hydroxide. The precipitate formed was removed by centrifugation,and 
500yl of the supernatant was removed for estimation of the radioactivity 
as described above. The hydrolysis rate was constant for at least 40 
minutes with plasma membrane fractions.
Electron microscopy
Samples of isolated membrane fractions were pelleted by centri­
fugation then fixed for 1-2 hours in 3% glutaraldehyde in sucrose-tris 
EDTA buffer (pH 7.4). The pellets were then washed and fixed with 
1% Osmium tetroxide for 1 hour. The pellet was washed in sucrose tris 
EDTA buffer, then dehydrated by passing it through a series of ethyl 
alcohol/water mixtures until,finally, the sample was washed three times 
with absolute ethanol.
The samples were embedded in Spurs resin and ultrathin sections 
cut with a microtome. The sections were stained with lead citrate and 
uranyl nitrate, before examination under an electron microscope.
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Transport assays in isolated membrane fractions 
Zero trans entry experiments were performed on isolated mem­
brane fractions by a modification of the methods of Carter et al. (1972) 
and Ludvigsen & Jarett (1980). All materials were from the sources 
described previously except for the filters which were from 
Millipore (UK) Ltd.
r 14 -I r 3 hlOyl of isotopically labelled sugar ( [U- C_|-D-glucose or I 3- ly-
D-allose) + unlabelled sugar in sucrose EDTA buffer was rapidly mixed
with lOyl of membrane suspension. Uptake was terminated after the
appropriate time by the addition of 1ml 0.3mM phloretin in sucrose-
tris-EDTA buffer. Phloretin was dissolved in sucrose tris EDTA buffers
in a similar manner to that described for albumin free Hepes buffer.
This mixture was then carefully pipetted into the centre of an 0.22p
pore size Millipore filter under suction on a Millipore filtration
apparatus. A further 1ml of stopping solution was then pipetted into
the centre of the filter and then the apparatus was washed with a further
10ml of stopping solution. The filter was removed and transferred to a
scintillation vial and 1ml of 1% (w/v) trichloroacetic acid in water
was added. The trapped radioactivity was estimated by liquid scintillation
-1counting using 10ml of triton:toluene:ppo scintillant (30:70:5gl ).
Blanks were performed by adding the membrane suspension after the 
addition of the phloretin stopping solution, and the equilibrium volume 
was determined by leaving samples to equilibrate for 45 min. Non­
mediated rates were taken as the transport that occurred in the presence 
of 50yM cytochalasin B. Average uptake rates were determined by 
equation 8.
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Tests for the purity of sugar analogues 
Thin layer chromatography
Two systems were used for the analysis of sugar analogues. 
Both systems use 0.5mm silica gel plates.
System I Ethyl acetate: Petroleum ether (40-60%p) 3:2
System II Butanol:ethanol:water 6:3:1
System I was used for the separation of hydrophobic heavily 
substituted derivatives whilst System II was used for the separation of 
more hydrophilic derivatives. Material on the plate was visualised by 
spraying the plate with 5% concentrated sulphuric acid in ethanol and 
heating to 150°C. This charred organic compounds to produce a darkened 
area.
Paper chromatography
The sugar analogues were both analysed and prepared by 
descending paper chromatography on Whatman 3MM paper using butanol: 
ethanol: water (49:11:19) as the solvent system. Material present on 
the paper was stained by first soaking in silver nitrate/acetone solution 
(a few drops of saturated aqueous silver nitrate in "v 200ml of acetone). 
The paper was then dried and then soaked in ethanolic sodium hydroxide 
(a few pellets of sodium hydroxide dissolved in a minimum of water added 
to 'v. 200ml of ethanol).
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The synthesis of 3-0-f^H)methyl -D-glucose
3-0-[[^H^methyl -D-glucose and 3-0 methyl -D-glucose were 
synthesised using the same protocol. [[ h |-methyl iodide (2.5Ci/mMol) 
and methyl iodide (500mCi/mMol) were from the Radiochemical
Centre, Amersham, 1,2-4,6-diisopropylidene-D-glucose was from Koch Light, 
and all other reagents were BDH Analar grade.
0.25g of 1,2-4,6,-diisopropylidene D-glucose were dissolved in 
1.5ml of dried 1,4-dioxan in a round bottom flask. 0.3g of freshly 
powdered anhydrous sodium hydroxide was added. The breakseal tube 
containing the radiolabelled methyl iodide was connected and the 
apparatus evacuated. After breaking the seal the contents were allowed 
to mix (the methyl iodide being removed from the breakseal by gentle 
heating) and the flask heated at 60°C overnight with magnetic stirring.
After cooling, the reaction mixture was then added to approximately 
100ml of ice water-diethyl ether mixture. The phases were allowed to 
separate, and the aqueous phase was removed. The aqueous phase was re­
extracted with ether and the ether extracts combined. The ether extracts 
were dried overnight by filtration and the ether and residual dioxan 
removed by rotary evaporation under reduced pressure. Yield 9mCi 
3 - 0 - methyl -1,2-4,6-diisopropyglidene D-glucose.
The product was dissolved in 1ml ethanol, then stirred for 
4 hours at 60-70°C with 0.5g Dowex X8-400 16-40 mesh(H^form).
The ion exchange resin was then removed by filtration, and the solvent 
removed by rotary evaporation. The product was then applied to Whatman 
3 M M chromatography paper and the 3-0-[^Hjmethyl-D-glucose separated 
by descending paper chromatography using butanol: ethanol:water (49:11:19) 
as the solvent system. After development of the chromatogram, the radio­
active 3-0-methyl glucose was eluted with water and diluted to
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0.5mCi/ml with 1% ethanol. The yield was 8.7mCi
The synthesis of 6-0-propyl-D-glucose
All reagents were BDH Analar grade except for the 1,2-iso- 
propylidene 3,5-0-benzylidene-glucofuranose which was prepared by 
Dr. G.D. Holman.
300mg of 1,2-isopropylidene-3,5-0-benzylidene glucofuranose 
were dissolved in 1.5ml of dried 1,4-dioxan. 0.3g of freshly powdered 
anhydrous sodium hydroxide and 500yl of 1-iodo-propane were added and the 
mixture heated at 70°C overnight with stirring.
The reaction mixture was then added to ice water-diethyl ether 
mixture and the phases were allowed to separate. The aqueous phase was 
removed, reextracted with diethyl ether and discarded. The combined 
diethyl ether extracts were then dried with anhydrous sodium sulphate.
The sodium sulphate was removed by filtration and the diethyl ether and 
residual dioxan and 1-iodo-propane removed by rotary evaporation under 
reduced pressure.
The product was then dissolved in 1ml of ethanol and stirred 
for 4 hours at 60-70°C with 0.5g Dowex X8-400 16-40 mesh (H form).
The ion exchange resin was removed by filtration and the resin washed 
with distilled water. The water ethanol mixture was extracted with 
diethyl ether and the ether extract discarded. The aqueous phase was 
dried by rotary evaporation. The product was applied to Whatman 3 .N.M. 
chromatography paper and developed using butanol: ethanol:water 
(49:11:19) in a descending chromatography system. After development, the 
6-0-propyl-D-glucose was eluted with water,and the water was then removed by
103.
rotary evaporation. The product was then further dried in a desiccator. 
Yield 26mg 6-0-propyl-D-glucose.
The synthesis of 6 [\4-nitrobenzyl)-thiô^-9-3-D-ribofuranosyl purine (NBMI)
6[(4-nitrobenzyl)thiqJ-9-3-D-ribofuranosyl purine was synthesised 
by the method of Brajeswar et al. (1975). Nitrobenzyl bromWe and 6- 
mercaptopurine riboside (6-thio-inosine) were from the Sigma Chemical Co. 
All other reagents were BDH Analar grade.
lOOmg of 6 mercaptopurine riboside, 58mg of anhydrous potassium 
carbonate and 91mg of nitrobenzyl bromidi^e were dissolved in 3ml of dry 
dimethyl formamide. The reaction mixture was heated at 48-50°C for 2 
hours. The mixture was then cooled and poured into 20ml of cold dis­
tilled water and the solution adjusted to pH 7 with hydrochloric acid.
The gel like precipitate that formed was collected by filtration and 
washed with cold distilled water. The filtrate was dried by rotary 
evaporation and extracted three times with 15ml lots of ethyl acetate, 
and the original precipitate dissolved in the combined extracts. After 
concentration to 5ml ,crystalline material separated out. This product 
was allowed to crystallise, then washed with cold methanol before being 
recrystallised from methanol. The product gave a single spot when run 
on silica gel thin layer chromatograms using butanol:acetic acid:water 
(6:3:1). The product melted at 196°C. Yield 72mg.
RESULTS
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The viability of isolated adipocytes
The isolated adipocyte preparation was first studied using a 
range of criteria in order to ascertain that the isolated cells showed 
similar responses to whole tissue. The stability of the cells under 
the conditions used was also investigated.
Cell stability
Isolated adipocyte suspensions were studied by light microscopy, 
the cells being stained by the addition of a few drops of 0.05% methylene 
blue. The cells were of uniform appearance with nuclei visible in some 
cells. Few free fat globules were visible in fresh preparations. Fat 
globules can be identified from adipocytes due to the loss of the 
'signet ring' appearance of the intact adipocyte and the formation of a 
uniform droplet. As the preparation aged over a period of hours,more fat 
droplets became apparent. Samples of adipocyte suspensions at 40% packed 
cell volume were counted in a haemocytometer,and gave a count of approx­
imately 4 X 10^ cells/ml,.which is consistent with the figure given by 
Gliemann (1967) for a similar preparation. The estimation of adipocyte 
numbers is subject to a large error due to the instability of isolated 
adipocytes in the glass haemocytometer chamber.
Table 7 shows the results of experiments performed in order to 
determine the optimal conditions for the collagenase digestion of whole 
tissue. The release of the cytosolic enzyme lactate dehydrogenase 
(Ec.1.1.1.27) was used as a measure of the rate of cells lysis. Samples 
of the suspending medium were taken before and after collagenase digestion, 
and assayed for lactate dehydrogenase activity. In addition the stimu­
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order to measure the sensitivity of the cells to hormones.
Preliminary experiments had shown that 0.5mg/ml collagenase 
gave optimal digestion conditions. The experiments presented in Table 7 
were performed in order to determine the best pretreatment of the 
tissue. These results indicate that whilst cell damage is caused by 
mincing the tissue, a longer digestion time is required and a poor yield 
was obtained by using whole tissue. The optimal procedure which was 
used for further experiments, was coarse mincing of the tissue with 
scissors into 2-4mm cubes prior to digestion with collagenase.
The long-term stability of the adipocyte preparation was also 
studied. Fig. 5 shows the release of lactate dehydrogenase activity 
into the suspending medium by a 40% packed cell volume suspension of 
adipocytes. The cells were washed before being resuspended in fresh 
buffer,and samples of the infranatant were taken after the cells had been 
allowed to float to the surface, The results shoŵ , that for long-term 
incubations the presence of 1% bovine serum albumin is necessary to pre­
vent cell lysis. Changing the major cation in the buffer (K^ 140mM,
Na 4.7mM, as opposed to the standard buffer which contains Na 140mM, 
and 4.7mM,) had little effect on the lysis rate.
The total lactate dehydrogenase content of the isolated cells 
showed only slight variation between preparations/with a value of 
9.08 ± 0.49 lU ml of packed cells (n = 12). A similar variation in 
activity was seen in whole tissue with an activity of 7.63 ± 0.52 lU/g 
wet weight (n = 4)^though this value may be underestimated due to the 
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The release of lactate dehydrogenase by isolated adipocytes suspended 
in (a) hepes buffer; (•) hepes buffer + 1% bovine serum albumin;
(■) high potassium hepes buffer + 1% bovine serum albumin.
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Table 7 also shows typical lipogenic responses to lOnM insulin 
by adipocyte preparations. These values compare well with the 10-20 
fold stimulations of lipogenesis shown by whole epididymal fat pads 
incubated under similar conditions. These results indicate that the 
response of isolated adipocytes to insulin is similar to that observed 
before disruption of the tissue. The response of isolated cells to 
catecholamines was also examined. Fig. 6 shows the changes in cyclic 
AMP levels in adipocytes on treatment with 5.5pM adrenaline and lOyM 
isoprenaline. The 1.4 fold increase in cyclic AMP in response to 
adrenaline is similar to the results of Butcher et al. (1966) who 
reported a 55% increase in the cyclic AMP content of adipocytes in
response to 5yM adrenaline. The rate of accumulation of cyclic AMP is,
however, slower than that reported by Birnbaum & Goodman (1977) for whole
tissue. The results of Birnbaum & Goodman showed the peak concentration of
cyclic AMP to occur within 3 minutes of the addition of 1.4yM adrenaline, 
with a return to normal levels 20 minutes after stimulation.
Despite the differences observed in the rates of accumulation, 
these results indicate that the cyclic AMP system of this adipocyte 







0 15 30 45 60
Time (min)
The cyclic AMP content of isolated adipocytes following catecholamine 
stimulation. (•) control; (■) +5.5 yM adrenaline; (a ) + 10 yM 
isoprenaline.
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Characterisation of adipocyte subcellular fractions
Initial attempts to prepare subcellular fractions from rat 
adipocytes by the hypotonic lysis method of Rodbell (1967) proved un­
satisfactory due to the highly conta minated membrane preparation pro­
duced. The method of McKeel & Jarett (1970) gave more reproducible 
results,and is at present used by many other investigators. The homo­
genisation of the cells is of critical importance to the purity and 
yield of the final fractions. Vigorous homogenisations resulted in 
much of the plasma membrane forming very small vesicles. These were 
similar to the microsomal vesicles and were thus sedimented in the 
microsomal fractions. More gentle homogenisation leads to the plasma 
membrane forming larger sacs and sheets of membrane, which can be separated 
from the microsomal fraction.
The isotonic conditions used in this preparation prevent the 
rupture of organelles and allow the preparation of intact mitochondria 
and nuclei. This prevents contamination of the prepared membrane 
fractions with mitochondrial or nuclear membranes.
The addition of EDTA to the medium was found to be necessary 
in order to prevent clumping of the membranes and to give reproducible 
separations. The high concentration used by McKeel & Jarett was 
however found to be unnecessary and a lower concentration was found to 
be effective.
Purity of fractions
The purity of the various fractions was determined by the 
purity of the characteristic enzyme markers for each fraction (Table 8).
Ill
Table 8.

















Succinic dehydrogenase activity was chosen as a marker for 
the mitochondrion, since it is found exclusively in this organelle  ̂
tightly bound to the inner membrane (Bachmann et al. 1966). As 
Table 8 shows this activity is mainly found in the mitochondrial fraction, 
with only slight contamination of the plasma membrane fraction.
NADH oxidase
This enzyme was chosen as a marker for the microsomal fraction. 
Avruch & Wallach (1971) reported that NADH oxidase activity is found in 
both the microsomal and the mitochondrial fractions. A rapid potassium 
ferricyanide independent reaction was observed in the mitochondrial 
fraction, with no increase in the rate of NADH oxidation being observed 
on the addition of potassium ferricyanide. Table 8 shows the activity of 
this enzyme in the fractions produced, with no activity being detected 
in the plasma membrane fraction.
5* nucleotidase
5' nucleotidase has been used as a marker enzyme for the plasma 
membrane fraction by many other workers (Avruch & Wallach (1971); Kono 
et al. (1977) and Cushman & Wardzala (1980)). Table 8 shows that this 
activity is mainly recovered in the plasma membrane fraction, with small 
amounts in the mitochondrial and microsomal fractions. This activity 
may represent plasma membrane contamination of these fractions.
In order to determine the orientation of the prepared plasma 
membranes,the presence of latent 5' nucleotidase activity was investi­
gated. De Pierre & Karnovsky (1973) showed histochemically that 5' 
nucleotidase is an exoenzyme located at the plasma membrane with the
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active site facing the external solution. Since AMP is a charged 
molecule it cannot penetrate the cell membrane, and is therefore only 
available to 5.' nucleotidase activity which is on the ,outside face of 
membrane vesicles, i.e. those plasma membrane vesicles which are 'right 
side out'. The addition of a low concentration (0.05% v/v) of the non­
ionic detergent Triton X-100 leads to disruption of vesicles,.allowing 
enzyme (which is isolated from its substrate in 'inside out' vesicles), 
access to the substrate. The plasma membrane 5' nucleotidase activity 
increase from 2.48 yMol/h/mg protein to 4.57 yMol/h/mg protein in the 
presence of 0.05% v/v Triton X-100, whereas the activity in the micro­
somal fraction increased from 0.40yMol/h/mg protein to 0.51yMol/h/mg 
protein in the presence of detergent. These results suggest that the 
plasma membrane preparation is a mixture of approximately 1:1 'right side 
out' and 'inside out' vesicles.
A similar approach was used on isolated adipocytes in order to 
investigate whether all the 5' nucleotidase activity is accessible at 
the cell surface. Homogenisation of isolated adipocytes in 0.05% Triton 
X-100 leads to a doubling of the 5' nucleotidase activity. The activity 
expressed by whole cells was 25.72 ± 0.17nMol/h/20yl packed cells,
(n = 11) whilst after homogenisation the activity was 53.67 ± 5.13nMol/ 
h/20yl packed cells (n = 3). This result is similar to that reported 
by Stanley et al. (1980) who reported a 20-50% increase in activity in 
a similar experiment. Thus 5' nucleotidase may not be a satisfactory 
marker enzyme for the plasma membrane because of the possibility that 
activity may also be present in intracellular membranes.
114.
Electron microscopy
In order to investigate the morphological characteristics of 
the membrane fractions prepared from adipocytes, samples of the membrane 
fractions were examined by electron microscopy.
Plasma membrane
The plasma membrane fraction consisted of large membranous sacs 
with numerous invaginations and microvesicles (Fig. 7). There was little 
evidence of mitochondrial contamination, the major contaminant being 
microsomal membranes similar to those shown by McKeel & Jarett (1970).
As can be seen from Fig. 7 microsomal membranes were often trapped within 
large vesicles.
Mitochondria
The mitochondrial fraction appeared to contain mostly swollen 
mitochondria with clearly descernible cisternae. The outer membrane was 
still present in most cases (Fig. 8). The mitochondrial fraction was 
contaminated with the occasional intact nucleus and some small membrane 
vesicles. Glycogen aggregates were also occasionally observed in this 
fraction.
Microsomal fraction
The microsomal fraction consisted mainly of closed vesicles 
considerably smaller than those observed in the plasma membrane fraction. 
There was also a considerable amount of unidentified densely stained 




Plasma membrane vesicles from a Ficoll gradient showing sacs of plasma 





Mitochondrial fraction from bottom of ficoll gradient. The mitochondria 
are swollen but most appear to retain the outer membrane. Small vesicles 





Microsomal fraction showing small closed vesicles and some membrane 
fragments. x 63,000.
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Hexose transport in subcellular fractions 
D-glucose displaceable cytochalasin B binding to the micro­
somal fraction of adipocytes has been shown by Cushman & Wardzala (1980), 
and stereospecific D-glucose uptake has been demonstrated in liposomes 
containing protein extracts of microsomal membranes by Suzuki & Kono 
(1980). Martin & Carter (1970) demonstrated D-glucose transport in 
isolated plasma membranes and showed that insulin pre-stimulation of 
D-glucose transport persists in the isolated membranes.
Fig. 10 shows the uptake of 5mM D-glucose in subcellular 
fractions of both basal and insulin stimulated cells. In plasma membranes 
the trapped volume is equal to 0.82yl/mg protein in membranes prepared 
from both insulin stimulated and basal cells and remains constant for at 
least 30 minutes,indicating that no incorporation of the label is occurring. 
The rate constant for 5mM D-glucose uptake in plasma membranes prepared 
from basal cells is 0.024 ± 0.005 sec (n = 8) whereas in plasma mem­
branes prepared from insulin stimulated cells the rate constant is 
-10.117 ± 0.022 sec (n = 8), showing that the rate is increased by
insulin. The rate constant for 5mM D-glucose uptake into microsomal
-1membranes is 0.069 ± 0.032 sec (n = 6) for membranes from basal cells,
and for membranes from insulin stimulated cells it is 0.068 ± 0.008 
-1sec (n = 6) indicating no change in the rate of uptake when the cells 
were pretreated with insulin. The trapped volume of the microsomal 
fraction is 0.61yl/mg protein in microsomes from both basal and insulin 
stimulated cells.
The rate constant for the uptake of 5mM D-allose in adipocyte
-1plasma membranes is 0.38 ± 0.15min (n = 4) for membranes prepared 
from insulin stimulated cells. The trapped volume of D-allose is 











A time course for the uptake of 5mM D-glucose in (•) plasma membranes 
isolated from basal cells; (O) plasma membranes isolated from 
insulin stimulated cells; (^) microsomal membranes isolated from 
basal cells; (a ) microsomal membranes isolated from insulin 
stimulated cells.
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The rate constants for 5iriM D-allose uptake in the microsomal fraction
of both basal and insulin stimulated cells are similar at 0.55 ± 0.38
. -1 . -1min (n = 4) for basal cells and 0.54 ± 0.20 min (n = 4) for insulin
stimulated cells. This rate is similar to the rate for D-glucose uptake 
in the microsomal fraction.
The magnitude of the stimulation of hexose transport in plasma 
membranes by lOnM insulin is less than that seen in whole cells (see p. 12i) 
However, this is consistent with the observations of other workers using 
a similar preparation. The membrane system also shows differences in 
the relative stimulation by insulin of D-glucose and D-allose transport.
A similar difference in the relative stimulation of 3-0-methyl-D-glucose 
and D-allose transport is bbserved in whole cells when the rate due to 
non-mediated uptake is not subtracted. The non-mediated uptake can be 
measured by blocking mediated uptake with 50yM cytochalasin B (see p. 124). 
The difference in the -relative insulin stimulation is thus presumed to 
be due to a non-mediated component in the transport of hexoses into 
membrane vesicles.
The facilitated diffusion of hexoses in plasma membranes from 
adipocytes can be completely blocked by 50yM cytochalasin B (Ludvigsen & 
Jarett, 1980). The rate of D-glucose transport in microsomal membranes 
is however unaffected by 50yM cytochalasin B. There is also no change 
in the rate of D-glucose transport in microsomal membranes over a range 
of 1 to 20mM D-glucose.
The uptake of D-glucose by microsomal membranes does not show 
saturation kinetics, stereospecificity or inhibition, indicating that 
the uptake of hexoses into these fractions occurs by a non-mediated route.
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The transport of D-allose in adipocytes
Fig. 11 shows the uptake of 1.3mM D-allose in adipocytes 
treated with lOhM insulin. The uptake follows a simple exponential 
function of time^and fractional fillings of up to 75% gave linear plots 
vs time using the integrated rate equation (see p. 90 ). Fig. 11 also 
shows the efflux of D-allose from adipocytes which had been preincubated 
for 45 min with tracer D-allose. The rates of influx and efflux are 
equal,indicating that at equilibrium D-allose is in free solution within 
the cell and non-metabolised. The equilibrium volume of D-allose is 
similar to the 3-0-methyl-D-glucose equilibrium volume and equal to 
1.8yl/100yl packed cells. These results are consistent with D-allose 
being transported but not metabolised.
In the presence of insulin the transport of 1.3mM D-allose 
gives a t^ of 1.5 minutes, whereas in the absenqe of insulin the rate 
is approximately 50 times slower with a t^ —  75 minutes. In basal
cells,D-allose transport cannot be completely inhibited by 50yM cyto­
chalasin B, or D-glucose. If this non-mediated rate is subtracted from 
the total uptake rate the increase in mediated transport on insulin 
stimulation is identical to that observed when 3-,0—methyl D-glucose is 
used as the substrate. The ratio of permeabilities for 3-.0«methyl- 
D-glucose in basal and insulin stimulated cells is similar to that 
observed for D-allose and equal to 44.
The kinetic parameters for zero trans entry of D-allose in
insulin treated adipocytes (Fig. 12) show = 271.3 ± 34.2mM and
oi . — 1V  ̂ = 68.7 ± 7.3mMmin . The Vmax for D-allose is similar to that for zt










Time courses for the fractional efflux (O) and fractional influx (k) of 
1.3 mM D-allose in adipocytes treated with 10 nM insulin. In insulin 
treated cells the influx t, - 1.77 + 0.13 min (n = 12). In basal cells
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Zero trans influx of D-allose in adipocytes treated with 10 nM insulin.
(Best fit estimates 
+ S.E. from weighted regression, n = 5)
=  271.3 + 34.2 mM, = 1.15 + 0.12 mM sec  ̂zt - zt -
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adipocytes reported by Taylor & Holman (1981). The Km for D-allose is 
much higher and therefore, at the concentration of D-allose used in the 
inhibition studies, the D-allose permeability is very low since the con­
centration of substrate (1.3mM) is much lower than its Km. Under these 
circumstances the permeability is given by the ^^K ratio.
In insulin-stimulated cells the non-mediated uptake of D-allose 
is a small component of the total uptake. This did not significantly 
influence the inhibition plots until the mediated uptake of D-allose 
was significantly inhibited (at ^  values greater than 6) when the 
inhibition plots tended to form a curve. By subtracting the non-mediated 
D-allose uptake (the rate in the presence of 50]jM cytochalasin B) ^  vs I 
plots remained linear. Fig. 13 shows the inhibition of D-allose uptake 
by 3-0-methyl-D-glucose and 2-deoxy-D-glucose corrected for non-specific 
uptake. In both cases the inhibition plots remain linear up to the 
practical limits of the experiment.
Fig. 14 shows the equilibrium exchange of 3-0-methyl-D-glucose
in insulin-stimulated adipocytes. The experiment shows a K°^ = 4.54 ±
oi -10.59mM and a V = 0.82 ± 0.04 mM sec , which is similar to the value ee
given by Taylor & Holman (1981) of K°^ = 4.45mM and = 0.84mM sec ^ee ee
measured over a lower concentration range. There is no evidence in the 
adipocyte for the non-linearity in reciprocal plots, observed by 
Holman et al. (1981) in the human erythrocyte.
The l&n for 3-0-methyl-D-glucose exchange is very similar to 
the Ki for 3-0-methyl-D-glucose inhibition of D-allose exchange 
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The inhibition of D-allose exchange (in adipocytes stimulated with 
10 nM insulin) by 2-deoxy-D-glucose (A),K^=0.74+ 0.03 mM (S.E., n=10); 
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The equilibrium exchange of 3-0-methyl-D-glucose in adipocytes
treated with 10 hM insulin. 
-1
= 4.54 + 0.59 mM, = p.82 +ee - ee -
0.04 mM sec 
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(Best fit estimates + S.E. from weighted regression,
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Hydrogen bonding requirements for the insulin sensitive hexose transporter
of the rat adipocyte 
The hydrogen bonding requirements of the adipocyte hexose trans­
porter were examined by studying the inhibition of D-allose exchange by 
a range of D-glucose analogues. The relative Ki's of the analogues give 
a measure of the affinity of the analogue for the hexose transporter.
Due to the effects of metabolism (see p . 161 ) the comparisons were con­
fined, as far as possible, to studies involving poorly metabolised D- 
glucose analogues. All analogues were equilibrated with the cells for 
30 min before the transport assay was performed, so that the analogues 
were on both sides of the membrane.
C-1 analogues
D-glucose had a Ki of 8.62 ± 0.71mM for the inhibition of D-
allose exchange in adipocytes. Removal of the C-1 hydroxyl to produce
1-deoxy-D-glucose gave a large reduction in affinity with no detectable
inhibition over the concentration range studied (Fig. 15). A C-1 hydroxyl
is not essential for transport however. Fig. 16 shows the uptake of 1-
deoxy-D-glucose by insulin treated adipocytes in the presence and
absence of D-glucose. At the concentration used uptake is slow, but D-
glucose inhibits the uptake showing that 1-deoxy-D-glucose is transported
by the D-glucose transport system. The initial rate of uptake for 1-deoxy-
-1D-glucose in the absence of D-glucose is 20mM min . Assuming a Vmax 
for 1-deoxy-D-glucose of 60-80mM min (the Vmax for both D-allose and 
3-0-methyl-D-glucose) then the approximate Km for 1-deoxy-D-glucose is 
> 150mM.
Fluoro substitution of hydroxyls has previously been used by 
Barnett et al. (1973a) to indicate hydrogen bonding. B-glucopyranosyl 
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The i n h i b i t i o n  of D - a l l o s e  tra n s p o r t  (in cells tr eated wit h 
10 nM insulin) by D - g l u c o s e  an a l o g u e s  m o d i f i e d  at C-1.
(A) 1 - d e o x y - D - g l u c o s e ,  > 150 mM; (■) 5 - t h i o - D - g l u c o s e ,
= 4 2.1 + 6.0 mM  (S.E., n=12); (•) D- glucose, = 8.62 +
0.71 mM (S.E., n=34); (a ) g - D - g l u c o p y r a n o s y l  fluoride.
= 6.87 + 0.59 m M  (S.E., n=18).










A time course for the uptake of 85 mM l-deoxy-D-^6~^Hj-glucose in cells 
treated with 10 nM insulin in the presence (□) and in the absence of 
(■) 50 mM D-glucose. Results are the means of duplicate observations.
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electronegative fluorine atom appears to accept a H group from the trans­
porter with no loss of affinity when compared to the hydroxyl of D- 
glucose. This indicates that the electronegative oxygen group of the 
hydroxyl probably forms a hydrogen bond with an electropositive group 
from the transporter. The hydrogen atom of the hydroxyl group does not 
appear to form a significant hydrogen bond with an electronegative group 
on the transporter.
Substitution at C-1 of D-glucose results in a fused pyranose 
ring form. The results of C-1 substitution indicate that the pyranose 
ring is accepted with high affinity by the site (g-glucopyranosyl 
fluoride) and transported (1-deoxy-D-glucose), therefore the open chain 
form of the sugar molecule is not required.
The ring oxygen
Replacing the ring oxygen with a. ring sulphur results in a 
large loss of affinity. The Ki for 5-thio-D-glucose is 42.1 ± 6.0raM 
(Fig. 15). This indicates that a hydrogen bond is formed from the trans­
porter to the electronegative ring oxygen.
C-2 analogues
The effect of modifications at the C-2 position of the D-glucose 
molecule is shown in Fig. 17. Because ofithe high affinity of 2-deoxy-D- 
glucose and D-mannose for hexokinase and the effects of metabolism on 
sugar transport (see p.161 ) the study was confined to D-galactose 
analogues modified at C-2.
The Ki of 2-deoxy-D-galactose (20.75 ± 3.04mM) is slightly less 
than that of D-galactose (Ki = 24.29 ± 3.05mM). This indicates 








The inhibition of D-allose transport (in cells treated with 10 nM 
insulin) by D-galactose analogues modified at C-2. (a) D-talose,
= 35.4 + 5.3 mM (S.E., n=10); (□) D-galactose, = 24.49 + 3.05 mM
(S.E., n=12); (■) 2-deoxy-D-galactose, = 20.75 + 3.04 mM (S.E., 
n=9) .
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that a gluco-configuration hydroxyl at C-2 interferes with binding. 
D-talose, the D-galactose analogue with a manno configuration hydroxyl 
at C-2, has a Ki = 35.4 ± 5.3mM indicating that a manno configuration 
hydroxyl at C-2 interferes with binding to a greater extent than a 
gluco-configuration hydroxyl.
C-3 analogues
D-allose, the substrate used in these experiments is the C-3 
epimer of D-glucose. It has a very low affinity (Km 271.3 ± 34.2mM) 
compared to D-glucose or D-galactose. Fig. 18 shows the inhibition of 
D-allose exchange by C-3 analogues of D-glucose. 3-deoxy-D-glucose also 
shows low affinity(Ki = 40.31 ± 4.2ImM) indicating that a hydrogen bond is 
probably directed to the gluco-configuration hydroxyl at C-3. The 
presence of an alio configuration hydroxyl at C-3 interferes with 
binding. 3-deoxy-3-fluoro-D-glucose has a high affinity (Ki = 7.97 ± 
0.44mM) suggesting that a hydrogen bond is probably directed towards the 
electronegative oxygen (or fluorine) at C-3, rather than from the hydrogen 
atom of the C-3 hydroxyl towards an electronegative group on the trans­
porter.
C-4 and C-6 analogues
D-galactose, the C-4 epimer of D-glucose, has a lower affinity 
for the adipocyte hexose transporter than D-glucose. The Ki for D- 
galactose inhibition of D-allose exchange is 24.29 ± 3.05mM. If a 
hydrogen bond is directed towards a gluco configuration hydroxyl at the 
C-4 position of D-glucose during transport it is less important than 
those at the ring oxygen, C-1 and C-3. The possibility that the lowering 
of affinity is due either to a galacto-configuration hydroxyl interfering 











The inhibition of D-allose transport (in cells treated with 10 nM 
insulin) by D-glucose analogues modified at C-3. (■) 3-deoxy-D-glucose,
= 40.3 + 4.2 mM (S.E., n=10); (□) 3-deoxy-3-fluoro-D-glucose,
= 7.97 + 0.44 mM (S.E., n=24).
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eluded.
Fig. 19 shows the inhibition of D-allose exchange by C-4 
and C-6 analogues of D-glucose. A C-6 hydroxyl or fluorine, atom appears to 
slightly increase binding when these substitutions are compared with 
the relevant C-6 deoxy analogue. Thus 6-deoxy-D-glucose(Ki = 11.08 ± 
0.63mM)has lower affinity than D-glucose, whilst D-fucose (6-deoxy-D- 
galactose Ki = 33.97 ± 5.03mM)has a lower affinity than D-galactose. 
6-deoxy-6-fluro -D-galactose has a Ki = 6.67 ± 0.37mM indicating a 
hydrogen bond is formed between the transporter and the C-6 hydroxyl 
but this bond is not as important as those bonds to the ring oxygen, C-1 
and C-3. Removal of the C-6 hydroxyl results in a greater affinity loss 
for the D-galactose derivative (D-fucose) than for the corresponding 
D-glucose derivative (6-deoxy-D-glucose). This may indicate that the 
proposed hydrogen bond to C-6 becomes more important when the hydrogen
bonding or spatial requirements at C-4 are not met.
Removing the C-6 carbon (C-5 hydroxy methyl) group altogether 
also reduces affinity. D-xylose can be regarded as a D-glucose analogue 
lacking the C-5 hydroxy methyl group and L-arabinose as a D-galactose 
analogue without the C-5 hydroxy methyl group. The Ki for D-xylose is 
45.56 ± 3.25mM and for L-arabinose the Ki is 49.69 ± 4.93mM. Thus both
analogues have low affinity with little discrimination between the D-
glucose and D-galactose analogues.
D-xylose transport in adipocytes
Fig. 20 shows the equilibrium exchange of D-xylose in insulin-
stimulated adipocytes. The experiments were performed in an identical
r* 14 "Imanner to the exchange of D-allose and 3-0-methyl-D-glucose using |_U- C_|- 
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The inhibition of D-allose transport (in cells treated with 10 nM 
insulin) by D-glucose analogues modified at C-4 and C-6. (a) L-arabinose,
= 49.69 + 4.93 mM (S.E., n=21); (O) D-xylose, = 45.56 + 3.25 
(S.E., n=24); (a ) D-fucose, = 33.97 + 5.03 mM (S.E., n=15);
(□) 6-deoxy-D-glucose, = 11.08 + 0.63 mM (S.E., n=ll); (■) 6-deoxy-
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The equilibrium exchange of D-xylose in adipocytes treated with 10 nM 
insulin. = 53.21 + 1.45 mM, = 0.75 + 0.01 mM sec ^ . (Best
fit estimates + S.E. from weighted regression, n=5).
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adipocytes since the D-xylose did not come to equilibrium and the radio­
activity continued to be accumulated by the cells. The rate of meta­
bolism of ImM D-xylose was slow at 0.18nMol/h/10^ cells (compared to
5 ■ .1.08nMol/h/10 cells for 0.12mM D-glucose) compared with the rate of
transport,and therefore the equilibrium exchange parameters for D-xylose
can be estimated. D-xylose shows a = 53.21 ± 1.45mM and a ofee ee
-10.75 ± O.OlmM sec . The Vmax is similar to that observed for the 
exchange of 3-0-methyl-D-glucose (see p.124 ) and D-allose (see p.121). 
The Km for D-xylose transport is similar to the Ki measured for D-xylose 
inhibition of D-allose exchange indicating that the Ki does provide a 
good measure of : the apparent Km.
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Spatial requirements for binding to the external site of the adipocyte
hexose transporter 
Alkyl substituted hexoses have previously been used to investi­
gate the spatial requirements of the erythrocyte hexose transporter 
(Barnett et al., 1973b). In order to reveal the spatial features of the 
outside site some analogues were added with the substrate, but, where 
indicated, some analogues were allowed to equilibrate across the mem­
brane for 30 minutes before the transport rate was estimated.
C-1 substitution
Fig. 21 shows the inhibition of D-allose exchange in insulin- 
treated adipocytes by a series of C-1 substituted D-glucose analogues.
The inhibition is greatly reduced if a methyl group is introduced into the 
a or 3 configuration. Methyl-a-D-glucoside has a Ki of 57.9 ± 13.6mM 
while methyi-3-D-glucoside shows no detectable inhibition over the con­
centration range tested.
Also shown in Fig. 21 is a comparison of the affinities of two 
disaccharides. Maltose has a Ki = 23.5 ± 2.ImM whilst trehalose shows 
no detectable inhibition. This indicates that trehalose (a -1, 1, gluco- 
pyranosyl-glucopyranoside) is hindered from binding by the a-1, 1, linkage 
and the relatively unhindered C-4 and C-6 positions do not bind well.
With maltose (a - 1, 1,4-glucopyranosyl-glucopyranose) there is an 
unhindered reducing glucose unit which is apparently able to bind to the 
external site with the bulky non-reducing glucose unit projecting 
from the site. This, together with the inability of the site to accept 
a methyl group at C-1, indicates that the external site requires a 











The inhibition of D-allose transport (in cells treated with 10 nM 
insulin) by (a ) g-methyl-D-glucoside (30 minute preincubation);
(□) a-methyl-D-glucoside (30 minute preincubation), K. = 57.9 + 13.6 mM 




The results shown in Fig. 22 show the inhibition of D-allose 
exchange by C-2 substituted Drglucose analogues, D-glucosamine and 
N-acetyl-D-glucosamine were equilibrated with the cells for 30 minutes 
before the transport assay. D-glucosamine binds well (Ki = 9.05 ± 0.66mM) 
but the introduction of the acetate group in N-acetyl-D-glucosamine 
reduced the inhibition to undetectable levels.
If 3-0-methyl-D-glucose (Fig. 23) is compared with 2-3-di-O- 
methyl-D-glucose (Ki = 42.09 ± 7.5ImM), then it is seen that the additional 
methyl group at C-2 markedly reduces affinity. This indicates that there 
is very little space around C-2 when the hexose molecule is bound to the 
transporter.
C-3 substituted analogues
In contrast to the lack of space around C-1 and C-2, C-3 
accepts a methyl group well (Fig. 23). 3-0-methyl-D-glucose has high 
affinity Ki 4.75 ± 0.36,mM. The affinity is higher than D-glucose and 
may be due to hydrophobic bonding of the methyl group or, alternatively, 
the methyl group may confer increased electronegativity to the adjacent 
oxygen,which accepts a hydrogen bond from the transporter (see p. 132).
The Ki calculated for 3-0-methyl-D-glucose inhibition of D-allose is 
very similar to the equilibrium exchange Km for 3-0-methyl-D-glucose 
(see p . 124 also Taylor & Holman, 1981; Whitesell & Gliemann, 1979, and 
Vinten et al., 1976). Loten et al. (1976) also measured 3-0-methyl-D- 










The inhibition of D-allose transport (in cells treated with 10 nM 
insulin).(4)2,3-di-O-methyl-D-glucose, = 42.1 + 7.5 mM (S.E., n=ll);
(•) D-glucosamine, = 9.05 + 0.66 mM (S.E., n=12); (a ) N-acetyl- 












The inhibition of D-allose transport Cin cells treated with 10 nM 
insulin) by (•) 3-0-methyl-D-glucose C30 minute preincubation) and
by (A.) 3-0-propyl-D-glucose, = 11.26 + 2.12 mM (S.E., n=12) .
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Increasing the size of the alkyl group at C-3 from a methyl 
to a propyl group results in a reduction of affinity. The Ki for 
3-0-propyl-D-glucose when present only in the external solution is
11.26 ± 2.12idM. Thus, though there is more space around C-3 than at 
C-1 or C-2, the propyl group is subject to steric hindrance.
C-4 and C-6 substituted analogues
4,6-0-ethylidene-D-glucose is a good inhibitor of D-allose 
uptake (Fig. 24) with a Ki comparable with that of D-glucose. The 
Ki for 4,6-0-ethylidene-D-glucose is 6.11 ± 0.50mM. This result 
indicates that the bulky group directed towards C-4 does not interfere 
with binding, and supports the suggestion (based on the inhibition by 
maltose) that the sugar orientation in the outer transport site is such 
that C-4 projects into the external solution.
The results with C-6 substituted hexoses are less easy to 
interpret. 6-0-methyl-D-galactose and 6-0-propyl-D-glucose have low 
affinity compared to their parent hexoses. (The Ki for 6-0-methyl-D- 
galactose is 87.25 ± 17.85mM and for 6-0-propyl-D-glucose it is 78.1 ± 
12.6mM). 6-0-pentyl-D-gW<tch%cis however a good inhibitor (Ki 4.66 ±
0.23mM) which may be due to hydrophobic interactions occurring. Some 
of this inhibition may be due to nonspecific or detergent-like action 
though no increased lysis was observed.
The difference between the high affinity of 4,6-0-ethylidene- 
D-glucose and the low affinity of 6-0-propyl-D-glucose (both compounds 
having a bulky substitution at C-6) is probably due to random orientation 
of the alkyl group that can occur in 6-0-propyl-D-glucose but not in
4,6-0-ethylidene-D-glucose. Thus the bulky group in 6-0-propyl-D-glucose 









The inhibition of D-allose transport (in cells treated with 10 nM 
insulin) by (a ) 6-0-methyl-D-galactose (30 minute preincubation)
^ 87,3 + 17.9 mM (S.E., n=9); (•) 6-0-propyl-D-glucose, = 78.1 
+ 12.6 mM (S.E., n=23) ; (^) 6-0-pentyl-D-galactose, = 4.fe(?+ 0.23mM 
(S.E., n=12) ; (O) 4,6-0-ethylidene-D-glucose, = 6.11 + 0.50 mM 
(S.E., n=12).
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oxygen, while in 4,6-0-ethylidene-D-glucose the bulky group must project 
towards C-4.
Side specific analogues for the adipocyte hexose transport system
Bà^er & Widdas (1973a) using an osmotic swelling method, have 
shown that 4,6-0-ethylidene-D-glucose is not transported by the human 
erythrocyte hexose transport system but enters the cell by an alter­
native route that is D-glucose insensitive.
# , r 14 "IFig. 25 shows the uptake of 20mM 4,6-0-ethylidene-D-|_U- C_|
glucose by an insulin-stimulated adipocyte preparation at 37°C and 16°C.
At 37°C this compound equilibrates across the adipocyte plasma membrane
-1in less than 15 minutes (the rate constant is 0.228 min ). The rate
Q  ̂ — 2of 16 C is slower with a rate constant of 0.0213 min . Fig. 31 also
shows that the uptake of 4,6-0-ethylidene-D-glucose is inhibited by 0.3mM
-1phloretin (rate constant 0.124 min ).
Barnett et al. (1973b, 1975) reported that n'-propyl-g-D-
glucoside also penetrates the erythrocyte plasma membrane independently
of the hexose transport system. Fig. 26 shows the uptake of 5mM n'-butyl-
p— ^ —I  ̂ r“ 3 “I •3“D-[_6- Hj-glucoside, 5mM n ’propyl-3~D-|_6- Bj-glucoside and 5mM methyl-
3-D-[6-^Hj-gTucoside by adipocytes at 37°C. The 4, 6-0-ethylidene-D-
glucose, n'-propyl-3-D-glucoside and n ’-butyl-3-D-glucoside space at
equilibrium was identical to the space occupied by 3-0-methyl-D-glucose
at equilibrium and equal to 1.8yl/100yl packed cells. This value remained
constant for at least 90 min for all four sugars. The methyl-3“D-glucoside
did not reach equilibrium over the time course studied and the rates are









Uptake of 20inM 4*6“0-ethylidene-|^U-^^cJ-D-glucose at 37 C in basal
adipocytes (v); in adipocytes treated with 10 nM insulin (•); and
in insulin treated cells in the presence of 50mM D-glucose (■) . Also
shown is 4,SrO-ethylidene-D-glucose uptake in the presence of 0.3 nM
O
phloretin (^) and uptake at 16 C(i).(2 experiments with duplicate 
observations except phloretin and low temperature treatment which 









The uptake of 5 mM methyl-g-D-glucoside (A); n'propyl-g-D-glucoside (•) ;
Oand n'butyl-g-D-glucoside (a) in insulin treated cells at 37 C, Single 
experiments with triplicate observations in each case).
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same experiment. These results indicate that there is no breakdown or 
metabolism of these compounds over a 90 min incubation time.
Table 9 summarises the rate constants for the uptake of
4,6-0-ethylidene-D-glucose and the n ’alkyl-3~D-glucosides measured in 
the presence and absence of insulin, and shows that these compounds are 
taken up by a route insensitive to insulin. Table 9 also shows that the 
uptake of these compounds is not inhibited by 50mM D-glucose. The uptake 
rates are considerably increased by increasing the size of the alkyl 
group and this is consistent with penetration through lipid regions of 
the membrane. The uptake rates increase (Table 9) in the order methyl < 
propyl < butyl < ethylidene.
4,6-0-ethylidene-D-glucose added to the external solution of 
a rat adipocyte suspension inhibits the exchange of D-allose with a 
Ki = 6 .llmM (see p. 143). The Ki for the inhibition of 40pM 3-0-methyl- 
D-glucose exchange by 4,6-0-ethylidene-D-glucose added to the external 
solution is 6.54 ± 0.56mM and is thus similar to the Ki estimated using 
D-allose as the substrate. The exchange of 40yM 3-0-methyl-D-glucose 
is rapid (t$ = 3.15 sec) and exchange was measured over a period of 
three seconds. Thus estimates of the inhibition of 3-0-methyl-D-glucose 
exchange can be made rapidly before the inhibitor has significantly 
penetrated the membrane. Additional inhibition by 4,6-0-ethylidene-D- 
glucose as it reaches the internal solution of the adipocyte would be 
expected to reduce the Ki for 3-0-methyl-D-glucose exchange. Fig. 27 
shows that the Ki for 4,6-0-ethylidene-D-glucose remains constant for up 
to 90 minutes indicating that there is no increase in affinity for this 
compound as it reaches the inside site of the sugar transport system.
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+ lOnM insulin 
(ratç constant 
min )
+ lOnM insulin 
+ 50mM D-glucose 
(rate constant 
min )
4,6-0-ethylidene- 0.221 ± 0.027 0.222 ± 0.038 0.202 ± 0.035
D-glucose (n = 3) (n = 4) (n = 3)
methyl-g-D- - 0.0035 ± 0.0004 -
glucoside (n = 10)
n ' -propyI-3-D- 0.061 ± 0.002 0.076 ± 0.003 0.061 ± 0.004
glucoside (n = 6) (n = 15) (n = 6)
n' -butyl-3~D- 0.202 ± 0.015 0.238 ± 0.015 0.197 ± 0.007











A plot of 1/K. against time of incubation with 20 mM inhibitor.
(•) 4,6-0-ethylidene-D-glucose; C") 6-0-propyl-D-galactose; and
(a) methyl-3-D-glucoside. (2-3 experiments with triplicate obs-
O
ervations in each case). Cells were insulin treated and at 37 C
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Also shown in Fig. 27 is ^^Ki for 6-0-propyl-D-galactose 
plotted against increasing preincubation time. The Ki for 6-0-propyl- 
D-galactose is high and, within experimental error, is approximately 
constant over the course of the experiment.
Fig. 28 shows the inhibition of AOyM 3-0-methyl-D-glucose 
exchange by n'-propyl-g-D-glucoside and by n'-butyl-D-glucoside with 
increasing preincubation time. As the glucosides enter the intracellular 
space the Ki for n'butyl-g-D-glucoside changes from 63.25 ± 8.85mM to 
10.98 ± 1.23mM while the Ki for n'-propyl-g-D-glucoside changes from 
138.3 ± 47.5mM to 13.4 ± 2.2mM in the same period. There is no change 
in the final inhibition constants for longer preincubation times up to 
90 minutes. Methyl-g-D-glucoside shows no change in Ki over a 90 minute 
period which is consistent with the very slow penetration rate for this 
compound. Thus in each case the Ki closely follows the penetration 
rates for the glucosides, indicating that C-1 alkyl glucosides can 
inhibit hexose transport when in the internal solution. Fig. 29 shows 
the inhibition of 40yM 3-0-methyl-D-glucose exchange by phenyl-3“D-glucoside 
with increasing incubation time. The rapid penetration of phenyl-3~D- 
glucoside and n'butyl-3~D-glucoside may account for the apparent external 
inhibition shown by these compounds, since the inhibitor may be able to 
enter the cell during the assay period and give detectable inhibition 
at the inner site.
Fig. 30 shows the inhibition of 1.3mM D-allose exchange by n'- 
propyl-3~D-glucoside after a 30 minute incubation. This time is 
sufficient to equilibrate the alkyl sugar to equal concentrations on both 
sides of the membrane. The Ki for n'-propyl-3~D-glucoside inhibition of 
D-allose exchange is 17.98 -  1.46mM. In the same experiments, cells were 













A plot of 1/K_ against time of incubation with 20 mM inhibitor.
(■) n ’propyl“3”D-glucoside and (a) n'butyl-g-D-glucoside. (2
experiments with triplicate observations in each case) . Cells











A plot of 1/K^ against time of incubation with 20 mM phenyl-g- 
D-glucoside. (2 experiments with triplicate observations). 












The inhibition of 1.3 mM D-allose uptake in insulin treated cells at 
37 C by n'propyl-g-D-glucoside (K^ = 17.98 + 1.46 (S.E., n=30)) ( a ) ;  
and by n'propyl-g-D-glucoside in the presence of 5 mM 3-0-methyl-D- 
glucose (#). = 50.68 + 6.26 (S.E., n=15)).
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washed twice over a period of 30 minutes in 1% albumin-Hepes buffer at 
37°C before the transport assay was performed. The cells showed no 
detectable inhibition of D-allose exchange,indicating that n'-propyl-# 
-D-glucoside inhibition is reversible and that no permanent effect on 
the cells occurs. The inhibition of D-allose exchange by 20mM ethanol 
and by 20mM propan-l-ol after 30 minutes preincubationiis slight with 
the ethanol Ki > lOOmM and the propan-l-ol Ki » 150mM.
Also shown in Fig. 30 is the inhibition of D-allose exchange 
by n'-propyl-3”D-glucoside in the presence of 5mM 3-0-methyl-D-glucose 
with both sugars equilibrated across the membrane. 3-0-methyl-D-glucose 
increases the Ki for n'-propyl-g-D-glucoside indicating that the gluco­
side is displaced from its binding site by 3-0-methyl-D-glucose.
(
Fig. 31 shows the inhibition of 3-0-methyl-D-glucose exchange 
by]OinM 4,6-0-ethylidene-D-glucose and lOmM n ’-propyl-3~D-glucoside. In 
both cases the analogues show competitive inhibition of 3-0-methyl-D- 
glucose exchange. This result indicates that both analogues are com­
petitive with transported sugars with respect to their binding sites.
In order to confirm that the alkyl-g-D-glucosides are inhibitors 
at the inner face of the plasma membrane, zero-trans exit experiments were 
performed. In zero trans exit experiments the inhibitor is only present 
at the inner face of the plasma membrane, inhibitor present on the out­
side being diluted by 100-fold. Thus inhibitors acting at the outside 
binding site would not be expected to inhibit 3-0-methyl-D-glucose exit. 
Table 10 shows the Ki's calculated for the inhibition of 40pM 3-0-methyl- 
D-glucose exit at 37°C. 20mM n'-propyl-g-D-glucoside is an effective 
inhibitor whereas 20mM 4,6-0-ethylidene-D-glucose and 6-0-propyl-D- 













The equilibrium exchange of 3-0-methyl-D-glucose in insulin treated 
adipocytes (#), K^^^=3.61 + 0.19mM,and in the presence of lOmM n'-propyl- 
3-D-glucoside (■), K^^^=5.21 + 0.14mII,and lOmM 4,6-0-ethylidene-D-glucose
“ 8.32 + 0.52 mM , (Best fit estimates + S.E, from weighted 
regression, n=5 in each case).
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Table 10. Inhibition of 3-0-methyl-D-glucose tracer exit by alkyl 




(corrected for efflux using 






















Average tracer efflux t^ = 3.48 ± 0.42 sec (n = 12)
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to the technical difficulties involved in measuring zero trans exit 
in adipocytes, but clearly show that the inner site accepts n ’-propyl- 
3-D-glucoside but not 4,6-0-ethylidene-D-glucose. The lack of detectable 
inhibition in this experiment by 6-0-propyl-D-galactose indicates that 
C-6 alkylated sugars may not bind well to the inside site. Taken with 
the 3-0-methyl-D-glucose exchange results, this indicates that 6-0-propyl- 
D-galactose may be a better external inhibitor than internal inhibitor 
but the Ki’s for both sites are high and no great confidence in the Ki 
estimates for this compound can be claimed.
6-0-propyl-D-gàlactose is thus a poor side specific analogue 
but 4,6-0-ethylidene-D-glucose and n ’-propyl-3-D-glucose are very side 
specific for the external and'internal sites of the transporter respect­
ively.
A comparison of the hydrogen bonding and spatial requirements for binding 
to the adipocyte hexose transporter in basal and insulin treated cells
Table 11 compares the spatial and hydrogen bonding requirements 
of insulin-treated and basal cells. 3-0-methyl-D-glucose was used as 
the substrate in basal cells. The 3-0-methyl-D-glucose/D-allose 
permeability ratio is the same in both basal and insulin-treated cells.
Also the similarity of the Km for 3-0-methyl-D-glucose transport and the 
Ki for 3-0-methyl-D-glucose inhibition of D-allose exchange suggests that 
the two sugars share the same transport system. Thus a comparison of the 
Ki values in basal and insulin-treated cells using two different substrates 
is reasonable.
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Table 11. A comparison of the sugar transport specificity in basal and 
insulin-treated cells S7*cl
In basal cells AOyM 3-0-methyl-D-glucose was the substrate
and Ki values were determined at 20mM inhibitor. The mean basal
uninhibited uptake rate is t| = 3.14 ± 0.5 min which is about 55 times
slower than in insulin-treated cells. The Ki values are compared with
the present and previously reported results on insulin-treated cells





D-glucose 9.61 + 2.24 n=12) 8.62 ± 0.71 (n=34)
5-thio-D-glucose 37.58 + 6.6 n=5) 42.1 + 6.0 (n=12)
1-deoxy-D-glucose NDI n=6) NDI (n=12)
methyl-g-D-glucoside NDI n=6) NDI (n=12)
2-deoxy-D-galactose 21.58 + 2.04 n=6) 20.75 ± 3.04 (n=9)
2-3-di-O—methyl-D-glucose 38.73 ± 5.54 n=6) 42.09 + 7.48 (n=ll)
3-0-propyl-D-glucose 8.93 + 0.8 n=6) 11.26 ± 2.12 (n=12)
3-deoxy-D-glucose 32.53 ± 1.58 n=3) 40.31 + 4.20 (n=10)
4-6-0-ethylidene-D-glucose 8.00 + 3.53 n=6) 6.11 + 0.50 (n=12)
D-galactose 30.50 + 7.22 n=6) 24.49 + 3.05 (n=12)
Drfucose 35.34 + 8.59 n=4) 39.35 + 5.03 (n=15)
6-deoxy-D-glucose 14.17 + 3.91 n=6) 11.08 + 0.63 (n=ll)
6-0-methyl-D-galactose 98.31 ±30.18 n=6) 87.25 ±17.85 (n=9)
6-0-pentyl-D-galactose 5.11 + 1.51 n=5) 4.66 + 0.23 (n=12)
Results are mean ± S.E.M. 
* The ratio of tracer permeability of 3-0-methyl-D-glucose/D-allose is 
approximately equal to 45 for basal and insulin treated cells.
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In basal cells the poor hydrogen bonding analogues 5-thio-D-glucose,
1-deoxy-D-glucose, 3-deoxy-D-glucose, D-fucose and 6-deoxy-D-glucose 
indicate that as in insulin treated cells the important hydrogen-bonding 
positions are the ring oxygen, C-1, and C-3 with a less important hydrogen 
bonding group at C-6. The low affinity of methyl-g-D-glucoside, 2,3-di-O- 
methyl-D-glucose, 3-0-propyl-D-glucose and 6-0-methyl-D-galactose for 
the hexose transport system of basal cells indicates that insulin has no 
effect on the spatial requirements of the site. Table 11 also shows that 
D-glucose, D-gàlactose, 4,6-0-ethylidene-D-glucose and 6-0-pentyl-D- 
galactose have similar affinities in basal and insulin-treated cells.
It can thus be concluded that insulin does not cause a major shape change 
in the site which might have been expected to affect the specificity 
requirements. Instead insulin probably leads to an increase in the 
number of sites available, with identical specificity.
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The effect of metabolism on the regulation of hexose transport
Foley et al. (1980a) reported that sugar metabolites accelerated 
the transport of hexoses in the adipocyte. In order to further investi­
gate the role of metabolites, the inhibition of D-allose transport by 
metabolised and non-metabolised D-glucose analogues was studied.
Fig. 32 shoWs the inhibition of tracer D-allose exchange by D- 
glucose in the presence and absence of 2mM potassium cyanide. In normal 
cells these results show D-glucose to have a Ki of 8.62 ± 0.71mM for the 
inhibition of D-allose transport. Loten et al. (1976) reported a Ki of 
14.8mM for the same experiment. Other groups however have reported a 
lower Ki value. Whitesell & Gliemann (1979) have reported a D-glucose 
Ki of 7mM using tracer 3-0-methyl-D-glucose as a substrate while 
Foley et al. (1978) using L-arabinose as substrate, reported a Ki for D- 
glucose of 8mM,
Isolated plasma membranes behave differently. Fig. 33 shows
S/the V vs S plot for zero trans entry of D-glucose in plasma membranes 
prepared from insulin-treated adipocytes. This shows the plasma membrane 
system to have a Km of 23.9 ± 3.9 .mM (n = 4) at 37°C. Ludvigsen &
Jarett (1980) reported a D-glucose Km of 9-26mM for D-glucose transport 
in plasma membranes isolated from insulin-stimulated adipocytes. The 
change in Km was found to be related to the incubation time prior to 
homogenisation. The Km increased as the preincubation was extended.
In the experiments presented here, the cells were preincubated for 15 min 
before homogenisation. Further evidence for a difference in kinetic 
parameters between whole cells and isolated membranes is provided by 
the results of Cushman & Wardzala (1980) who reported that the Ki for 
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The inhibition of D-allose exchange (in cells treated with 10 nM insulin)
by D-glucose in the absence of potassium cyanide (#), K.= 8.62 + 0.71 mM1 —
(S.E., n=34); and in cells treated with 2mM potassium cyanide (■),












The equilibrium exchange of D-glucose in plasma membranes from insulin
treated cells. K = 23.9 + 3.9 mM and V = 1.65 + 0.46 mM sec ^ . (Best^ - max -
fit estimates + S.E., n=4).
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was 30mM.
One possible cause of this anomaly may be the regulation of 
transport in intact adipocytes by sugar metabolites. In order to 
investigate the transport process separately from metabolism the 
adipocytes were treated with 2mM potassium cyanide after treatment with 
insulin. This concentration of cyanide rapidly depletes the intra­
cellular ATP levels (Kono et al., 1976, 1977) and thus prevents the 
phosphorylation of hexoses by hexokinase. Fig. 32 shows the effect of 
potassium cyanide treatment on the inhibition of D-allose exchange by 
D-glucose. The Ki for D-glucose changes from 8.62 ± 0.71mM in control 
cells to 12.08 ± 0.68mM in cyanide-treated cells. The presence of 2mM 
potassium cyanide does not affect either the D-allose equilibrium volume 
or the rate of tracer D-allose exchange.
Fig. 34 shows the inhibition of D-allose exchange by 3-0-methyl- 
D-glucose in adipocytes in the presence and absence of cyanide. There is 
no significant change in the Ki of 3-0-methyl-D-glucose, the Ki for 
control cells is 4.75 ± 0.36mM (n = 18) whilst in cyanide-treated cells 
it is 4.77 ± 0.48mM ‘(n = 12). This confirms the observations with 
D-allose and is consistent with the observations of Kono et al. (1977) who 
showed no effect of cyanide poisoning on the rate of 3-0-methyl-D-glucose 
transport in adipocytes.
2-deoxy-D-glucose is an analogue of D-glucose which is trans­
ported by the D-glucose transport system of the rat adipocyte (Olefsky, 
1978). It is a substrate for hexokinase, which converts it to 2-deoxy-D- 
glucose-6-phosphate,.which is only slightly metabolised. Fig. 35 shows the 
inhibition of D-allose exchange in insulin-stimulated adipocytes in the 
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The inhibition of D-allose transport (in cells treated with lOnM insulin) 
by 3-0-methyl-D-glucose in the absence of potassium cyanide (#), K^= 4.75 
+ 0.36 mM (n=18); and in the presence of 2 mM potassium cyanide (■),












The inhibition of D-allose transport (in cells treated with lOnM insulin) 
by 2-deoxy-D-glucose in the absence of potassium cyanide (•), K^= 0.74 
+ 0.03 mM (S.E., n=15), and in the presence of 2mM potassium cyanide (■)
K^= 5.80 + 0.44 mM (S.E., n=30).
167.
for 20 minutes with 2-deoxy-D-glucose before estimating the inhibition 
of D-allose exchange. The Ki for 2-deoxy-D-glucose in control cells 
is 0.74 ± 0.03mM (n = 15) whilst in cyanide-treated cells it is 5.80 
± 0.44mM (n = 30).
D-glucose-l-phosphate, D-glucose-6-phosphate and 2-deoxy-D- 
glucose-6-phosphate showed no detectable inhibition of D-allose exchange 
when added exogenously to adipocytes.
Regulation of hexose metabolism in adipocytes, the relationship to hexose 
transport and the action of insulin
A number of compounds other than the recognised hormones have 
been shown to affect hexose metabolism in adipocytes. In order to 
investigate possible effects of these compounds on hexpse transport a 
number of compounds were screened for effects on hexose transport. In 
addition a number of these compounds have been implicated in the action 
of insulin, and these effects have also been studied.
All the test compounds were added exogenously to cells at 
O.lmM (final concentration) unless otherwise stated. • The compounds were 
tested for possible effects on basal cells, cells stimulated with 50pM 
insulin (approximately | maximal stimulation) and cells stimulated with 
lOnM insulin (a ten-fold excess of that required for maximal stimulation 
(Whitesell & Gliemann, 1979)). In all cases the compound was incubated 
with the cells for 30 minutes. Transport was assayed by the uptake of 
ImM 3-0-methyl-D-glucose in 20 seconds (basal cells), 5 seconds (for 
half maximal stimulation) and 1 second (fully stimulated with insulin).
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These times have been shown by Taylor & Holman (1981) to give a good 
estimate of the initial rates of uptake at this concentration.
The effects of adenosine and adenosine nucleotides
Adenosine and related compounds have been shown to affect the 
metabolism of adipose tissue (Dole, 1961) and some reports have indicated 
that the hexose transport system may be regulated by these compounds 
(Taylor & Halperin, 1976).
Adenosine
Fig. 36 shows the effects of adenosine and its related nucleotides 
on the rate of ImM 3-0-methyl-D-glucose uptake. Adenosine deaminase was 
added at llU/ml to the suspending buffer,and the adenosine transport 
inhibitor NBMI was present at 4pM. Cass & Patterson 1975 showed that 
4pM NBMI completely inhibited adenosine uptake in erythrocytes.
The uptake of adenosine by adipocytes was studied using the
method described for zero trans entry experiments except that
adenosine was used as the radiolabel and 4pM NBMI was used in place of 
phloretin in the stopping solution. The uptake of ImM adenosine by adi­
pocytes was found to be rapid with a =  16.39 ± 1.52 sec (n = 4) in basal
cells with a similar t| = 16.46 ± 4.27 sec (n = 4) for cells stimulated
with lOnM insulin. Adenosine achieved a similar equilibrium volume 
(1.76yl/100yl packed cells) to that found for 3-0-methyl-D-glucose 
\l.8yl/lOOyl packed cells). There was no accumulation of adenosine 
beyond equilibrium for at least 2 minutes suggesting that the metabolism 
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The effect of adenosine analogues on the rate of 1 mM 3-0-methyl-D-glucose 
uptake in basal adipocytes, adipocytes treated with 50 pM insulin and 
adipocytes treated with 10 nM insulin. All rates + S.E. n=4 for all 
analogues.
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No significant effects of O.lmM adenosine were observed on 
the rate of hexose transport in either basal or fully-stimulated adipo­
cytes. A significant (p > 0.005) reduction of the rate of hexose 
transport was observed in adipocytes which had been submaximally 
stimulated with adenosine.
At lower concentrations of adenosine there were small increases 
in the rate of hexose transport in basal cells (Table 12). The maximal 
stimulation (14.3%) was observed at lOyM adenosine. Taylor & Halperin 
(1979) also reported that lOyM adenosine gave a maximal stimulation of 
glucose oxidation in basal cells but reported a much larger effect 
(approximately 50% increase).
There was no significant effect of adenosine deaminase on the 
rate of 3-0-methyl-D-glucose over a prolonged incubation period 
(60 minutes).
Fig. 37 shows the effects of longer incubations of adipocytes 
with O.lmM adenosine and 0.5mM D-glucose. No significant differences 
between the control and adenosine-treated cells were observed. The slow 
increase in the rate of 3-0-methyl-D-glucose transport in basal cells is 
believed to be due in part to the release of fatty acids by the cells.
Also shown in Fig. 37 is the effect of increasing the osmolarity 
of the suspending buffer by the addition of 400mM mannitol. The results 
show that a hyperosmolar buffer produces an insulin-like stimulation of 
hexose transport. Similar results were obtained by Clausen et al. (1970) 
in both muscle and adipocyte preparations. Whilst the magnitude ofjthe 
stimulation is similar to that reported by Clausen et al., this experi­
ment shows a slower rate for the activation of hexose transport.
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0 0.658 ± 0.019 (n = 4)
O.lpM 0.488 ± 0.063 (n = 3)
lyM 0.704 ± 0.074 (n = 4)
lOyM 0.752 ± 0.069 (n = 4)
0. ImM 0.625 ± 0.029 (n = 4)
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The effect of incubating adipocytes in 1% albumin Hepes buffer containing 
(•) no addition, (a ) 0.1 mM adenosine, (■) 400 mM mannitol, on the rate 
of 3-0-methyl-D-glucose transport.
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The effect of Adenosine 5* phosphates on 3-0-methyl-D-glucose transport
The only adenosine 5 ’ phosphate to show any significant effect
was ATP (Fig. 36) which reduced the effects of insulin. In cells stim­
ulated with 5QpM insulin the addition of ATP prevented stimulation by 
insulin (p > 0.005). In. cells maximally stimulated with insulin the 
reduction observed is not significant (p > 0.1) within the experimental
error. There is no significant effect of ATP in basal cells.
The effects of cyclic nucleotides on 3-0-methyl-D-glucose transport
The role of cyclic nucleotides in catecholamine action has been 
intensively studied,.and cyclic nucleotides have been shown to act as the 
intracellular second messengers for this system. Cyclic nucleotides have 
also been implicated in the action of insulin. Fig. 39 shows the effects 
of the addition of a number of cyclic nucleotides and cyclic nucleotide 
analogues on 3-0-methyl-D-glucose transport in adipocytes. Cyclic nucleo­
tides have been shown to be transported by avian erythrocytes (Davoren 
& Sutherland, 1963) and human erythrocytes (Holman 1978, 1979) so that
a sufficient amount may be able to enter the adipocyte when added exo­
genously. The lipophilic derivative dibutyryl cyclic AMP (Henion et al., 
1972) has also been used to elevate intracellular cyclic AMP levels.
Both cyclic AMP and dibutyryl cyclic AMP show no significant 
effects in both basal and insulin stimulated adipocytes. There was also 
no effect of cyclic AMP on cells half maximally stimulated with insulin, 
control cells showed a rate of 1.97 ± 0.23% filling/second (n = 4) 
whilst with O.lmM cyclic AMP the rate was 1.67 ± 0.24% filling/second 
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The effect of cyclic nucleotides and cyclic nucleotide derivatives on 
the rate of 1 mM 3-0-methyl-D-glucose transport in basal adipocytes 
and adipocytes treated with 10 nM insulin. All rates + S.E., n=4 
for all analogues.
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Also shown in Fig. 38 are the effects of guanosine monophosphate 
cyclic CMP and a range of 8 bromo-substituted cyclic nucleotides. There 
were no significant effects of any of these compounds.
The effects of nucleosides on 3-0-methyl-D-glucose transport
In addition to adenosine other nucleosides were also tested for 
effects on 3-0-methyl-D-glucose transport. The results of these experiments 
are shown in Fig. 39. In basal cells both inosine and xanthine showed 
significant stimulations of the transport rate (p > 0.005 in both cases). 
None of the other compounds tested showed any significant effects.
In adipocytes stimulated with lOnM insulin, inosine and xanthine 
show slight inhibition of 3-0-methyl-D-glucose transport. However, within 
experimental error these results are insignificant (p > 0.1 in both cases). 
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The effect of purines and purine nucleosides on the rate of 1 mM 
3-0-methyl-D-glucose uptake in basal adipocytes and adipocytes 
treated with 10 nM insulin. All rates + S.E., n=4 for all analogues
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Effects of NAD and ADP ribosylation inhibitors
ADP ribosylation of adipocyte plasma membrane proteins has 
been shown by Malbon & Gill (1979). In order to investigate whether 
ADP ribosylation is of importance in the regulation of hexose transport, 
cells were treated with the ADP ribosylation inhibitors 3-amino-benzamide 
and nicotinamide. Fig. 40 shows the results of these experiments, with 
neither of these compounds producing significant changes in the rate of
3-0-methyl-D-glucose transport. There was also no effect on the insulin 
response when these compounds were added before insulin.
No significant effects of NAD or NADH were observed when these 
compounds were added to basal cells. There was also no effect of 
NAD on insulin-stimulated cells (Fig. 12).
Fig. 40 also shows the results of experiments in which the anion 
transport inhibitor 4-acetamido-4’-isothiocyanato-stilbene-2-2*-disulphonic 
acid (SITS) was added to adipocytes. There was no significant effect of 
SITS on basal or insulin-stimulated 3-0-methyl-D-glucose transport in 
adipocytes. Fig. 40 also shows that chlorpromazine has no effect on 
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Hexose transport in the rat epididymal adipocyte is increased.by 
more than 20-fold by insulin. The extreme sensitivity of the adipocyte 
towards insulin and the relative ease with which pure preparations of 
adipocytes can be obtained has led to intensive study of this system, 
in order to investigate the mechanism of hormonal regulation of hexose 
transport.
The isolated adipocyte preparation 
The preparation of isolated adipocytes involves the exposure of 
cells to a crude mixture of proteases which may alter the characteristics 
of the cell through proteolysis of the cell surface. It is therefore im­
portant to ensure that the isolated cell behaves in a similar manner to the 
cells in intact tissue. The rate of lipogenesis from D-glucose provides a 
convenient measure of the rate of metabolism by adipocytes in whole tissue, 
since cells other than adipocytes would not be expected to show rapid lipo­
genesis. When whole epididymal fat pads are incubated in a buffer contain­
ing radiolabelled D-glucose the addition of a maximal dose of insulin leads 
to a 10 to 20-fold stimulation of lipogenesis. In the intact tissue many 
of the cells are not in free contact with the bulk solution and the rate 
of lipogenesis may be rate limited by the availability of substrates 
(Gliemann & Vinten, 1974). Insulin is also rapidly degraded by intact 
adipose tissue (Antoniades & Gershoff, 1966) and therefore some of the 
adipocytes in whole tissue may be exposed to a submaximal dose of insulin. 
The results presented in this thesis show that the isolated adipocyte 
preparation used in these experiments showed a larger increase in the rate 
of lipogenesis in response to insulin than whole adipose tissue. A similar 
result was reported by Gliemann (1968) who proposed that the differences 
were due to the isolated cells being in contact with the bulk solution.
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It can therefore be concluded that the metabolism and hormonal responsive­
ness of the isolated adipocyte is similar to that observed in intact 
tissue. Since the rate of lipogenesis from low concentrations of D-glucose 
is limited by the transport of D-glucose into the adipocyte (Gliemann, 1968) 
the rate of lipogenesis from tracer D-glucose gives a measure of the rate 
of D-glucose transport. This suggests that the hexose transport rate is also 
unchanged by isolation.
Many investigators report that some isolated adipocyte preparations 
show much smaller increases in the rate of lipogenesis or hexose transport 
in response to maximal doses of insulin. The reasons for this variation 
are not clear but may be due to a number of factors.
Crude collagenase preparations from different cultures of 
Clostridium histolyticum show marked differences in the proportions of 
collagenase and trypsin-like activity present. The presence of small amounts 
of trypsin-like activity is however required in order to produce complete 
disruption of the tissue. Purified collagenase preparations are less 
effective in disrupting tissue. Mild trypsin digestion of the adipocyte 
leads to marked stimulation of glucose transport (Kono, 1969). This effect 
is reversible with the cells recovering after 15-20 minutes. Thus the 
collagenase preparation is most effective when it contains a small amount 
of trypsin-like activity in addition to collagenase activity. By allowing 
the cells to wash over a period of 15-20 minutes the effects of trypsin­
like activity can also be eliminated. The variability of commercial 
collagenase preparations (Czech, 1980) requires careful screening in order 
to select the most effective preparation (see p. 79 ).
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In order that consistent results are obtained adipocyte pre­
parations must be handled carefully. Vega & Kono (1979) showed that 
mechanical agitation or centrifugation of adipocytes leads to a large 
increase in the rate of 3-0-methyl-D-glucose transport in the absence of 
hormones. In most cases the differences in the magnitude of the insulin 
effect on hexose transport are not due to increases in the rate of insulin 
stimulated hexose transport but are due to changes in the basal rate. This 
leads to changes in the magnitude of the insulin response when expressed as 
a fold stimulation. Thus during the preparation of isolated adipocytes 
(especially basal cells) it is important to ensure that mechanical agitation 
is kept to a minimum.
Salans et al. (1981) have shown that dietary changes which lead 
to an increase in the size of adipocytes (i.e. increased fat content) alter 
the rate of D-glucose transport. Thus adipocytes prepared from obese 
animals show increased rates of basal hexose transport, and show a reduced 
stimulation of hexose transport in response to insulin. The age and diet 
of the animals used for the preparation of adipocytes will thus influence 
the magnitude of the stimulation of hexose transport by insulin. In order 
to eliminate this source of variability animals must be of similar ages and 
weights and maintained on a uniform diet.
The choice of :container for holding adipocyte suspensions is 
also important. Adipocytes have been shown to adhere to glass surfaces 
and this is followed by cell lysis (Rodbell, 1961). The adhesion of cells 
is reduced by the use of siliconising treatments which react with the glass 
surface to produce an organic silicone layer which gives the surface non­
wetting properties. These treatments do not appear to provide the most 
suitable surface and can only be used for short periods. The use of plastic
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vessels to contain adipocyte suspensions offers a more suitable alter­
native since adipocytes do not adhere to this surface. These materials 
also appear to absorb free lipid released by cell lysis and hence prevent 
the rapid lysis of cells that occurs following the release of lipid into 
the medium. Not all plastics are however suitable for the preparation of 
adipocytes as some types of plastic appear to release plasticisers and 
other complex organic molecules into the buffer solution. These compounds 
have detrimental effects on cells (Cook et al., 1976). Polystyrene and 
polypropylene were found to be the most suitable plastics for holding 
adipocyte preparations and these were used wherever possible.
The long-term viability of adipocytes is mainly influenced by 
the stability of the cells. A high concentration of bovine serum albumin 
in the buffer was found to be required to prevent a rapid exponential lysis 
of the adipocytes. Suspensions of adipocytes at a cell density of greater 
than 40% packed cells were found to be less stable than those at lower cell 
densities. Since isolated adipocytes have a density less than that of the 
suspending buffer the cells float to the surface to form a layer of packed 
cells at the surface. It is important to ensure that adipocyte suspensions 
are gently resuspended every few minutes in order to prevent this aggre­
gation. The choice of buffer is also important. Marshall & Olefsky (1981) 
have recently reported that tris(hydroxymethyl)ainino methane buffers 
give an insulin dependent loss of insulin receptors from the cell surface, 
an effect not observed with other buffering agents.
The cytoplasmic volume of an adipocyte is a very small proportion 
of the total intracellular volume of the adipocyte and therefore the ratio 
of surface area to cytoplasmic volume is small when compared with other cell 
types (Angel & Farkas, 1970). Thus hexoses rapidly equilibrate across the 
cell membrane and rapid measurements are required in order to measure
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initial rates of transport (Whitesell $ Gliemann, 1979). Alternatively 
integrated rate equations which allow for backflux can be used (Taylor & 
Holman, 1981). Czech (1976a)and Siegel & Olefsky (1980) used relatively 
long periods to measure the rate of transport and thus these experiments 
may have underestimated the initial rate of transport (Whitesell & Gliemann, 
1979; Taylor & Holman, 1981) with a resulting underestimate in the increase 
in the rate of hexose transport due to insulin.
Thus the isolated adipocyte preparation is subject to a number 
of experimental errors which will reduce the apparent effect of insulin.
When all these factors are taken into account the insulin stimulation of 
hexose transport in the adipocyte is probably in excess of 50-fold.
The kinetics of hexose transport in the adipocyte
Previous reports by Whitesell & Gliemann (1979), Taylor & Holman 
(1981) and the results presented in this thesis show that 3-0-methyl-D- 
glucose is transported symmetrically by the adipocyte hexose transport 
system. The effect of insulin is to increase the Vmax without affecting 
the Km. The symmetry of hexose transport by the adipocyte is unaffected 
by insulin.
The modified method of performing zero trans exit experiments 
(by measuring the zero time concentration in the presence of 50yM 
cytochalasin B) gives a more accurate estimation of the internal substrate 
concentration at zero time. Taylor & Holman (1981) reported a K^° = 2.66mM 
for the zero trans exit experiment compared to a K?^ = 6.51mM for the 
infinite cis experiment which also measures the-. Km for the internal 
site. The modified zero trans exit technique gives a K^° = 5.65 mM which
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is very similar to the value for the infinite cis influx experiment of 
Taylor & Holman. The reason for the discrepancy when phloretin is used 
to determine the internal substrate concentration at zero time is not 
clear. This effect may be related to the ability of phloretin to 
inhibit non-mediated transport through the membrane as shown by the 
inhibition of 4,6-0-ethylidene-D-glucose uptake by phloretin (see p . 145). 
In influx experiments the error due to this effect of phloretin is 
minimal with only slight differences between blanks performed using 
phloretin and cytochalasin B, Only when hexose transport was almost 
completely inhibited did the difference between phloretin and cytochalasin 
B blanks become significant (see p . 124 ).
The interaction of two substrates with the hexose transport system
Of the variety of models proposed to account for the transport 
of hexoses (see p. 37) the simple carrier model is the most widely accepted. 
When two substrates S and T interact with the carrier this can be represented 
schematically as
Using a similar symbolism to that described previously (see p.37) 
in an extension of the analysis of Stein & Lieb (1974a) a unidirectional 
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In the inhibition experiments the substrate (D-allose) was at
a low concentration relative to its Km. If S = S. and T = T. ino 1 o 1




From this equation it can be seen that the carrier model predicts that the 
Ki for T will be equal to the exchange Km for T. Also the inhibition con­
stant for T should be independent of the substrate used. If the assumption 
of equal inhibitor distribution is not met as is the case for a non-trans- 
ported inhibitor added externally then the apparent Ki will mainly reflect 
the affinity of the inhibitor for the external site.
The results presented in this thesis show that the Km's for 
3-0-methyl-D-glucose and D-xylose equilibrium exchange in the adipocyte are 
similar to the Ki's determined by the inhibition of D-allose exchange. This 
result does not exclude the possibility of multiple site models where sub­
strate and inhibitor can interact with the transporter. The allosteric 
pore model (Holman, 1980) for example predicts that the ratio of tracer 
permeabilities (V/K) through the low and high affinity components may be 
different for different tracers and the Ki's need not equal the equilibrium 
exchange Km's. If however the V/K ratios for the low and high affinity 
forms are approximately equal then only a single Km (or Ki) will be 
apparent (Holman et al., 1981).
Holman et al. (1981) reported evidence for negative cooperativity 
in hexose transport in the human erythrocyte. The results of Holman et al's 
experiments revealed non-linearity in plots of S/V vs S for D-glucose 
exchange in human erythrocytes. Similar non-linearities were also observed
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in the inhibition of tracer 3-0-methyl-D-glucose, D-fructose and D-xylose 
exchange in human erythrocytes. The results indicated the presence of two 
apparent affinity constants of 2mM and 26mM for D-glucose. There was less 
evidence for non-linearity in equilibrium exchange and inhibition experi­
ments in the adipocyte with the equilibrium exchange of 3-0-methyl-D-glucose 
and the inhibition of D-allose exchange by 3-0-methyl-D-glucose showed 
linear reciprocal plots over a wide range of 3-0-methyl-D-glucose concen­
trations. The significance of this result will be discussed further on 
P- 208.
Hydrogen bonding requirements for binding to the insulin stimulated hexose
transporter of adipocytes 
From the Ki values for inhibition of D-allose transport of the 
analogues tested it is possible to construct a model for sugar binding to 
the transporter (Fig.41 ).
The high affinity of 3~fluoro-D-glucose and the transport of
1-deoxy-D-glucose, which are both fused pyranose ring analogues of D-glucose, 
indicate that the transporter accepts the substrate in pyranose ring forms 
rather than in the open chain form. Studies on hexose molecules in solution 
using nuclear magnetic resonance techniques have indicated that the a 
and particularly the 3 forms of all common monosaccharides exist predom­
inantly in the conformation (Ferrier & Collins, 1972). Le Fevre (1961) 
has proposed that the selectivity of the transport system depends on the 
conformation of the hexose molecule, however since all the analogues used 
in the experiments described in this thesis will exist predominantly in the 
conformation selectivity based on the stability of different conform­









The scheme shows the proposed features of the active site at the 
external surface of the sugar transporter in adipocytes. The important 
hydrogen bonding sites are the ring oxygen, C-1, C-3 and to a lesser 
extent C-6. A close approach of the transporter to the sugar at C-1 and 
C-2, and to a lesser extent at C-3 and C-6 but not at C-4 is suggested. The 
perferred conformation is glucopyranose.
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to specific groups on the transporter rather than the relative stabil­
ities of hexose forms.
The important hydrogen bonding positions on the sugar molecule 
appear to be the ring oxygen, the C-1 hydroxyl, a gluco- configuration 
hydroxyl at C-3, and to a lesser extent a hydroxyl at C-6. The C-2
hydroxyl is unimportant and in the manno-configuration may cause steric
hindrance. The role of the C-4 hydroxyl in binding is not as clear as
for the other positions but may become important in the absence of a
hydroxyl at C-6.
In many respects therefore the hydrogen bonding requirements of 
the adipocyte hexose transport system closely resemble those of the human 
erythrocyte (Barnett et al., 1973a; ICiJklenberg & Dolansky, 1972), the 
blood brain barrier (Betz et al., 1975) and the sodium independent hexose 
transporter in the basal-lateral membranes of intestinal cells (Wright et al.,
1980). The adipocyte system differs from the erythrocyte system principally 
in the apparent lack of specificity at the C-4 and C-6 positions. There are 
also smaller differences between the affinities for D-glucose and D- 
galactose (and between analogues in the D-glucose series compared to the 
D-galactose series) in the rat adipocyte and the human erythrocyte. The 
loss of the C-6 hydrogen bond is also less important in the adipocyte when 
compared to the human erythrocyte system.
Interpretation of the results in terms of ascribing specific 
hydrogen bonding groups is nod straightforward, since binding may not be to 
a single site. Thus although hydrogen bonds are at some stage involved at 
the ring oxygen, C-1, C-3 and C-6 hydroxyls, these positions need not 
necessarily form hydrogen bonds to the transport system simultaneously.
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and sharing of hydrogen bonding groups as the sugar is translocated 
may occur. Also in solution hexoses will exist with the ring oxygen and 
hydroxyl groups hydrogen bonded to water molecules, and changes in the 
hydration shell of the molecule may affect the apparent affinity constants.
Spatial requirements for hexose binding to the insulin sensitive adipocyte
hexose transporter
The use of hexoses alkylated at the various hydroxyls has been 
used as a measure of the space available around the different hydroxyl 
groups when the hexose is bound to the transport system. In order to 
investigate the features of the outside site inhibitors were added with 
substrate to the external solution.
In these experiments the important spatial restrictions to 
binding were at C-1 and C-2, but not at C-4 and C-6. This implies a strict 
orientation of the sugar molecule in the outside active site with C-1 of 
the sugar facing inward. This result is very similar to that reported for 
the human erythrocyte by Barnett et al. (1973b, 1975), with very small 
differences, the adipocyte having a somewhat 'looser' fit at C-1 and C-3 
as compared to the erythrocyte since in the adipocyte a-methyl-D-glucoside 
and 3-0-propyl-D-glucose show more affinity as inhibitors than in the 
erythrocyte. This difference is however small when compared with the very 
clear difference in spatial requirements between C-1 and C-4 shown by both 
systems.
In order to study the inside requirements for binding to the 
transport system, it is necessary to prepare analogues which can enter the 
cell independently of the transport system. Alkyl substituted D-glucose analogues
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inhibit both the erythrocyte and adipocyte transport system but are not 
transported by it. The rate of uptake of alkyl sugars into adipocytes 
is dependent upon the size of the lipophilic substitution, thus methyl- 
g-D-glucose is taken up 27 times slower than n'-propyl-^-D-glucoside.
The rate of methyl-$-D-glucoside uptake probably represents the lowest 
limit for non-mediated uptake (Vinten, 1978). The uptake of alkyl sugars 
is through a route which is insulin-insensitive and not inhibited by 50mM 
D-glucose. The results show the uptake of 4,6-0-ethylidene-D-glucose to 
be very temperature-sensitive and to be slightly inhibited by phloretin. 
The effect of phloretin on membrane fluidity (Plagemann, 1981) may explain 
the apparent inhibition of 4,6-0-ethylidene-D-glucose entry by phloretin. 
These results suggest that alkyl sugars enter the adipocyte via a non­
mediated route.
The asymmetric inhibition of the 6-alkyl sugars and 4,6-0- 
ethylidene-D-glucose indicate that the inner and outer binding sites for 
hexoses on the transport system are arranged so that the orientation of 
the sugar molecule is conserved as it passes from one site to the other. 
Thus at both inner and outer sites C-1 faces the internal solution whilst 
C-4 faces the external solution. On the basis of this information it is 
possible to construct a model for the interactions of the hexose molecule 
with the transporter (Fig. 42 ).
The poor inhibition of 6-0-propyl-D-galactose is in contrast 
to the human erythrocyte, since in the erythrocyte system this analogue 
has a high affinity for the outside site (Barnett et al., 1973b, 1975). 
This, in conjunction with the weaker hydrogen bond to C-6, indicates that 
the adipocyte transport system has a slightly different structure to the 




The proposed structure of the transporter. (a) In the absence 
of substrate the system is closed. (b) Binding to the external site 
destabilises the interface between subunits. Sufficient space is avail­
able to accommodate a bulky group at C-4. (c) Binding to the internal
site opens the internal subunit interface. Sufficient space is available 
to accommodate a bulky group at C-1.
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The presence of hydrophobic regions immediately adjacent to 
both the inside and outside hexose binding sites of the adipocyte is 
suggested by the increased affinity of hexose analogues with hydrophobic 
substitutions at C-1 and C-4/C-6. Thus the Ki of C-1 alkylated D-glucose 
analogues decreases in the order n ’-propyl > n'-butyl > phenyl. Similarly 
6-0-pentyl-D-gàlactose is a much better inhibitor than 6-0-propyl-D-galactose^ A 
similar hydrophobic region was proposed to be present adjacent to the 
external site of the human erythrocyte hexose transport system by 
Barnett et al.,(1973b, 1975). Novak & Le Fevre (1974) also reported that 
sugars with large hydrophobic substitutions were good inhibitors of hexose 
transport in the erythrocyte although their results did not show the clear 
spatial differences reported by Barnett et al. (1973b, 1975). The results 
of Novak & Le Fevre may be due to hydrophobic binding through the alkyl 
groups rather than hydrogen bonding to the glucose moiety. A major problem 
with the use of highly substituted D-glucose analogues is the detergent-like 
properties of these molecules which reduces the potential uses of these 
compounds.
Other sugar analogues whihh have been tested for side specific 
properties in the human erythrocyte show poorer side specific properties 
and have a high Ki for transport indicating weak binding to the transporter.
1,2-isopropylidene-D-glucofuranose is not side specific (Baker et al.,
1978, Krupka & Deves, 1980). This is probably because this compound exists 
as a furanose ring whereas the site requires a pyranose ring (Kahlenberg & 
Dolansky, 1972; Barnett et al., 1973a). Methyl-2,3-di-O-methyl-a-D-glucos*^ 
(Baker et al., 1978; Widdas, 1980) is also a poor side specific analogue 
with a high Ki for the inhibition of hexose transport in the human erythro­
cyte.
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The presence of hydrophobic regions adjacent to the site may 
also account for the very high affinity of the competitive inhibitors 
phloretin (Jennings & Solomon, 1976) and cytochalasin B (Basketter &
Widdas, 1978; Vinten, 1978). Taylor & Gagneja (1975) put forward stereo­
chemical evidence for cytochalasin B having a spatial distribution of
4four oxygen atoms similar to those found in the conformation of D- 
glucose and proposed that these atoms may participate in the binding of 
cytochalasin B to the active site of the hexose transporter. Hydrogen 
bonding to these positions does not account for the very high affinity 
of cytochalasin B and' additional hydrophobic interactions around the active 
site may therefore be involved. The very low Ki of cytochalasin B in the 
adipocyte, reported to be 0.25yM by Vinten (1978) when compared to D-glucose 
Ki 8.62mM, suggests that a major proportion of the binding to the hexose
transporter may be via hydrophobic interactions. If this is the case the
value of cytochalasin B as a side specific analogue directed towards the
internal active site is reduced.
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Metabolite regulation of hexose transport
Regulation of metabolism via feedback inhibition of an early 
step in a metabolic pathway is a well-recognised phenomenon (Newsholme & 
Start, 1973). Since the transport of D-glucose into the cell represents 
the initial step in its metabolism regulation of D-glucose transport offers 
the potential for efficient control of metabolism. In adipocytes which 
are maximally stimulated with insulin the transport of D-glucose ceases to 
be the rate-limiting step in lipogenesis when the external D-glucose con­
centration exceeds 1 to 2mM (Gliemann, 1968, Czech, 1976). Hales & Randle 
(1963) reported that the blood glucose level in fed rats was 147mg/100ml 
(8.2mM) and that the serum insulin level was 130yU/ml (approximately 800pM). 
Whitesell & Gliemann (1979) reported that 3-0-methyl-D-glucose transport 
in the isolated rat adipocyte was maximally stimulated by 200pM insulin.
Thus in the post-absorbtive state hexose transport may not be the rate- 
limiting step for lipogenesis. Despite the large stimulation of the rate 
of hexose transport in the adipocyte it is therefore possible that insulin 
may offer only a coarse regulation of hexose metabolism through changes in 
the transport rate. If this is the case metabolite regulation of hexose 
transport may offer an important fine control of hexose metabolism.
The results presented in this thesis indicate that phosphorylated 
sugars may interact with the transporter in a different manner to non- 
phosphorylated sugars. There is a marked reduction in the inhibition of 
D-allose exchange when the phosphorylation of D-glucose and 2-deoxy-D- 
glucose is inhibited by cyanide poisoning, whereas the inhibition of D- 
allose exchange by 3-0-methyl-D-glucose is unaffected.
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Kono et al. (1977) reported that ATP depletion does not affect 
the transport of the non-phosphorylated D-glucose analogue 3-0-methyl-D- 
glucose in the adipocyte. Thus the effects of intracellular ATP depletion 
are linked to changes in the intracellular concentration of metabolites of 
the transported hexose and not to a generalised requirement of ATP for 
transport. This result also eliminates the possibility of a direct effect 
of cyanide on the hexose transport system. The largest effect of ATP 
depletion is on the inhibition of D-allose exchange by 2-deoxy-D-glucose.
In normal adipocytes this analogue is principally converted to 2-deoxy- 
D-glucose-6-phosphate with very small amounts of 6-phospho-2-deoxy-gluconate 
also being formed (Olefsky, 1978) . This result suggests that the effects 
observed are due to sugar-6-phosphates or 6-phosphogluconates, although 
effects due to other 2-deoxy-D-glucose metabolites which may be effective 
at very low concentrations cannot be ruled out.
The lack of inhibition of D-allose exchange by sugar phosphates 
added externally is not surprising, since these charged molecules would not 
be expected to penetrate the plasma membrane.
Foley et al. (1980a) have also reported anomalies in the transport 
of phosphorylated sugars in adipocytes. Foley et al. reported a three­
fold acceleration of tracer (a concentration very much lower than the Km) 
2-deoxy-D-glucose uptake following a 30 minute pre-exposure of insulin 
stimulated adipocytes to lOmM D-glucose or D-mannose. There was no 
accelerating effect with non-phosphorylated sugars or non-hexose meta­
bolites. The accelerating effect was reduced in basal adipocytes (1.5 fold 
increase) consistent with the reduced intracellular concentrations of 
glucose and its metabolites in the absence of insulin (Foley et al., 1980).
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The acceleration of tracer 2-deoxy-D-glucose uptake required a 5 minute 
pre-exposure to D-glucose and the threshold glucose concentration which 
gave, the effect was 2.5mM. These results were interpreted by Foley et al. 
as an acceleration of the transport of 2-deoxy-D-glucose through a change 
in the Vmax, and they suggested that these results were not due to changes 
in the rate of 2-deoxy-D-glucose phosphorylation since their methods 
measured the total 2-deoxy-D-glucose uptake in 2 seconds.
Foley & Gliemann (1981) have also reported that adipocytes can 
accumulate free intracellular 2-deoxy-D-glucose against its concentration 
gradient. They also reported that a high extracellular concentration of 
2-deoxy-D-glucose accelerates the efflux of 2-deoxy-D-glucose from 
adipocytes suggesting a rapid dephosphorylation reaction. From their 
results Foley & Gliemann (1981) proposed that the dephosphorylation of
2-deoxy-D-glucose-6-phosphate occurs in a cellular compartment where the 
newly-formed 2-deoxy-D-glucose cannot rapidly diffuse to the transport 
system.
From their results Foley et al. (1980a) proposed a model for 
hexose transport in the adipocyte in which two in-series rate-limiting 
barriers control the uptake of hexoses. Foley et al. proposed that one 
barrier is rate-limiting for 3-0-methyl-D-glucose transport whilst the 
other is partially rate-limiting for 2-deoxy-D-glucose in the absence of 
metabolites.
The results presented in this thesis show increased inhibition 
of D-allose exchange by phosphorylated sugars. These results do not 
reflect the rates of transport of these sugars and also do not differ­
entiate between an increased affinity of the transported sugar for the 
transport system in the presence of metabolites or the inhibiton of
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hexose transport by metabolites. Foley et al. (1980a) report only a 
slight accelerating effect when adipocytes are preincubated with 2-deoxy- 
D-glucose and on the basis of this result suggest that the metabolite 
responsible for regulation is not a sugar-6-phosphate. In contrast the 
results presented in this thesis indicate that of the phosphorylated 
sugars 2-deoxy-D-glucose is the most sensitive to the depletion of ATP.
Inhibition of hexose transport by sugar-6-phosphates or an 
allosteric interaction of sugar-6-phosphates with the hexose transport 
system may provide a possible explanation of the results of Foley et al. 
D-glucose will compete with 2-deoxy-D-glucose for hexokinase leading to a 
reduction in the size of the sugar-6-phosphate pool (since glucose-6- 
phosphate will be rapidly metabolised) which leads to an increased rate 
of hexose transport. 2-deoxy-D-glucose will not affect the size of the 
sugar-6-phosphate pool and will therefore have no effect. Direct com­
petition of sugar-6-phosphates for the inside site of the hexose trans­
porter is unlikely due to the spatial requirements of this site which make 
it unable to accept sugar molecules with a bulky group at C-6. Any 
regulation of hexose transport (either acceleration or inhibition) by a 
hexose metabolite would therefore be expected to occur through either a 
separate allosteric modifier site or through chemical modification of the 
transporter using a sugar metabolite as the substrate.
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Models for hexose transport
A number of mammalian sodium independent hexose transport 
systems have now been studied with respect to their substrate specificities. 
The results of experiments on the human erythrocyte (Barnett et al., 1973a. 
KaAlenberg & Dolansky, 1972), basal lateral membranes from the small 
intestine (Wright et al., 1980), the brain (Betz et al., 1975) and the rat 
adipocyte (the results presented in this thesis) show that the substrate 
specificity (and hence the hydrogen bonding requirements) are very similar 
in all these tissues. In other tissues where detailed analogue studies 
have not been performed the commonly used sugar analogues show an order of 
affinities similar to those observed in the characterised tissues, suggesting 
similar hydrogen bonding requirements. The spatial requirements for hexose 
transport in the human erythrocyte (Barnett et al., 1973b, 1975) and the 
rat adipocyte (the results presented in this thesis) are also very similar.
It therefore seems reasonable that all the mammalian sodium independent 
hexose transport systems share a common mechanism of action.
A similar situation is also found with the mammalian sodium 
dependent hexose transport systems of the intestinal and kidney brush border 
membranes. Both these systems are similar to one another but differ 
markedly from the sodium independent hexose transport systems (Silverman, 
1976).
Despite the similarity of substrate specificity, mammalian 
sodium independent hexose transport systems from different tissues differ 
with respect to the hormonal regulation of transport and the symmetry of 
the kinetic parameters describing transport. Thus hexose transport in the 
adipocyte is extremely sensitive to hormonal stimulation whereas in the 
erythrocyte there is little evidence for hormonal control of transport.
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Current views on the mechanism of hormonal stimulaton of hexose trans­
port favour the proposal of Wardzala et al. (1978) that hormonal
stimulation leads to an increased number of functional transporters 
within the membrane rather than a change in the transporter itself.
Thus hormonal regulation may be independent of the mechanism of hexose 
transport. The adipocyte and human erythrocyte hexose transport systems 
also differ in the symmetry of transport. In the human erythrocyte zero 
trans entry has a low Km and Vmax, zero trans exit has a high Km and Vmax, 
and equilibrium exchange also shows a high Km and Vmax. In contrast the 
rat adipocyte shows similar Km and Vmax values regardless of the experi-r 
mental protocol used. Thus hexose transport in the human erythrocyte is 
asymmetric whilst the rat adipocyte is symmetrical.
It has been suggested that the asymmetry of hexose transport in 
the human erythrocyte arises because uptake is limited by bulk association 
with haemoglobin within the cell (Holman & Naftalin, 1975, Baker & Naftalin, 
1979). Thus a symmetrical transport system will show apparent asymmetry. 
Challis et al. (1980) reported that the removal of 95% of the haemoglobin 
from human erythrocytes was without effect on the asymmetry of transport, 
suggesting that the association of hexoses with haemoglobin does not 
affect the transport parameters. Rabbit erythrocytes (Regen & Morgan,
1964) show symmetrical transport parameters further supporting the prop­
osal that the asymmetry of the human erythrocyte hexose transport system 
is a property of the transport system rather than an effect produced by 
the cell contents.
It is therefore reasonable to propose that a model for the 
transport of hexoses across mammalian cells should be able to encompass 
both symmetrical and asymmetrical transport systems without a major 
change in the mechanism. The kinetic models which have been proposed
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to account for the experimental observations can be divided into 
sequential and simultaneous models. According to sequential models a 
single substrate molecule can bind to a single substrate binding site 
which is sequentially available on either face of the membrane. In con­
trast simultaneous models allow substrate molecules to bind simultaneously 
to substrate binding sites on both faces of the membrane, to form a 
ternary complex.
Recently Krupka & Devés (1981) have proposed that D-glucose 
transport in the human erythrocyte occurs by a sequential process. In 
their experiments Krupka & Devés studied the inhibition of D-glucose exit 
by mixtures of phloretin and cytochalasin B. They interpreted their 
results as being consistent with a sequential model in which phloretin 
and cytochalasin B are unable to bind to the transporter simultaneously.
These experiments were however performed using a very high concentration 
of D-glucose (124mM) inside the cells which is well above the half saturation 
constant for the inside site. The inside site will therefore be saturated 
with D-glucose greatly reducing the inhibition by cytochalasin B (Basketter 
& Widdas, 197%). Basketter & Widdas (1978) reported that phloretin is not 
a good side specific analogue and suggested that phloretin may be able to 
bind to both sides of the membrane.
Sogin & Hinkle (1980) studied the binding of cytochalasin B to 
the human erythrocyte hexose transporter which had been reconstituted into 
liposomes and reported that cytochalasin B binding was reduced in the 
presence of D-glucose. They also reported that the side specific trans­
port inhibitors used by Barnett et al. (1973b; 1975), n'-propyl-g-D-gluco- 
side (inside site) and 6-0-propyl-D-glucose (outside site) also reduced the 
binding of cytochalasin B. This result suggests that the inner and outer 
sites are able to interact.
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Gorga & Lienhard (1981) have studied the kinetics of cytochalasin 
B binding to fragments of the human erythrocyte membrane. The membrane 
fragments were treated with sodium hydroxide and EDTA in order to remove 
a second high affinity cytochalasin B binding site which is not sensitive 
to D-glucose (Jung & Rampai, 1977). Gorga & Lienhard reported that cyto­
chalasin B binding was competitively inhibited by D-glucose, n'-propyl-g- 
D-glucoside and 4,6-0-ethylidene-D-glucose. They were unable to find any 
evidence for a stable ternary complex being formed between cytochalasin B 
and 4,6-0-ethylidene-D-glucose, n'-propyl-g-D-glucosèkor D-glucose.
Gorga & Lienhard concluded that although this result does not exclude models 
in which there is simultaneous occupancy of the transporter by two or more 
substrate molecules this observation does restrict the ternary complex to 
one of very low stability.
Studies on the D-glucose transport system of the human erythrocyte 
which was reconstituted into liposomes (Sogin & Hinkle, 1978, and Baldwin 
et al., 1979) have suggested that the stoichiometry of cytochalasin B binding 
is approximately 0.5 cytochalasin B binding sites per polypeptide chain.
More recent studies (Baldwin & Lienhard, 1981) using a different detergent 
preparation suggest that the stoichiometry of binding may be higher at 0.8 
binding sites per polypeptide chain and these authors have suggested that 
the ratio may be unity.
The transport activity of reconstituted preparations is however 
low with only 5% of the activity of the intact erythrocyte being expressed. 
Baldwin & Lienhard (1981) have suggested that this is due to a reduced 
turnover number and not dénaturation of the transport protein(s) during 
purification. The reason for the reduced turnover number is not clear 
but may be due to a poor reconstitution into liposomes (Baldwin & Lienhard,
1981).
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Jung et al. (1980) have studied the structure q f  the hexose transporter 
in the human erythrocyte plasma membrane by radiation inactivation analysis 
and have suggested that the functional transporter has a molecular weight 
of 200,000 daltons. In contrast gel electrophoresis shows the cytochalasin 
B binding protein isolated from human erythrocyte membranes to have a 
molecular weight of 46,000 daltons (Gorga et al., 1979). Thus the results 
reported so far suggest that the transporter may exist as a complex of 
subunits within the membrane.
The most widely used kinetic model for hexose transport is that 
of the carrier (Widdas, 1952) in which a hexose molecule can bind to a site 
which is sequentially available on either side of the membrane. In its 
simplest form the carrier model proposes equal half saturation constants 
for the binding of substrate on both internal and external faces of the 
membrane. If the rates of movement of the carrier across the membrane 
are equal when the carrier is loaded or unloaded then this model fits the 
observed symmetrical transport parameters of the rat adipocyte (Taylor &
Holman, 1981).
In order for the simple carrier model to show accelerated 
exchange transport as observed in the human erythrocyte it is necessary 
to postulate different rates of translocation for loaded and empty 
carriers. Lieb & Stein (1972) have shown that this model predicts that 
the Km for the infinite cis experiment should be greater than or equal to 
one half of the Km for equilibrium exchange. In the human erythrocyte the 
Km for the infinite cis procedure is at least an order of magnitude smaller 
than the Km for equilibrium exchange. This model also cannot account fcr 
the asymmetric Km and Vmax values observed for zero trans entry and exit 
in the human erythrocyte. Gorga & Lienhard (1981) have proposed that the
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asymmetry of hexose transport in the human erythrocyte may be due to the 
fact that D-glucose is a mixture of a and 3~D-glucose forms. Whilst this 
may in part explain the observations made in the human erythrocyte it is 
incompatible with the symmetrical transport parameters observed in the 
adipocyte which would have to show asymmetry of hexose transport in order 
to cancel out this effect.
Geek (1971) proposed an asymmetric carrier model with different 
half saturation constants for the inner and outer substrate binding sites 
in addition to differential mobilities of empty and loaded carriers. In 
the human erythrocyte the Km*s for infinite cis entry and infinite trans 
exit experiments are low (both experiments measure the Km for the inside 
site)(Hankin et al., 1972 and Baker & Naftalin, 1979) and therefore in­
consistent with the predictions of this model which predicts high Km values 
for these experiments (Lieb & Stein, 1972). The additional assumption of 
unstirred layer effects (Regen & Tarpley, 1974) requires large unstirred 
layers in order to produce significant effects (Lieb & Stein, 1972).
Under conditions where the active site is close to the surface of the 
membrane the unstirred layers would have to be impossibly large.
Unstirred layers may however be important if the active site is deeply 
embedded in the membrane or in a water-filled pore model such as that 
proposed by Foley et al. (1980a)(see p. 48 )•
The inhibition constants for the inhibition of hexose transport 
in the rat adipocyte by the side specific analogues described in this 
thesis are very similar to the inhibition constants reported for these 
analogues in the human erythrocyte. Baker et al. (1978) reported the 
Ki's for 4,6-0-ethylidene-D-glucose inhibition of 2mM 3-0-methyl-D-glucose 
exchange in the human erythrocyte at 16°C to be 14mM for the outside site 
and approximately 120mM for the inside site. In the adipocyte the Ki for
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4,6-0-ethylidene-D-glucose inhibition of 40yM 3-0-methyl-D-glucose exchange 
at 37°C is 6.4mM when the inhibitor is outside only and is unchanged when 
the inhibitor has equilibrated across the cell membrane. Barnett et al. 
(1975) reported a Ki of approximately 20mM for n'-propyl-g-D-glucoside 
inhibition of D-glucose exit in human erythrocytes at 18°C. In the 
adipocyte the Ki for n'-propyl-g-D-glucoside inhibition of AOyM 3-0-methyl- 
D-glucose exit is 8.88mM at 37°C. These results suggest that the affinities 
of these inhibitors for the inside and outside sites are similar in both 
symmetrical and asymmetrical systems. There is no evidence for the ten­
fold difference in the affinities of the inside and outside sites in the 
erythrocyte which would be expected on the basis of a model which predicts 
asymmetric affinities for the human erythrocyte and symmetrical affinities 
for the adipocyte.
Carrier models also lack a possible locus for the action of a 
glucose metabolite (Foley et al., 1980a). The difference in the apparent 
Vmax values for 2-deoxy-D-gIucose and 3-0-methyl-D-gIucose transport in the 
adipocyte reported by Foley et al . is also incompataible with a simple i .. 
carrier model.
Whilst carrier (sequential) models are consistent with the data 
of Gorga & Lienhard (1981) and account for much of the kinetic data for 
hexose transport in the adipocyte and the erythrocyte, anomalies between 
the predictions of these models and the experimental observations remain. 
These anomalies are sufficient to reject these models as they are presently 
postulated, and in view of this a number of simultaneous models have 
been proposed. These models allow for multiple occupancy of the trans­
porter by substrate.
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Pore models predict stable ternary complexes which are in­
compatible with the observations of Gorga & Lienhard (1981) since the 
two hexose binding sites are independent of one another. The polar creep 
model of Bowyer & Widdas (1956) has kinetic predictions which are similar 
to the asymmetric carrier and this model is subject to the same incon­
sistencies described previously. The pore model of Naftalin (1970) pre­
dicts symmetrical transport parameters and therefore cannot account for 
the observation of asymmetry in the human erythrocyte.
Ginsburg & Stein (1975) reported the presence of two operational 
affinities for D-glucose on the inside face of the human erythrocyte mem­
brane. They also suggested that the external site of the human erythrocyte 
membrane may also show two operational constants. The tetramer model of 
Lieb & Stein (1970) predicts the presence of two affinity constants on both 
faces of the membrane. There is less evidence for two affinities in the 
adipocyte since the infinite cis and zero trans Km's are similar (Taylor & 
Holman, 1981). The tetramer model is unable to account for the asymmetry 
of Vmax values for zero trans entry and zero trans exit experiments in the 
human erythrocyte. The tetramer model also predicts that a stable ternary 
complex would be formed between cytochalasin B and 4,6-0-ethylidene-D- 
glucose since there is no interaction between inward and outward facing 
sites. Le Fevre (1973) proposed the introverting hemiport model which is 
mechanistically similar to the lattice pore and tetramer models. This 
model accounts for the high Km for zero trans exit and equilibrium 
exchange, and for the low Km for infinite cis entry observed in the 
erythrocyte. However the introverting hemiport will show symmetrical 
rates of entry and exit, and does not account for the Vmax for zero trans 
entry being less than the Vmax for zero trans exit in the human erythrocyte. 
Giving this model symmetrical Km values to fit with the adipocyte
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data leads to the hemiports becoming symmetrical microcarriers. The 
interaction of sugar molecules with the microcarriers on each face of the 
membrane should however be independent of one another so that this model 
is also inconsistent with the results of Gorga & Lienhard .
A model similar to the introverting hemiport has been proposed
by Foley et al. (1980a) to account for hexose transport in adipocytes.
The observation of different apparent Vmax values for 2-deoxy-D-glucose 
and 3-0-methyl-D-glucose suggests two different barriers for hexose entry 
(Foley et al. 1980a). Foley et al. propose that the accumulation of meta­
bolites increases the Vmax of the rate limiting barrier for 2-deoxy-D-
glucose. The overall Vmax of transport through the pore will be governed
by the Vmax of the rate limiting microcarrier. Foley et al. (1980) point 
out that this model may have similar kinetics to the model of Regen & 
Tarpley (1974) of a carrier with an unstirred layer. A full kinetic 
analysis of the Foley et al. model has not been performed, although the 
unidirectional flux equation will be of a complex form containing 11 
independent parameters. Holman et al. (1981) hsve derived an equation 
describing the inhibition of tracer exchange for this model and this 
equation predicts that different tracers may give different Ki's. As 
described previously there is no evidence for different Ki's when differ­
ent tracers are used in the adipocyte (see p. 48 ).
A further development of two gate pore models is the allosteric 
pore (Holman, 1980) which accounts well for the asymmetry observed in human 
erythrocytes. Simulated results for hexose transport using this model are 
in close agreement with the observed results for the human erythrocyte 
hexose transport system. In particular this model accounts well for the 
low internal Km shown by infinite cis entry and infinite trans exit 
experiments (Holman, 1980). Further evidence for the involvement of
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allosteric effects has been presented by Holman et al. (1981) who have 
reported negative cooperativity in human erythrocyte hexose transport 
(see p.186 ). Their results suggest that there is a shift from a low 
Km transporter form to a high Km transporter form as the concentration 
of hexose is increased. The allosteric pore model can also explain the 
observation by Levine et al. (1971) that the Ki for D-glucose inhibition 
of sorbose flux in the erythrocyte is much less than that predicted from 
the D-glucose exchange Km. The resülts of Holman et al. (1981) show that 
this anomaly is due to the Ki measurements being made using a low concen­
tration of D-glucose whilst the exchange Km determinations are made using 
a high concentration of D-glucose. The experiments of Holman et al. (1981) 
used a range of D-glucose concentrations which revealed the low and high 
Km’s for both experiments.
Kinetic analysis of the allosteric pore model gives seven 
independent parameters determining the rate of flux through the pore 
(Holman, 1980). The asymmetry and cooperativity of the allosteric pore 
model are dependent upon subunit interface stability constants. As des­
cribed in the Introduction (see p. 52) the symmetry of transport is con­
trolled by the subunit interface stability constants K^^ and K^^
When Kgg = K^^ symmetrical transport parameters will result. The para­
meters Kgg and K^^ also control the magnitude of the cooperative effects 
observed. If these parameters are less than unity the model will show 
negative cooperativity and if these parameters are greater than unity then 
the model will show positive cooperativity. No cooperativity will be 
observed in reciprocal plots if the ^^K ratios for monovalently and 
divalently occupied pores are equal.
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Thus the allosteric pore can be readily adapted to account 
for the observations of hexose transport in the adipocyte. There is 
little evidence for cooperative effects in the equilibrium exchange of
3-0—methyl—D—glucose in the adipocyte over a wide range of substrate concen­
trations (40yM to 60raiM see p. 124). Since values of the ratios which 
are close to 1 give very small deviations from linearity in reciprocal . 
plots cooperative effects may be present in the adipocyte, but may be 
undetectable by the present methodology.
This model is also consistent with the similar Ki's for the 
side specific analogues in the human erythrocyte and rat adipocyte (see 
p.204). The asymmetry of the erythrocyte is due to different subunit 
interface stabilities when the pore is divalently occupied from outside 
or inside. Negative cooperativity in the binding of a side specific 
analogue may lead to a non-linearity in ^°/V vs I plots. This may 
however be a small effect not detectable over the concentration ranges 
used.
The allosteric pore provides an obvious mechanism for the 
regulation of hexose transport by metabolites in the adipocyte. The 
interaction of metabolites with one of the subunits or a regulatory 
subunit could lead to an alteration in the transport parameters through 
allosteric effects.
The adipocyte hexose transporter is relatively insensitive to 
inactivation by fluorodinitro benzene (FDNB)(Czech et al., 1978) when 
compared to the human erythrocyte (Bowyer & Widdas, 1958). The results 
of Holman et al. (1981) showed that the effects of FDNB were greater on 
the high Km component of hexose transport in human erythrocytes. This 
result was interpreted as an effect at the inner pore gate, which the
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allosteric pore predicts to have a lower interface stability constant 
and therefore to be more reactive towards FDNB. The allosteric pore 
model proposes that the inner pore gate of the adipocyte is more stable, 
leading to symmetrical transport parameters, and is therefore less 
reactive to FDNB.
A major objection to the allosteric pore model as presently 
described seems to be that the model requires a stable ternary complex 
between 4,6-0-ethylidene-D-glucose and cytochalasin B which is incon­
sistent with the observations, of Gorga &  Lienhard (1981). Gorga &
Lienhard have however interpreted their results using scheme (a).
(a) (b)
T — -■■■"*: TI T II Til11 It 11 I
TL "̂  ̂TLI T L ^ = ^  TLI
Where T is the transporter, L the ligand (cytochalasin B) and I the inhibitor
4,6-0-ethylidene-glucose. Scheme (a) takes no account of the possi­
bility of a stable ternary complex containing two 4,6-0-ethylidene-D- 
glucose molecules which competitively reduces the concentration of a 
stable 4,6-Q-ethylidene-D-glucose/cytochalasin B complex (Scheme b ) .
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Hexose transport in subcellular fractions of adipocytes
Martin & Carter (1970) reported that when plasma membranes 
were prepared from isolated adipocytes the D-glucose transport rate was
2-6 fold faster in plasma membranes prepared from insulin-stimulated 
cells when compared to plasma membranes prepared from basal cells. A 
similar five-fold increase in the rate of D-glucose transport was 
observed in the experiments with plasma membranes described in this 
thesis. This stimulation is considerably less than the stimulation of
3-0-methyl-D-glucose transport observed in intact adipocytes. The 
increased rate of transport in plasma membranes from insulin-treated 
cells is due to an increase in the Vmax for D-glucose transport 
(Ludvigsen & Jarett 1979, 1980). The Km for D-glucose transport was un­
changed by insulin. Ludvigsen & Jarett showed that the Km for D-glucose 
transport was 9mM if membranes were prepared immediately after isolation 
of the cells. If however the cells were preincubated for 15 minutes 
before fractionation the Km was 26mM in membranes from both basal and 
insulin-stimulated cells. In intact cells the kinetic parameters for 3-0- 
methyl-D-glucose transport remain constant for several hours after iso­
lation. In the experiments described in this thesis the Km for D-glucose 
transport in plasma membranes from insulin-treated cells was 15.6mM.
This is higher than the Ki for D-glucose inhibition of D-allose exchange 
in intact cells (8.62mM). Some of these differences may reflect the 
difficulty of maintaining cell viability in the large-scale adipocyte 
preparations required for the preparation of isolated plasma membranes. 
Alternatively these effects may reflect the loss of a regulatory influence 
such as the effects of metabolites (see p. 195).
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Studies on the microsomal fractions prepared from adipocytes 
have suggested the presence of facilitated diffusion systems for D-glucose 
(Suzuki & Kono, 1980, and Cushman & Wardzala, 1980). The results pre­
sented in this thesis show that D-glucose uptake into this fraction occurs 
rapidly via a non-specific route. This rapid non-specific process may well 
obscure a specific facilitated diffusion process for the transport of D- 
glucose into the vesicles. Carter et al. (1972) reported that the 
’leakiness’ of plasma membrane preparations could be reduced by brief soni- 
cation or exposure to hypotonic conditions. In the experiments described 
in this thesis sonication of the microsomal fraction was not carried out 
in order to maintain the orientation of the membranes.
Carter et al. reported that prior to sonication large amounts of 
the plasma membrane were present as sheets whereas after sonication the 
membrane was almost entirely vesicularised. Electron micrographs of the 
microsomal membranes (see p.11^ indicate that the microsomal fraction con­
tains many small closed vesicles consistent with the observation that D- 
glucose is taken up and trapped in a structure which is retained by the 
filter. It is interesting to note that phloretin apparently traps 
hexoses in the microsomal fraction during the 15 to 20 seconds required 
for the filtration. The use of reagents which alter the properties of 
the lipid bilayer (such as phloretin or anaesthetics) may provide a 
means of reducing the non-specific uptake of hexoses and allow further 
investigations of the transport of hexoses in the microsomal fraction.
If hexose transport can be established the side specific analogues des­
cribed in this thesis may allow a determination of the orientation of the 
transporter within the microsomal membranes.
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The possibility thzt the microsomal hexose transporter exists 
in an inactive form has been suggested by the results of Karnielli et al. 
(1981). Their results show that the insulin mediated transfer of 
cytochalasin B binding sites from the microsomal fraction to the plasma 
membrane occurs slightly earlier than the increase in 3-0-methyl-D-glucose 
transport. Thus there is the possibility that the transporter is in some 
way inactivated or the active site is masked by an extrinsic protein when 
it is in the interior of the cell. Any form of masking would however have 
to be displaced by cytochalasin B or removed by detergent extraction in 
order to account for the results of Cushman & Wardzala (1980) and Suzuki 
& Kono (1980).
The substrate specificity of hexose transport in insulin-stimulated and basal
adipocytes
The study of the substrate specificities of the hexose trans­
porter in both basal and insulin-stimulated adipocytes presented in this 
thesis indicates that there is no significant change in either the hydrogen 
bonding or spatial requirements of the adipocyte hexose transport system 
on stimulation with insulin. This observation is consistent with the hypo­
thesis of an increased number of sites of identical specificity in the 
plasma membrane as proposed by Wardzala et al. (1978). Changes in the 
transporter that would lead to a reduced turnover number might be expected 
to modify the spatial requirements for the transporter.
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The effect of purines on the regulation of hexose transport
in adipocytes
It has been suggested that adenosine and its nucleotides play 
an important role in the regulation of adipocyte metabolism (Dole, 1961 
and Fain et al., 1972). The results of the experiments presented in this 
thesis show a very small effect of adenosine on basal cells with the maxi­
mal stimulation of 3-0-methyl-D-glucose transport occurring with lOyM 
adenosine. This effect (14.3% stimulation) is however considerably smaller 
than the 50% increase in the glucose oxidation rate observed by Taylor & 
Halperin (1976) with a similar concentration of adenosine. Experiments 
with exogenous adenosine deaminase and the adenosine transport inhibitor 
NBMI indicated that there is no effect of endogenous adenosine released 
by adipocyte preparations (Schwabe et al., 1973). The small effects of 
adenosine are difficult to study due to the instability of basal hexose 
transport in adipocytes. Other stimuli, especially mechanical agitation 
which are difficult to control reproducibly lead to large changes in the 
rate of hexose transport : which obscure the small effect of adenosine.
In adipocytes maximally stimulated with insulin there was no 
effect of adenosine on the transport of 3-0-methyl-D-glucose. Adenosine 
did however appear to reduce the rate of hexose transport in adipocytes 
which had been stimulated with a sub-maximal dose of insulin. As des­
cribed previously,maintaining sub-maximal effects is difficult, due to 
the rapid degradation of insulin, so this result should be interpreted 
with caution. The results of Taylor & Halperin (1976) showed a 200% 
increase in the rate of D-glucose oxidation when adenosine was added to 
cells maximally stimulated with insulin. This suggests that the effects 
of adenosine on insulin-stimulated cells may be on the enzymes of glucose
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metabolism rather than an additional stimulation of the rate of hexose 
transport.
Of the purine and pyrimidine nucleosides tested inosine
was found to give a small stimulation of hexose transport in 
basal adipocytes. Kypson & Hait (1976) reported that uridine and inosine 
were able to activate lipolysis in adipose tissue and increase the uptake 
of D-glucose by heart and skeletal muscle (Kypson & Hait, 1978). Kypson 
& Hait (1976) proposed that the effects of uridine were due to an increase 
in the glycogen content of the cells with no effect on the hexose transport 
rate, whereas inosine increased D-glucose uptake without affecting the 
glycogen content.
The stimulation of basal hexose transport by inosine is small 
when compared to the effects of insulin and it is therefore unlikely that 
inosine plays an important role in the action of insulin. The mechanism 
of inosine action is not clear. Malbon et al. (1978) have studied the 
binding of adenosine and adenosine analogues to the adipocyte plasma mem­
brane and have reported two classes of adenosine binding sites unrelated 
to the adenosine transporter or adenosine deaminase. Malbon et al. found 
inosine to be a poor inhibitor of adenosine binding and it is therefore 
unlikely that the effects of inosine are mediated through purinergic 
receptors.
The only nucleotide to have any effect on the transport of 3-0- 
methyl-D-glucose was adenosine triphosphate, which inhibited hexose trans­
port in insulin-treated cells. There was no effect of ATP in basal cells. 
Chang et al. (1974) reported similar results with adipocytes. Exo­
genous ATP has been shown to phosphorylate membrane proteins (Chang et al., 
1974) but this phosphorylation was independent of insulin. Chang et al.
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have suggested that these phosphorylations are not involved in the action 
of insulin but are involved in long-term regulation of hexose transport.
Possible second messengers for insulin action
A number of possible second messengers for insulin have been 
proposed (see Czech, 1977).
The regulation of hexose transport by cyclic nucleotides
The role of cyclic nucleotides as second messengers for the 
regulation of glycogen metabolism by catecholamine hormones is a well- 
established phenomenon. A number of reports have suggested that cyclic 
nucleotides are second messengers for the intracellular actions of insulin, 
and that they may also be involved in the regulation of hexose transport.
In the experiments described in this thesis a range of cyclic 
nucleotides and cyclic nucleotide derivatives were added exogenously to 
suspensions of adipocytes. No significant effects of cyclic nucleotides 
were observed, even over prolonged periods of up to two hours. Most of 
the reports describing the effects of cyclic nucleotides on hexose trans­
port are based on experiments where the metabolism of D-glucose was studied 
and the results were interpreted as changes in the rate of glucose trans­
port. These indirect experiments cannot differentiate between changes in 
the rate of transport of hexoses through the plasma membrane or changes 
in a rate limiting step in the metabolism of D-glucose.
Schiramel & Goodman (1971) reported that dibutyryl cyclic AMP 
increased the D-xyl&se space in whole adipose tissue and interpreted this 
result as an increase in the rate of hexose transport. The results pre­
sented in this thesis indicate that D-xylose is slowly metabolised by 
adipocytes. The long incubations (30 minutes) used by Schimnel & Goodman
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would therefore have allowed metabolism of the radiolabelled D-xylose 
to occur. Thus the use of D-xylose does not give a true measure of the 
transport râte when long incubation times are used.
Correze et al. (1979) reported that low concentrations of di­
butyryl cyclic AMP (0.1-0.5mM) stimulated the rate of 2-deoxy-D-glucose 
uptake in normal (basal) rat adipocytes. At higher concentrations of 
dibutyryl cyclic AMP (5-lOmM) the uptake of 2-deoxy-D-glucose was inhibited 
In their experiments Correze et al. used relatively long times for the 
uptake of 2-deoxy-D-glucose and report a small increase (40%) in the 
transport rate in response to a maximal dose of insulin. Foley et al. 
(1980b) have suggested that transport ceases to be the rate limiting step 
for 2-deoxy-D-glucose uptake after a few minutes and thereafter uptake is 
limited by the rate of phosphorylation. Thus the effects of dibutyryl 
cyclic AMP on 2-deoxy-D-glucose uptake reported by Correze et al. may 
reflect changes in the metabolic state of the adipocyte rather than changes 
in the rate of transport.
Insulin has been demonstrated to lower intracellular cyclic AMP 
levels by both inhibiting adenyl cyclase (Hepp & Renner, 1972) and by 
activating cyclic nucleotide phosphodiesterase (Kono et al.. 1976). In 
the experiments described in this thesis no inhibitory or potentiating 
effects of cyclic AMP or dibutyryl cyclic AMP were observed in insulin- 
stimulated cells. This result suggests that insulin mediated changes in 




Cyclic GMP has also been proposed as an intracellular second 
messenger for insulin action by Illiano et al. (1973) who reported
a four-fold increase in intracellular cyclic GMP levels in the presence 
of insulin. The results presented in this thesis show no effect of cyclic 
GMP or 8-bromo cyclic GMP on the rate of 3-0-methyl-D-glucose transport 
in basal or insulin-stimulated adipocytes. Pinkett & Perlman (1975) 
reported that exogenous 8-bromo-cyclic GMP stimulated the uptake of 2-deoxy- 
D-glucose in the rat diaphragm, although there was no effect of cyclic GMP 
or dibutyryl cyclic GMP. These experiments are subject to the criticisms 
described earlier regarding the use of D-xylose (see p.216 ) and 2-deoxy- 
D-glucose (see p.217) as a means of measuring hexose transport. It seems 
unlikely therefore that cyclic GMP is involved in mediating the action of 
insulin on the hexose transport system.
Another approach to elevating cyclic nucleotide levels inside 
the cell is the use of cyclic nucleotide phosphodiesterase inhibitors. The 
use of these compounds to study the effects of cyclic nucleotides on 
hexose transport is however complicated since these compounds may inhibit 
hexose transport. Theophylline and 3-isobutyl-l-methy1-xanthine have been 
shown to inhibit hexose transport in the human erythrocyte by Challis et al.
(1980). The inhibitory effect of xanthine on 3-0-methyl-D-glucose trans­
port in insulin-stimulated adipocytes may be related to the inhibition of 
hexose transport by methyl xanthines. If this is the case the stimulatory 
effect of xanthine on basal adipocytes may be underestimated, but will still 
be a small stimulation relative to that produced by insulin.
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Overall the study of the effects of cyclic nucleotides presented 
in this thesis show that no major effects of these compounds occur when 
they are added exogenously to adipocytes. This suggests that cyclic nucleo­
tides are not involved in the regulation of hexose transport by insulin.
Membrane ADP ribosylation
Malbon & Gill (1979) reported that cholera toxin stimulated the 
ADP-ribosylation of the adipocyte plasma membrane and le4 to an activation 
of lipolysis. Malbon & Gill showed that a number of membrane proteins were 
ADP-ribosylated including the regulatory subunit of adenyl cyclase. The 
results presented in this thesis show no effects of either substrates or 
inhibitors of ADP ribosylation on the rate of hexose transport or its stim­
ulation by insulin in the adipocyte. NAD is the substrate for the enzyme 
responsible for ADP ribosylation (NAD-glycohydrolase). The lack of effect 
of NAD is unexpected since it is unlikely that this compound can penetrate 
the plasma membrane. Fain et al. (1972) have reported increases in the 
rate of lipolysis on the addition of NAD to adipocytes, and proposed that 
this occurred through the adenosine moiety. Thus the lack of effect of 
NAD on 3-0-methyl-D-glucose transport is consistent with the results dis­
cussed earlier which showed only slight stimulation of the hexose transport 
rate with purines.
Nicotinamides affect the synthesis of NAD (Clark et al., 1971) 
and therefore deplete the intracellular pool of NAD. In addition nico­
tinamides also inhibit NAD-glycohydrolase activity and would therefore 
markedly reduce ADP ribosylation (Purnell & Whish, 1980). A more specific 
inhibitor of ADP-ribosylation, 3-amino-benzamide, has been shown to enter 
cells and lead to changes in ADP-ribosylation in vivo.(Purnell, 1981).
The lack of effect of these compounds on either basal or insulin-stimulated
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adipocytes suggests that ADP ribosylation of membrane proteins is not 
involved in the regulation of hexose transport by insulin.
Anion transport
Beigelman & Hollander (1962) first demonstrated the ability of 
insulin to hyperpolarise the plasma membrane of adipocytes. In order to 
investigate the possible role of anion transport in the action of insulin 
the anion transport inhibitor SITS (Knauf & Rothstein, 1971) was added to 
adipocytes. There was no significant effect of SITS on basal or insulin- 
stimulated cells at a concentration which effectively blocks anion transport 
in erythrocytes (Knauf & Rothstein, 1971). This result does not rule out 
the possibility that cation gradients may be involved in the regulation of 
hexose transport (Clausen, 1975).
There is at present little evidence for the involvement of second 
messengers in the stimulation of hexose transport by insulin. The results 
presented in this thesis provide some further circumstantial evidence for 
the proposals of Cushman & Wardzala (1980) and Suzuki & Kono (1980) that 
insulin mediates its action through the recruitment of additional trans­
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